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Chapter 1
Histology of the mature gastro-intestinal tract
The gastro-intestinal tract is organized in four distinct layers, which are 
consistent from mouth to anus. Surrounding the gastro-intestinal lumen is the 
mucosa, followed by the submucosa, tunica muscularis and serosa. The inner 
layer of any epithelial-lined hollow organ (e.g., mouth, gut, trachea, lung, etc) is 
called the mucosa, which itself consists of the epithelium, lamina propria and the 
muscularis mucosa, which forms the boundary between mucosa and submucosa. 
The submucosa is a connective tissue layer supporting the mucosa and allows 
flexibility during peristalsis. It contains a vascular plexus, which gives rise to the 
capillary bed of the mucosa and also a delicate nerve network, called Meissner’s 
plexus. The tunica muscularis consists of an inner circular layer and an outer 
longitudinal layer. Between the two muscle layers lies the Auerbach’s plexus. 
Coordinated contraction of these layers is responsible for rhythmic peristalsis. 
The adventitia or the serosa is the outermost layer of the gastrointestinal tract 
and has a supportive function. 
The mucosa is the most characteristic layer of the gastrointestinal 
wall. Tissue specialization and surface shape are correlated with functional 
differentiation along the tract. Each region contains certain cell types which are 
adapted to carry out the characteristic functions of secretion and absorption.  
The stomach is responsible for the formation and processing of the 
ingested food into a thick acidic fluid known as chyme. Anatomically four regions 
can be distinguished in the stomach: cardia, fundus, corpus and pylorus (Fig. 
1). The cardia is a narrow region at the gastroesophageal junction. While the 
fundus is frequently filled with gas, it is the corpus that is mainly involved in 
the formation of the chyme. The pylorus separates the stomach and its acidic 
environment from the small intestine. Histologically, the fundus and corpus of 
the stomach are identical and consist of simple columnar epithelium with glands. 
The gastric mucosa is organized into numerous mucosal invaginations called 
gastric units, in which the stem cells and the various differentiated progeny are 
localized. The gastric units comprise the pit, which are formed by invaginations 
of the epithelial layer into the mucosa and the flask-shaped gland, which can 
be further subdivided into isthmus, neck, and base regions (Fig. 1). The four 
major functional cell types present are the mucus producing neck cells, the acid 
and intrinsic factor producing parietal (oxyntic) cells, the chief (zymogenic) cells, 
which secrete pepsin, and several types of endocrine cells secreting hormones 
such as gastrin and somatostatin1-2 (Fig.1).
The small intestine digests and absorbs nutrients, which are the end 
products of the digestive process. The small intestine can be subdivided in three 
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Zymogenic or Chief cells:    Secretion of digestive enzymes 
Parietal neck cells:              Production of gastric acid 
Mucous neck cells:             Secretion of mucus 
Mucous foveolar cells:       Secretion of mucus 
Fundus 
Cardia 
segments, the duodenum, jejunum and ileum. The duodenum receives enzymes 
from the pancreas and bile from the liver, and contains Brunner’s glands, which 
produce bicarbonate-rich fluid to neutralize the acidic contents from the stomach. 
The mucosa of the small intestine is specialized for absorption of nutrients and 
consists of a layer of simple columnar epithelium. To increase the intestinal 
absorptive area, the mucosa is formed into fingerlike structures, the villi. In 
between, at the base of the villi, the intestinal crypts of Lieberkühn reside.
Lastly, the large intestine comprises of the caecum, colon, rectum and 
anus and its function is to absorb water, electrolytes and gasses from the chyme, 
and subsequently to compact the residues into feces for eventual excretion. Villi 
are excluded from the large intestine, but instead the crypts of Lieberkuhn are 
richly present
The intestinal tract is characterized by four main intestinal cell lineages, 
which are classified into absorptive and secretory groups. The first group is 
represented by columnar cells, which are called enterocytes and colonocytes 
in the small and large intestine respectively, and are the most abundant cells 
present3-4. To increase the absorptive area, these cells harbor an apically located 
Figure 1: Schematic representation of the stomach and its main cell types.
Typical anatomy and histology of a mammalian stomach. There are a number of variations in 
mammalian gastric anatomy, however the most prominent regions in most mammals are the corpus 
and a distal antrum or pylorus. The gastric epithelium is organized into repeating gastric units that are 
invaginations from the surface and contain 4 main gastric cell types. The chief cells (red), the acid 
producing parietal cells (blue) and the mucous producing neck (green) and foveolar (purple) cells. 
Figure adapted from Mills et al, 20112.
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brush border. The secretory group is represented by the goblet cells, entero-
endocrine cells and the Paneth cells. The goblet cells produce and secrete 
mucins onto the intestinal surface, in order to lubricate and protect the mucosa4-5. 
The entero-endocrine cells produce peptide hormones, such as cholecystokinin, 
secretin and gastric inhibitory peptide4, 6. Lastly, the Paneth cells, which contain 
large secretory granules and express a number of proteins with antibacterial 
actions, such as lysozyme4, 7. Besides ensuring a sterile crypt environment, these 
cells have an important role in regulating the stem cell compartment in the crypts 
of Lieberkühn8-9 (Fig.2).
 
Intestinal stem cells and the epithelial renewal process
The intestinal epithelium is a rapidly self-renewing tissue. The turnover 
time of the murine small intestinal epithelium is approximately 5 days. The epithelial 
renewal process takes place along the so called crypt-villus axis. This renewal 
process involves proliferation of multipotent progenitor cells or stem cells, which 
reside at the base of the crypts. Stem cells divide and give rise to other stem 
cells with self renewal capacity, and to a highly proliferative population of transit 
amplifying daughter cells. Transit amplifying cells are proliferative uncommitted 
progenitors, which undergo rapid cell division for 4-5 rounds10. Proliferation 
ceases in the upper third of the crypt .Transit amplifying cells then move out of 
the crypt compartment and subsequently differentiate into the four main cell types 
of the intestinal tract. The enterocytes, goblet and entero-endocrine cells form the 
epithelial lining of the villus and move up the villus, where they die after reaching 
the tip after 2-3 days. The Paneth cells on the other hand are the only terminally 
differentiated cell type, which reside within the crypt stem cell zone of only the 
small intestine, where they live for 6-8 weeks. 
The primary driving force behind the proliferation of epithelial cells 
in the intestinal crypts is the Wnt/β-catenin signalling pathway, which is highly 
conserved throughout the animal kingdom (Fig.3)11-13. The central player in the 
canonical Wnt pathway is β-catenin. In the absence of a Wnt signal, β-catenin 
is targeted for proteasomal degradation through phosphorylations at N-terminal 
Serine residues. The degradation complex consists of the tumor suppressors 
axin and adenomatous polyposis coli (APC) and the kinases glycogen synthase 
kinase 3β and casein kinase I. When Wnt ligands signal through their Frizzled and 
low-density lipoprotein receptor–related protein (LRP) receptors, the destruction 
complex is inactivated, leading to accumulation of β-catenin because it is no 
longer targeted for degradation. Accumulated β-catenin can be transported into 
the nucleus and binds to transcription factors of the T cell factor/lymphocyte 
13
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Figure 2: Schematic representation of the intestinal epithelium and its main cell 
types. 
The intestinal epithelium has a highly structured organization. To increase the intestinal absorptive 
area, the mucosa is formed into fingerlike structures, called the villi. At the base of the villi the 
intestinal crypts of Lieberkuhn reside (A). The intestinal epithelial process takes place along the so-
called crypt-villus axis. This process involves proliferation of multipotent stem cells (red), which reside 
at the base of the crypts, with subsequent migration and differentiation of the transit amplifying (TA) 
cells (pink) along the villi. The four main cell types which are formed are the enterocytes (blue), the 
enteroendocrine cells (purple), the Paneth cells (dark green) and the mucus producing goblet cells 
(light green)(B). Figure adapted from Crosnier et al, 20068.
Figure 3: Timeline of human and mouse intestinal development.
Schematic representation of the blastocyst stage at E4.0 in mice or the first week post coitum in 
human, which is followed by the process of gastrulation resulting in the  formation the endodermal 
layer at E7.5 in mice and second week post coitum in human. At E9.5 in mice / third week in human 
the regionalization of the primitive gut takes place and the foregut, midgut and hindgut can be 
discriminated. From E14.5 (week 11 human) onwards cytodifferentiation and villus formation in the 
intestinal tract takes place.
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Chapter 1
enhancer factor (TCF/LEF) family, thereby forming an active transcriptional 
complex that activates target genes. A large variety of β-catenin target genes, 
have been described since the discovery that this pathway represents the 
dominant force behind the proliferative activity of the healthy intestinal epithelium. 
Whereas the involvement of the canonical Wnt/β-catenin signalling 
pathway in intestinal homeostasis is well described, the role of the non-canonical 
Wnt pathway is far less understood. Non-canonical Wnt signalling is described 
as the signalling routes that act independent of b-catenin. The most extensively 
studied non-canonical ligand Wnt5a gained attention over the last years, as it has 
been implicated in various human diseases including cancer, inflammatory bowel 
diseases and metabolic disorders14-16. 
Development of the gastro-intestinal tract
The gastro-intestinal tract develops through a complex mechanism of 
patterning, expansion and differentiation of the primitive gut. Early in vertebrate 
embryogenesis, gastrulation results in the three germ layers, the ectoderm, 
endoderm and mesoderm17-19. At the end of gastrulation, the morphologically 
homogeneous endoderm has already anterior (top) and posterior (bottom) 
characteristics, mainly by the expression of specific anterior or posterior 
markers20-21. Immediately after gastrulation, the endoderm is not yet committed 
to specific organ domains18. When explanted mouse E7.5 anterior endoderm 
is placed in contact with posterior mesoderm, posterior endodermal genes can 
be activated and vice versa. During development these anterior and posterior 
domains become more regionalized and by E9.5 in mice the foregut, midgut and 
hindgut regions can be discriminated. The foregut eventually gives rise to the 
esophagus, stomach and proximal part of the duodenum; the midgut develops 
into the caudal part of the duodenum, jejunum, ileum, caecum and proximal part 
of the colon; and the hindgut forms the caudal part of the colon and rectum. 
Before the placental connections are established, during development 
of the embryo, the omphalomesenteric duct (also referred to as vitelline duct) 
connects the midgut to the yolk sac. Normally, the omphalomesenteric duct 
involutes completely between the fifth to ninth week of human gestation (E9.5-E10 
of mouse development). However, if this resorption does not occur properly, the 
complete omphalomesenteric duct, or a part of it, may persist, which leads to 
various congenital anomalies of the intestine, such as Meckel’s diverticulum, 
which accounts for the most prevalent congenital disorder of the gastro-intestinal 
tract and occurs approximately in 2% of the population. 
15
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 1In mice, from E9.5-E13.5 the gut tube increases in length and the 
circumference increases due to the expansion of the lumen, epithelium and 
mesenchyme. At E11.5 the stomach epithelium is pseudo-stratified with little 
difference between presumptive forestomach and glandular stomach. This 
differentiation of the epithelium is first noted on E12.5. The epithelium of the 
forestomach begins to stratify on E13.5 and keratinisation is first noted on E16.5. 
In the glandular stomach the epithelium begins to stratify on E12.5 and primitive 
glands are formed on E16.522.
As the gut tube grows, the epithelium of the prospective small and large 
intestine reorganizes around E14.5 from a pseudostratified epithelium, to a 
columnar form23. At the same time point in development the emergence of villi in 
the small intestine and the process of cytodifferentiation into the characteristic cell 
types found in the various regions, takes place. Although the precise mechanisms 
that initiate and control epithelial reorganisation and villus morphogenesis is still 
not fully understood, it has been shown that interaction between the gut epithelium 
and mesenchyme provides both instructive and permissive cues to allow normal 
intestinal development24. The intestinal development completes postnatally, 
when the definitive crypts of Lieberkühn are formed. The crypts emerge from the 
intervillus epithelium. The development of the gastro-intestinal tract described 
here with embryonic time points for the mouse, is basically identical in all 
mammals although with different timelines (Fig.4). 
 The role of Sox2 and Cdx2 in the development of the primitive gut 
endoderm
Various signalling families, including BMP25-29, Hedgehog30-31, FGF32 and 
Notch33 , have been implicated to play a role in gut development. However, until 
now very little is known about one of the most basic facets of organogenesis, 
i.e. the dynamics of the expression of key transcription factors, which are the 
ultimate targets of signalling pathways. Transcription factors are proteins 
that play a key role in this regulation, as they act as molecular switches that 
determine fundamental decisions regarding proliferation, differentiation or cell 
fate of distinct cell populations34. It has now abundantly been demonstrated that 
sets of transcription factors from various families act in concert to control cell 
fate decisions and differentiation into each lineage. These factors include basic-
helix-loop-helix, POU domain, Runt domain, forkhead, HMG-box domain and 
homeodomain proteins. In this thesis the focus will lie on two specific members of 
the two latter super families of transcription factors, Sox2 and Cdx2 respectively. 
16
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Figure 4; schematic representation of the canonical wnt/β-catenin signaling 
pathway.
In the absence of Wnt ligand, a “destruction complex” phosphorylates the free cytoplasmic pool of 
β-catenin which then undergoes proteasomal degradation. When Wnt ligands engage the frizzled 
receptors, formation of the “destruction complex” is inhibited, leading to accumulation of free β-catenin 
in the nucleus where it serves as a coactivator for the Tcf/Lef family of transcription factors13. 
Figure 5: Sox2 and Cdx2 expression in the developing gut endoderm.
Schematic representation of the developing gut endoderm, from which the expression domains of 
Sox2 and Cdx2 become clear. Sox2 (green) starts to express at the anterior end of the endoderm, 
whereas Cdx2 starts at the posterior end. These domains will expand towards each other. From 
E9.25 the boundaries between the presumptive stomach and intestine are established and these 
domains will not overlap. Within the mature gastro-intestinal tract, Sox2 is expressed in the stomach 
and esophagus, whereas expression of Cdx2 is restricted to the intestinal epithelium. Figure adapted 
from Sherwood et al, 200935.
Ricci-Vitiani L et al. Gut 2008;57:538-548 Copyright © BMJ Publishing Group Ltd & British Society of Gastroenterology. All rights 
reserved 
Cdx2 
Sox2 
Sox2 + Cdx2 
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 1One of the earliest steps in patterning of the primitive gut is the 
regionalization into an anterior and posterior domain, which correlates with the 
expression of Sox2 and Cdx2 respectively35.  In mice, expression of Sox2 and 
Cdx2 can be detected at E7.75 in the most anterior and posterior endodermal 
cells35. Between E8.0 and E8.5 the expression domains of Sox2 and Cdx2 move 
towards each other, and eventually at E9.5 a reciprocal expression pattern is 
seen for both transcription factors (Fig.5)35. Later in development Cdx2 becomes 
restricted to the intestinal epithelium, with a sharp boundary, marking the 
transition from stomach to duodenum, while Sox2 is expressed in the stomach 
and esophagus35-38. Although Sox2 and Cdx2 are reciprocally expressed, it 
remains unclear whether Sox2 or Cdx2 has a dominant role in determining the 
fate of the developing gut endoderm.
Sox genes are widespread throughout the animal kingdom and at present 
up to 20 Sox genes have been characterized in mouse and human39-40. They play 
an important role in different aspects of embryonic development and are also 
found to be expressed in a number of adult tissues41-42. Proteins are grouped into 
this family if they contain an HMG domain with strong similarity (>50% of amino 
acids) to the HMG domain of SRY, which is also known as SRY-box43. This box 
gave the Sox family its name: SRY related HMG box. The HMG- box domain is a 
79 amino acid protein motif, through which proteins interact with DNA44. Although 
they share common DNA binding properties, the specificity of individual Sox 
proteins is the result of their expression pattern and their ability to associate with 
different partners41, 45-46. Sox2 plays an important role during various phases of 
vertebrate embryogenesis and is also expressed in a number of adult tissues. In 
mice, expression of Sox2 starts from the 4-8 cell stage of embryo development and 
is initially expressed in the inner cell mass (ICM) and extraembryonic ectoderm 
of blastocysts47. Sox2 is essential in both the establishment and the maintenance 
of pluripotent stem cells, which is supported by data showing that Sox2 null 
mutant mouse embryos die before gastrulation as a result of failure of epiblast 
development after implantation, and by the observation that deletion of Sox2 in 
embryonic stem cells results in inappropriate differentiation into trophoectoderm-
like cells48. Furthermore, forced expression of Sox2, in combination with Oct4, 
c-Myc and Klf4 endows somatic cells with pluripotency, giving rise to induced 
pluripotent stem (iPS) cells49-50. Recent studies have also established Sox2 as a 
wide spread marker of pluripotent and adult stem/progenitor cell types49-51.  
At later phases of normal embryogenesis, Sox2 expression is essential 
for the formation of several endodermal and ectodermal tissues, including lens 
epithelium52, sensory cells of the taste bud53, the nervous system54-56, the inner 
18
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ear57, and the retina58-59. In addition, it is essential in the formation of the foregut, 
from which the esophagus, stomach and duodenum originates60-63.  Modulating 
expression in mice showed the importance of Sox2 in the differentiation of 
the esophagus and stomach. Reduced Sox2 levels in mouse embryo models 
are associated with esophageal atresia and other developmental esophageal 
abnormalities including the presence of luminal mucus-producing cells, and 
ectopic expression of genes normally expressed in the glandular stomach63. 
Furthermore, in human, several congenital malformations, for instance 
anophthalmia, microphthalmia and the AEG (anophthalmia-esophageal-genital) 
syndrome64, have been associated with heterozygote mutations in SOX2, 
confirming the importance of Sox2 in development and differentiation processes.
 A second family of transcription factors which can be discriminated is 
the family of homeobox domain proteins. Homeobox genes are characterized 
by a 60 amino acid homeodomain65. Within this superfamily many subgroups 
can be distinguished, one of which is the group of Cdx (Caudal-type homeobox) 
genes. In mice and human there are three Cdx genes known, Cdx1, Cdx2, and 
Cdx4. These Cdx members play an essential role in the anterior-posterior (A-
P) patterning in both vertebrate and invertebrate embryos38, 66-71. In mice, Cdx2 
is expressed very early during embryogenesis, and is already observed at 
E3.5 in the trophoectoderm. Underscoring the importance of Cdx2 for normal 
development, homozygous Cdx2 -/- embryos fail to implant properly, resulting 
from a block in differentiation of the trophoblast72. At E8.5, expression shifts 
towards the posterior gut, neural tube and tail bud. At E12.5, the expression of 
Cdx2 is restricted to the primitive gut endoderm and in the mature digestive tract 
Cdx2 is exclusively expressed within the intestinal epithelium20, 37, 72-73. Cdx2 is 
an essential transcription factor for establishing intestinal cell fate. This was first 
shown in heterozygous Cdx2 knock-out mice, which developed polyps consisting 
of normally organized stomach mucosa in the paracaecal region of the intestine 
74. Importantly, Sox2 was ectopically expressed in the overlying endoderm75. It 
was suggested that local sporadic haploinsufficiency of Cdx2 caused an anterior 
homeotic shift in which undifferentiated intestinal endoderm defaulted to a gastric 
phenotype. Chimaeric studies using Cdx2-/- cells in wild-type hosts confirmed 
these observations and also studies done by Cdx2 ablation specifically in the 
embryonic endoderm showed an activation of the foregut transcriptional program, 
causing a forestomach phenotype76-77.  In all cases, ectopic expression of Sox2 
was noted. Table 1 shows an overview of the experiments described above and 
their results.
19
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 1Experimental approach Results
Sox2
Sox2 null mutant mice Failure of epiblast development after implantation. 
Deletion of Sox2 in ES cells Inappropriate differentiation into trophoectoderm-like 
cells.
Reduced levels of Sox2 in mouse 
foregut
Development of esophageal abnormalities (atresia, 
ectopic expression of genes normally expressed in the 
glandular stomach and  presence of luminal mucous 
producing cells)
Forced expression of Sox2 in 
somatic mouse cells
Induction of pluripotent stem cells, in combination with 
forced expression of Oct4, c-Myc and Klf4
Cdx2
Cdx2 null mutant mice Block in differentiation of the trophoblast.
Heterozygote Cdx2 knock-out mice Development of polyps in the paracaecal region, 
consisting of stomach mucosa. 
Chimaeric studies with Cdx2 null 
cells in wild type host mice
Undifferentiated intestinal endoderm defaults to gastric 
phenotype. 
Cdx2 ablation in embryonic mouse 
endoderm
Ectopic activation of the foregut program in the 
presumptive intestine
Table 1: Overview of experiments altering Sox2 and Cdx2 expression in mice 
Homeostasis of the mature intestinal tract and human colorectal cancer
Recently, a number of studies have reported ectopic expression of Sox2 
in a number of cancer types including lung, esophagus and breast cancer78-79. 
In these tumor types, aberrant Sox2 expression was associated with worse 
prognosis, attributed to the induction of a precursor-like state induced by Sox2. 
As such, the ectopic SOX2 expression previously observed in CRCs may likewise 
affect tumor progression80. 
Worldwide over 1,200,000 people are annually diagnosed with CRC, 
resulting in approximately 600,000 deaths every year. As such, CRC is the most 
frequent malignancy, and is the second most common cause of cancer-related 
mortality. CRC has been classified in different subtypes according to criteria 
such as their mutational status and histological appearance. Mucinous colorectal 
carcinoma is defined as a tumor with more than 50% mucinous differentiation 
on histologic examination, according to the WHO. The incidence of mucinous 
carcinoma among colorectal cancer patients is between 10-25%81-82.  Most evidence 
suggests that mucinous CRC portend a worse clinical prognosis. The reason for 
the worse prognosis in mucinous CRC is not clear. Aberrant expression of SOX2 
in a subset of CRCs with mucinous differentiation was reported previously80. Given 
the important role of SOX2 in determining cell fate the ectopic SOX2 expression 
20
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observed in mucinous tumors represented an attractive candidate to investigate 
in further detail. As aberrant expression of SOX2 has been linked to the induction 
of a precursor-like state in other tumor types, the ectopic SOX2 expression 
observed in CRCs may likewise affect tumor progression. 
Scope of this thesis
In order to take up nutrients from food and liquid, which is needed for 
the growth and maintenance of the body, a highly specialized digestive tract 
is warranted. The organs of the digestive tract together have a function in the 
ingestion, digestion and absorption of nutrients as well as the elimination of 
indigestible components of the food.  Both normal and abnormal development of 
these organs takes place under the control of various transcriptional regulators, 
such as Sox2, which plays an important role in stomach and esophageal 
development. Once formed, organ identity is strongly maintained and rarely 
converted into another tissue type. However, ectopic gastro-intestinal tissue 
arises outside its organ boundaries, in various situations including Barrett’s 
esophagus in which the normal squamous esophageal epithelium is replaced by 
specialized mucosal epithelium, intestinal metaplasia of the stomach and gastric 
heteroplasia in the developing intestinal tract. The mechanisms underlying the 
formation of this ectopic tissue are not fully understood. 
The overall aims of the research described in this thesis, are to investigate 
in more detail the role of Sox2 in establishing and maintaining organ identity. 
Furthermore, we examined the connection of ectopic Sox2 expression with 
various human diseases of the intestinal tract, such as colorectal cancer and 
various congenital anomalies. 
In chapter 2 we tested the Villin-rtTA inducer mouse line, by crossing 
it with a mouse line that expresses the histone H2B- green fluorescent protein 
(H2B-GFP) controlled by a tetracycline responsive regulatory element (TRE). 
We show that by administering different concentrations of doxycycline, the 
Villin-rtTA2-M2 system drives transgene expression in a dosage-dependent 
fashion specifically in the intestinal epithelium. Thus, we have generated a novel 
doxycycline-inducible mouse model, providing a valuable tool to study the effect 
of different gene dosages on intestinal physiology and pathology.
First, we used the mouse line described in Chapter 2 to specifically 
induce Sox2 expression in the presumptive intestinal tract during development. 
The results of this study are described in Chapter 3 of this thesis. The findings 
provide strong evidence that expression of Sox2 in the developing gut drives 
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 1the activation of the foregut transcriptional program and leads to conversion 
from an intestinal into a premature gastric-like epithelium, despite simultaneous 
expression of Cdx2. 
Next, we investigated the effect of ectopic expression of Sox2 in the 
mature intestinal tract using the same mouse model, of which the results are 
described in chapter 4. We found that ectopic expression severely alters the 
morphology of the villi and consequently alters intestinal homeostasis. However, 
in contrast to the developing gut, ectopic expression of Sox2 does not result in 
a conversion of intestinal cells into more gastric-like cells, indicating a loss of 
plasticity of the mature intestinal cells. 
As shown in mice, a strict balance between the transcription factors Sox2 
and Cdx2 is of great importance for normal intestinal development (Chapter 3) 
and imbalances in expression of either factor results in developmental defects 
in mice. However, in human little is known about the expression patterns of 
SOX2 and CDX2 in gut development. Therefore we examined the expression 
pattern of both transcription factors in intestinal duplications and vitelline duct 
anomalies, including Meckel’s diverticulum, which are congenital anomalies of 
the intestine, in which ectopic gastric tissue can be present. We compared cases 
with gastric heteroplasia, with cases consisting solely of intestinal tissue. The 
results described in chapter 5, show that also in human gut development a strict 
balance between SOX2 and CDX2 appears necessary for proper development. 
In chapter 6, we investigated whether we can detect aberrant SOX2 
expression in colorectal cancer, and whether this can be correlated with specific 
tumor characteristics and prognosis. We did not observe a correlation with 
mucinous differentiation as was previously suggested. In addition, our data may 
point to a weak association with Sox2 expression and worse prognosis. 
The overwhelming majority of CRC cases are initiated by activating 
mutations in the Wnt/β-catenin signaling pathway. Whereas the involvement of 
the canonical Wnt/β-catenin signalling pathway in intestinal homeostasis is well 
described, the role of the non-canonical Wnt pathway is far less understood. In 
chapter 7, we investigated the role of Wnt5a induction during different time frames 
of embryonic gut development and the mature intestinal tract. Our results indicate 
a role for Wnt5a during a restricted time-frame of embryonic development, but 
suggest no impact during homeostatic postnatal stages.
Lastly in the general discussion (chapter 8), we discuss our findings and 
indicate their clinical relevance. 
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Abstract
In order to develop a sensitive and inducible system to study intestinal 
biology, we generated a transgenic mouse model expressing the reverse 
tetracycline transactivator rtTA2-M2 under control of the 12.4 kb murine Villin 
promoter. The newly generated Villin-rtTA2-M2 mice were then bred with the 
previously developed tetO-HIST1H2BJ/GFP model to assess inducibility and 
tissue-specificity. Expression of the histone H2B-GFP fusion protein was observed 
exclusively upon doxycycline induction and was uniformly distributed throughout 
the intestinal epithelium. The Villin-rtTA2-M2 was also found to drive transgene 
expression in the developing mouse intestine. Furthermore, we could detect 
transgene expression in the proximal tubules of the kidney and in a population 
of alleged gastric progenitor cells. By administering different concentrations of 
doxycycline, we show that the Villin-rtTA2-M2 system drives transgene expression 
in a dosage-dependent fashion. Thus, we have generated a novel doxycycline-
inducible mouse model, providing a valuable tool to study the effect of different 
gene dosages on intestinal physiology and pathology.
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Introduction
The intestinal epithelium consists of distinct crypt-villus units, which 
undergo renewal through a tightly regulated sequence of proliferation, 
differentiation, migration and cell death. Distinct gene expression levels are 
necessary to maintain tissue homeostasis. Alterations of these levels will lead 
to disruption of the equilibrium between proliferation and cell death, and loss of 
tissue architecture 1.  
Many genes have been implicated in intestinal development and 
carcinogenesis. The temporal and spatial control over expression of specific 
genes at distinct dosage levels represents a powerful approach to evaluate 
their role during development as well as in tumor initiation and progression 
to malignancy. To address these questions, a model system is needed where 
tight regulation of intestine-specific gene expression at different dosages and at 
various time-points during development and adulthood is feasible. 
Different promoters have been described which are able to drive 
intestine-specific expression. While activity of the Fabpl596 promoter is restricted 
to the small intestine and cecum, its derivative Fabpl4x promoter has been 
shown to drive expression in more distal intestinal segments including ileum, 
cecum and colon. Both promoters reveal patchy transgene expression patterns 
2-3. More recently, the Villin promoter has become the promoter of choice for 
intestine-specific gene expression. Using a 9 kb promoter fragment, Pinto et 
al. demonstrated transgene expression throughout the cephalocaudal axis of 
the gut 4. Both this promoter construct and a 12.4 kb variant thereof have been 
used successfully to generate various transgenic models for intestinal specific 
expression 5-8 The Villin promoter is also active in the putative stem cells of the 
intestinal epithelium, as demonstrated by long-term labeling of crypt-villus units 
using a tamoxifen-dependent and Villin-driven Cre recombinase 8.
Inducible transgenic mouse models represent unique experimental tools 
to study transgene expression in a tightly regulated fashion. Ideally, such an 
inducible mouse model should drive homogeneous transgene expression in the 
tissue of interest exclusively upon induction and in a dosage-dependent manner. 
Furthermore, induction of gene expression should be reversible 9. Such a model 
is currently not available for the intestinal tract. Therefore, we set out to generate 
a mouse model allowing robust induction of intestine-specific gene expression.
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Materials and methods
Transgenic mice
The Villin-rtTA2-M2 construct was generated as follows. The rtTA2-M2 
sequence was PCR-amplified from the pUHrT62-1 vector 10 (gift from W. Hillen, 
Erlangen) using the forward primer 
5’-ATTCTCGAGGCCGCCACCATGTCTAGACTG-3’ and the reverse 
primer 5’-TAGATCGATTATCCTGGGAGCATGTCAAGG-3’. The PCR product 
was inserted into the vector containing the 12.4 kb Villin promoter 5 (a gift from 
D. Gumucio, Michigan) by digesting PCR product and vector using restriction 
enzymes XhoI and ClaI, and ligating both fragments. The final vector was sequence 
verified using the sequencing primers 5’-CTTTTCGGCCTGGAACTAATC-3’ and 
5’-CTGTCCAGCATCTCGATTG-3’. The 14.7 kb expression cassette was cut out 
of the plasmid backbone by PmeI digest, gel-purified and prepared for injection 
into fertilized FVB/N oocytes.  Founders were identified by PCR amplification of 
tail DNA using transgene specific primers (5’-CAAGACTTTCTGCGGAACAAC-3’ 
and 5’- GTGTCTCTCTTTCCTCTTTTG-3’). 
Transgenic Villin-rtTA2-M2 animals were bred with tetO-HIST1H2BJ/
GFP (H2BGFP) animals 11 (kindly provided by E. Fuchs, New York). Transgene 
expression was induced in compound heterozygous animals and their littermates 
by replacing normal drinking water with 5% sucrose water containing 2 mg/ml 
doxycycline (Sigma, D9891). Dox-treated water was changed every 2 days. After 
7 days of doxycycline treatment, mice were sacrificed and tissues were analysed 
for H2B-GFP-expression. 
Transgenic Villin-rtTA2-M2 animals were also bred with tetO-myc-Sox2 
transgenic mice 12. Doxycycline was administered to dams from gestational 
age 10.5 onwards in the drinking water (2 mg/ml doxycycline, 5% sucrose) and 
embryos were analysed at day 18.5. 
Cryosectioning 
The intestinal tract was removed, cut open and washed in PBS. Next, 
sections of ~10 cm were spread out flat on paper and fixed in 4% PFA for 60 
min and washed in PBS for 30 min. Swiss-rolls were placed in KP-CryoBlock 
(Klinipath, Duiven, NL) and frozen on dry ice. The left kidney was dissected, 
washed in PBS and frozen on dry ice using KP-CryoBlock. Five μm sections were 
31
Generation of a doxycycline-inducible mouse model to study intestinal biology
C
ha
pt
er
 2
cut and placed on SuperFrost Plus slides. The sections were stained with DAPI 
and analysed by fluorescence microscopy. 
Immunohistochemistry
Dissected tissues were fixed in 4% PFA overnight, processed and 
embedded in paraffin. Immunohistochemistry for GFP and Myc-tag was done 
using citrate antigen retrieval followed by overnight incubation in 5% non-fat 
dry milk/PBS with, respectively, 2.5 μg/ml rabbit anti-GFP antibody (Molecular 
Probes) and 12.5 μg/ml anti-C-myc clone 9E10 (Roche). The Rabbit ChemMateTM 
EnVisionTM kit (DakoCytomation) was employed as a secondary antibody, 
according to manufacturer’s instructions. 
FACS analysis
Duodenum, jejunum, ileum and colon were dissected, cut-open, washed 
in PBS and chopped into small pieces using a razor blade. Tissue pieces were 
left at 37˚C in digest medium (RPMI + p/s, 10%FCS, 5 ng/ml EGF, 0.03 ng/ml 
Hydrocortisone, 1x Insulin/Transferrin, 4 mg/ml Collagenase, 0.1 mg/ml Dispase, 
50 μg/ml DNAse) for 2.5h until 90% were single cells. The cell suspension was 
passed through a 40μm cell strainer, washed by doubling the volume using 2% 
FCS/PBS, and spun down for 8 min at 1200 rpm at 4˚C. To exclude non-epithelial 
cells from analysis, 1x106 cells were stained 30min in 100μl of lineage staining 
solution consisting of 2% FCS/PBS, 5 μg/ml Biotin anti-mouse CD31, 2.5 μg/
ml Biotin anti-mouse CD45 and 5 μg/ml Biotin anti-mouse TER-119 (all BD 
Pharmingen) at 4˚C. After a washing step, staining with the secondary antibody 
(0.2 μg/ml Strepavidin-PerCP-Cy5.5; BD Pharmingen) was performed in the 
dark at 4˚C. Cells were then washed and re-suspended in 0.2 μg/ml Hoechst in 
2%FCS/PBS in order to facilitate discrimination of live from dead cells. Fluorescent 
activated cell sorting analysis was performed on samples from each part of the 
intestine separately using a BD FACSAria. 
Western Blotting
Intestinal tissue specimens (~2 mm) were snap-frozen in liquid nitrogen 
and subsequently lysed in 200 μl Laemmli sample buffer for 30 minutes using 
a thermoshaker set at 1000 rpm and 75°C. Twenty μl of each sample was 
loaded on a 10% SDS-PAGE gel. Western blotting was performed according 
to standard procedures. Immunoreactive bands were detected using 4 μg/ml 
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rabbit polyclonal anti-GFP primary antibody (Molecular Probes) in 5% non-fat 
dry milk/PBS, followed by HRP-conjugated goat anti-rabbit antibody (Jackson 
ImmunoResearch Laboratories), and ECL-based chemiluminescence. As loading 
control, tubulin expression was assessed using 0.1 ug/ml rabbit polyclonal anti-
tubulin (Abcam).
Fluorescence in situ hybridisation (FISH)
Femur bone marrow cultures were treated with 100 ng/ml colcemid 
(GIBCO-BRL, KaryoMAX Colcemid solution) for 15 min to arrest cells at 
metaphase, and subsequently treated with 75 mM KCl, and fixed with methanol/
acetic acid (3:1). FISH was carried out to determine the chromosomal site of 
transgene integration, basically as previously described 13. As a specific probe 
a Biotin-16-dUTP-labeled Villin-rtTA construct was used. Slides were embedded 
in DABCO/Vectashield containing 4′,6-diamidino-2-phenylindole (DAPI) as 
counterstain. Initial determination of chromosomal location of the wild-type and 
the transgene integration signal was established by inverted DAPI band analysis. 
To confirm the specific localization of the integration site, we performed dual-
colour FISH using a Digoxigenin-11-dUTP-labeled probe specific for the telomeric 
region of mouse chromosome 2 (P1 clone 5309 14). Fluorescence signals were 
visualized with a Leica DM 6000B fluorescence microscope (Leica, Rijswijk, The 
Netherlands) using Mac Probe Software (version 4.3, Applied Imaging, Newcastle 
upon tyne, United Kingdom).  
Southern blot analysis of transgene copy number
Transgene copy number for the Villin-rtTA2-M2 line was determined from 
the intensity of fragments obtained after hybridizing HincII digested liver DNA with 
a 225 bp probe prepared by PCR amplification of a region within intron 1 of the 
endogenous Vil1 gene using specific primers: 5’-GAGGGAGGGGTATGTTTTAAG-
3’and 5’-GTGGACGAGCCTAGAGGAG-3’. The probe was designed so that no 
repetitive sequences were present using repeatmasker software (http://www.
repeatmasker.org/). This probe recognizes a 6.5 kb endogenous Vil1 band and a 
3.1 kb transgenic band. PhosphorImager analysis was performed using Image-
Quant software (Molecular Dynamics, Sunnyvale, CA).
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Results and discussion
Transgenic Villin-rtTA2-M2 founder lines were generated with a construct 
consisting of 12.4 kb murine Villin promoter sequence in front of the reverse 
tetracycline transactivator rtTA2-M2, previously described as an improved 
rtTA variant (‘Tet-On’) with strongly reduced background activity and a 10-fold 
increased sensitivity for doxycycline-driven induction 10. Southern blot analysis 
identified two transgenic founders. Functionality of the transgene was tested 
by breeding the transgenic animals with tetO-HIST1H2BJ/GFP mice. These 
mice express histone H2B-green fluorescent protein (H2B-GFP) controlled by a 
tetracycline-responsive regulatory element 11. Compound transgenic animals and 
wild type littermates were given drinking water supplemented with 5% sucrose, 
either with or without 2 mg/ml doxycycline. Induction of H2B-GFP gene expression 
was analyzed by fluorescence microscopy and immunohistochemistry. One 
transgenic line was identified that showed homogeneous and high H2B-GFP 
expression levels throughout the entire length of the intestinal tract, from the 
pyloric area to the distal colon and rectum (Fig. 1).
The H2B-GFP fusion protein was expressed in all epithelial cells of the 
small and large intestine, with slightly reduced expression levels in small intestinal 
crypts and the lower half of the colonic crypts (Fig. 1e,f,g,j,k). In agreement with 
previous reports 4-5, a very limited number of crypt-villus structures did not show 
H2B-GFP induction. No nuclear background fluorescence could be observed in 
the epithelial cells of all control animals, i.e. induced and un-induced wild type 
or single transgenic littermates, whereas a low level of auto-fluorescence was 
present in the cytoplasm, only detectable with long exposure times (Fig. 1a,c,h). 
Closer examination of the un-induced double-transgenic animals occasionally 
revealed a small number of positive epithelial nuclei barely detectable above 
background levels (data not shown). This very low level of leakiness in un-
induced animals was not detectable by FACS (see below) or by western analysis 
for the H2B-GFP protein, whereas a strong induction of transgene expression 
was observed in the doxycycline-treated animals (Fig. 2).
Notably, transgene expression was also observed in two additional 
organs outside the intestinal tract, namely kidney and stomach (Fig. 3).
In line with what has been reported for the 9 kb Villin promoter 8,  the 12.4 
kb variant employed for the generation of the Villin-rtTA2-M2 transgenic model 
revealed expression in the proximal tubules of the kidney (Fig. 3c). The same 
was found to be true for a limited number of stomach cells located in the antrum, 
at or below the isthmus of the glands (Fig. 3d). Their position along the crypt axis 
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Figure 1. “Tet On” regulated expression of the H2B-GFP fusion protein in the adult 
mouse intestine.
Immunofluorescence (a, c, e, h, j; original magnification 100x) and immunohistochemistry (b, d, f, 
g, i, k) analysis for H2B-GFP expression. Intestines from doxycycline-induced wild-type mice (a, b) 
have a similar GFP-background as un-induced Villin-rtTA;H2B-GFP littermates (c, d). After 7 days 
of doxycycline treatment, double transgenic mice show strong expression of nuclear H2B-GFP 
throughout the epithelial cells of the intestine (e,f,g,j,k). Expression reaches higher levels in the small 
intestinal villi than in the crypts (e, f, g).   
Figure 1 
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Figure 2. Induction of H2B-GFP expression after 
doxycycline treatment.
Western Blot analysis revealed no detectable levels of 
transgene expression in induced wild type animals and 
un-induced compound transgenic littermates. Doxycycline 
treatment of double transgenic animals resulted in high 
expression levels of H2B-GFP fusion protein throughout 
the intestinal tract. “TUB” is tubulin used as loading control; 
“GFP” is the doxycycline-induced H2B-GFP protein.
Figure 3. Transgene expression in kidney proximal tubules and stomach progenitor 
cells. 
a,b: Kidney and stomach of un-induced double transgenic animals do not show detectable levels of 
H2B-GFP. c: In the kidney of doxycycline-induced double transgenic animals, nuclear GFP staining 
(brown) is clearly observed in the proximal tubules as identified by PAS staining of the brush border 
(pink). d: Using fluorescence analysis (original magnification 250x), doxycycline-induced H2B-GFP 
was detected in a small population of cells of the stomach.    
Figure 2 
Figure 3 
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is reminiscent of the gastric progenitor cells with multi-lineage potential recently 
reported to express a b-galactosidase reporter cassette driven by the same 
Villin 12.4 kb promoter employed here 15. Hence, the Villin-rtTA2-M2 model fully 
recapitulates the expression pattern previously reported for other Villin transgenic 
models.
The Villin promoter has previously been shown to be expressed already 
from early phases of mouse embryonic development 8 16. From 6.5 dpc onwards, 
the Villin promoter is active in the extra-embryonic visceral endoderm and from 
9.5 dpc a clear activity has been shown in the hindgut. In the developing intestine, 
expression could be observed from 10.5 dpc onwards 8 16. Furthermore, parts of 
the urogenital tissue and the developing auditory system show Villin promoter 
activity during embryonic development 16. In order to demonstrate the utility of the 
Villin-rtTA2-M2 model for developmental studies, we bred transgenic animals with 
TetO-Myc-Sox2 mice 12 and analyzed the resulting embryos upon doxycycline 
induction. Administration of doxycycline to pregnant females from gestational age 
10.5 days onwards in the drinking water resulted in intestine-specific expression 
of Myc-Sox2 in the embryos (Fig. 4). 
This shows that the Villin-rtTA2-M2 mouse model is also able to drive 
transgene expression in the mouse embryo and can be used to study the effect 
of induced gene expression during development. 
Dual-color FISH (fluorescent in situ hybridization) analysis of metaphase 
chromosome spreads was performed with chromosome-specific probes to 
determine the chromosomal integration site of the Villin-rtTA2-M2 transgene 
13. As shown in Figure 5a, use of a chromosome 2 specific telomeric probe revealed 
Figure 4. Transgene expression in the developing intestine. 
Cross section through embryonal intestine at 18 dpc after 8 days of doxycycline induction. 
Immunostaining with an antibody against the myc epitope present within the Sox2 transgene reveals 
strong positive nuclear staining in intestinal epithelial cells (b). In wild type or single transgenic 
littermates only background staining is observed, mainly in the cytoplasm (a). 
Figure 4 
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that the Villin transgene has a single integration site at chromosomal position 
2A5. An additional, though considerably weaker signal was observed for the 
endogenous Vil1 gene on chromosome 1. The strong intensity of the transgenic 
signal indicates that multiple copies are likely to be integrated. Accordingly, 
Southern analysis revealed that approximately 35 copies of the transgene are 
present (Fig. 5b).
The inducible Villin-rtTA2-M2 system allows the titration of levels of 
transgene expression. Therewith it is possible to investigate the impact of gene 
dosages on differentiation processes in the intestine. To this aim, double transgenic 
Villin-rtTA2-M2/H2B-GFP mice were administered different doxycycline dosages 
(between 2 ng/ml and 2 mg/ml) via their drinking water for 7 days before being 
sacrificed. Frozen sections of these mice were analyzed and revealed that not 
only the expression level of H2B-GFP fusion protein but also that the relative 
number of crypt-villus units actively expressing the transgene decreased with 
lower doxycycline dosages. The overall pattern became patchier, clearly visible at 
a doxycycline concentration of 4 μg/ml (data not shown). H2B-GFP expression of 
duodenum, jejunum, ileum and colon of these animals were assessed separately 
using flow cytometry. To that aim, mouse intestinal specimens were digested 
and dissociated into single cell suspensions. Moreover, single cell gating was 
Figure 5. Assessment of transgene integration site and copy number. 
a: FISH analysis indicates that the Villin-rtTA2-M2 transgene integration maps on chromosome 2. The 
probe for the Villin-rtTA2-M2 transgene is labelled in green; the telomeric probe for chromosome 2 is 
labelled in red. b: Southern blot analysis of HincII digested DNA from a Villin-rtTA2-M2 transgenic and 
wild-type animal. The endogenous Villin band (6.5 kb) was used as a reference in PhosphorImager 
analysis to estimate the number of transgenic integrations to approximately 35. 
Figure 5 
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applied to exclude doublets. Voltages of the FACS were also adjusted so that 
the background levels are around 102 relative units. Background GFP (FITC) 
levels of epithelial cells from un-induced Villin-rtTA2-M2/H2B-GFP mice are 
indistinguishable from those derived from wild type controls (Fig. 6). In contrast, 
among intestinal cells from doxycycline-induced compound transgenic mice, high 
GFP levels were observed, compatible with up to an approximately 1000-fold 
induction. Stepwise reduction of doxycycline dosages led to a similar reduction of 
the average signal intensity per cell (Fig. 6).
Thus, treating transgenic animals with lower dosages of doxycycline 
can help to circumvent potential toxicity associated with the over-expression of 
certain transgenes. 
In conclusion, we have generated an inducible mouse model that upon 
doxycycline administration shows homogeneous transgene expression throughout 
Figure 6. The inducible Villin-rtTA2-M2 system allows titration of levels of transgene 
expression. 
Transgenic Villin-rtTA2-M2/H2B-GFP mice were administered different dosages of doxycycline 
between 2 ng/ml and 2 mg/ml in the drinking water for 7 days. Intestinal tissue specimens of duodenum, 
jejunum, ileum and colon were then analyzed by flow cytometry. Background GFP (FITC) levels of 
intestinal cells from un-induced Villin-rtTA2-M2/H2B-GFP double transgenic mice are indistinguishable 
from wild type controls. In contrast, we detected doxycycline-dosage dependent levels of GFP with 
a maximum induction of approximately 1000-fold in intestinal cells from doxycycline-induced double-
transgenic mice. 
Figure 6 
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the intestinal tract. Notably, expression levels can be tightly regulated without 
any significant leakiness. Therewith, this mouse model offers new opportunities 
for studying the impact of distinct gene dosages on intestinal homeostasis in 
the adult as well as during development of the mouse intestine, and will be a 
valuable tool for studying intestinal biology and pathology in vivo. This mouse 
model can furthermore be used for the identification of putative intestinal stem 
cells using a chase for several weeks after a pulse of doxycycline-induced H2B-
GFP expression. These experiments have been performed and have resulted in 
the identification of a low number of H2B-GFP-label retaining cells at the bottom 
of the crypt (Roth et al., manuscript in preparation).
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Abstract
various factors play an essential role in patterning the digestive tract. 
During development, Sox2 and Cdx2 are exclusively expressed in the anterior 
and posterior part of the primitive gut, respectively. However, it is unclear if these 
transcription factors influence each other in determining specification of the naïve 
gut endoderm. We therefore investigated whether Sox2 redirects the fate of the 
prospective intestinal part of the primitive gut. Ectopic expression of Sox2 in the 
posterior region of the primitive gut caused anteriorization of the gut towards 
a gastric-like phenotype. Sox2 activated the foregut transcriptional program, in 
spite of sustained co-expression of endogenous Cdx2. However, binding of Cdx2 
to its genomic targets and thus its transcriptional activity was strongly reduced. 
Recent findings indicate that endodermal Cdx2 is required to initiate the intestinal 
program and to suppress anterior cell fate. Our findings suggest that reduced 
Cdx2 expression by itself is not sufficient to cause anteriorization, but that Sox2 
expression is also required. Moreover, it indicates that the balance between Sox2 
and Cdx2 function is essential for proper specification of the primitive gut and 
that Sox2 may overrule the initial patterning of the primitive gut, emphasizing the 
plasticity of the primitive gut.
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Introduction 
The vertebrate digestive tract develops through a complex mechanism 
of patterning, expansion and differentiation of the primitive gut, which itself is 
formed after gastrulation as a result of folding of the definitive endodermal layer 
1-3. One of the earliest steps in patterning of the primitive gut is the regionalization 
into an anterior and posterior domain, which correlates with the expression of two 
transcription factors, Sox2 and Cdx2 respectively 4. During development these 
domains become more subdivided and by E9.5 the foregut, midgut and hindgut 
regions can be discriminated. The foregut eventually gives rise to the esophagus, 
stomach and proximal part of the duodenum; the midgut develops into the caudal 
part of the duodenum, jejunum, ileum, caecum and proximal part of the colon; and 
the hindgut forms the caudal part of the colon and rectum. Once regionalization 
has occurred, the gastro-intestinal tract becomes specified and cells differentiate 
into the characteristic types found in the various regions.
Sox2 is a member of a highly conserved family of transcription factors 
founded by the sex-determining gene Sry. Although individual Sox proteins share 
common DNA binding properties, their specificity is the result of their expression 
pattern and their ability to associate with different partners 5-6. Sox proteins are 
recognized as key players in the regulation of embryonic development and 
determination of cell fate and we recently described two novel partners for Sox2 
7. Sox2 plays an important role during early vertebrate embryogenesis and is 
required later in development in the brain, neural tube, germ cells and in the 
foregut and its derivatives 8-13.
Expression of Sox2 starts at the 4-8 cell stage of embryonic development 
and Sox2 gene inactivation results in early peri-implantation lethality 8. Modulating 
expression in mice showed the importance of Sox2 in the differentiation of the 
esophageal epithelium and morphogenesis of the esophagus and trachea 10 
12 14. Several congenital malformations in humans, for instance anophthalmia, 
microphthalmia and the AEG (anophthalmia -esophageal-genital) syndrome 15, 
have been associated with heterozygote mutations in SOX2. In addition, Sox2 is 
one of the key players in the induction of pluripotent stem cells from somatic cells 
16, confirming the importance of Sox2 in development and differentiation processes.
Cdx2 is a homeobox transcription factor involved in the establishment of 
the anterior-posterior polarity of the gut endoderm and is expressed from E8.5 
in the posterior part of the gut 17. Later in development Cdx2 becomes restricted 
to the intestinal epithelium, with a sharp boundary, marking the transition from 
stomach to duodenum 4 18-20.
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Conditional ablation of Cdx2 from the developing gut endoderm results 
in severe malformation of the intestinal tract and anteriorization of the posterior 
gut, evidenced by changes in the expression pattern of various transcriptional 
regulators  21. Interestingly, quantitative RNA expression analysis of Cdx2 mutant 
intestinal samples demonstrated ectopic activation of Sox2 expression in the 
posterior region. The aberrant expression of Sox2 after Cdx2 ablation coincided 
with an early anteriorization event of the gut. The apparent reciprocal expression 
pattern of Sox2 and Cdx2 suggests that these factors are able to influence each 
other. However, it remains unclear whether Sox2 or Cdx2 has a dominant role 
in determining the fate of the developing gut endoderm. In addition, aberrant 
SOX2 expression may underlie the formation of gastric metaplasia associated 
with intestinal inflammation22, and the formation of various human congenital 
anomalies of the gut, such as Meckel’s diverticulum in which ectopic gastric tissue 
can be present in the small intestine 23. Furthermore, our group and others have 
observed aberrant expression of SOX2 in human colorectal cancers, suggesting 
a role for SOX2 in colorectal tumor initiation or progression (manuscript in 
preparation)24.  
Therefore, we ectopically expressed Sox2 in epithelial cells of the 
prospective intestinal part of the primitive gut to investigate whether Sox2 is able 
to change the differentiation of the developing gastro-intestinal tract. Our data 
show that expression of Sox2 in the embryonic mouse intestinal epithelium leads 
to a fluid-filled, translucent swollen intestine with aberrant villi. The proliferation 
of epithelial cells in the Sox2 expressing intestines are no longer confined to 
the crypts, but rather distributed randomly throughout the intestinal epithelium. 
Moreover, Sox2 induced the expression of esophageal and stomach specific 
markers, resulting in an anteriorization of the intestinal epithelium. Although the 
expression level of Cdx2 is unaffected by ectopic Sox2 expression, we further 
show that induction of Cdx2 target gene expression is strongly reduced, because 
Sox2 leads to a reduced binding of Cdx2 to its target genes.
These findings provide strong evidence that expression of Sox2 in the 
developing gut drives the activation of the foregut transcriptional program and 
leads to conversion from an intestinal into a premature gastric epithelium, despite 
simultaneous expression of Cdx2. This indicates that the balance between Sox2 
and Cdx2 function is essential for proper specification of the primitive gut and 
that Sox2 can exert a dominant effect over Cdx2 to alter intestinal cell fate by 
redirecting the intestinal transcriptional program, emphasizing the plasticity of the 
primitive gut. 
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Materials and methods
Transgenic animals
The myc-Sox2 and Villin-rtTA transgenic mouse lines were previously 
described.10 25 Administration of doxycycline to dams from E8.5 or E14.5 onward 
in the drinking water (2mg/ml doxycycline, 5% sucrose) induced expression of 
myc-Sox2 in intestinal epithelium of double transgenic embryos. Each experiment 
was performed on at least three independent litters containing double transgenic, 
single transgenic and wild type pups. All double transgenic animals receiving 
doxycycline expressed nuclear Sox2 in the intestinal epithelium, throughout the 
entire intestinal tract and showed described phenotype. 
Histology
Embryos were obtained by caesarean section at E18.5. The gastro-
intestinal tract was isolated and stretched on pieces of filter paper, followed by 
fixation in 4% PBS-buffered paraformaldehyde (PFA) overnight at 4°C. Intestines 
were cut into 4-5 pieces and pre-embedded in 5% bacto-agar (BD) in PBS, before 
being embedded in paraffin according to routine protocols. 
Immunohistochemistry (IHC), Periodic Acid Schiff staining (PAS) and 
electron microscopy were performed as described previously.37,38 Antibodies 
are listed in Supplemental Table I. Differentiated and proliferative cells in the 
epithelium were quantified by counting at least 3 microscopic fields relative to the 
total number of epithelial cells.
Microarray analysis
The intestinal tracts of three control and two double transgenic embryos, 
which received doxycycline from E8.5 onwards, were isolated at E18.5 and 
individually used for transcriptome analysis using Affymetrix Mouse Genome 430 
2.0 microarrays as previously described.10  Subsequent analysis of the data was 
performed as described in detail in the supplementary data.
Chromatin immunoprecipitation (ChIP)
Small intestines of, 10 double transgenic and 10 control E18.5 
embryos were pooled and mechanically disrupted. Subsequently, the material 
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was crosslinked, sonicated and used to immunoprecipitate either Cdx2 or 
Sox2 complexes. The precipitated material was de-crosslinked and the co-
immunoprecipitated DNA fragments were used as template in qPCR reactions to 
amplify specific target sequences (primers are listed in supplementary table II). 
Details of the protocol are provided in the supplementary data.
Quantitative-PCR
RNA isolation, cDNA synthesis and subsequent qPCR analysis was 
performed as previously described.39 Data were analyzed using the 2-DDCt-
method.40 The gene-specific primers used are listed in Supplemental Table III. 
Results
Ectopic Sox2 expression in the caudal part of the developing gut 
endoderm 
Sox2 expression in the developing gut is restricted to the anterior part, 
which forms the stomach and other foregut derivatives. The posterior part is devoid 
of Sox2 expression, but expresses the homeobox protein Cdx2. Expression of 
Sox2 and Cdx2 is thought to be mutually exclusive, but it is unclear whether 
one has a dominant effect on the determination of the fate of the developing gut 
endoderm. Therefore we investigated the role of Sox2 in the patterning of the 
primitive gut and its influence on Cdx2 expression. 
Conditional expression of Sox2 in the intestinal epithelium was achieved 
by crossing mice carrying a myc-tagged Sox2 gene under the control of a tet-
inducible promoter with the Villin-rtTA transgenic mouse line, which drives 
expression of the rtTA gene in all intestinal epithelial cells 10 25. The rtTA protein 
drives expression of the Sox2 transgene in the intestinal epithelium in a doxycycline 
dependent manner. Induction of Sox2 in embryos was achieved by administration 
of doxycycline to the mother from E8.5 onwards. Double transgenic pups that 
received doxycycline through their mother were born at Mendelian ratio, but 
failed to thrive. Therefore, pups were isolated at E18.5 by caesarean section in 
order to investigate the intestinal abnormalities. 
Externally, the littermates showed no significant morphological 
abnormalities and all embryos were equally well developed. Intestinal tracts 
isolated from pups carrying only one of the two transgenes, or non-induced myc-
Sox2/Villin-rtTA double transgenic animals, appeared indistinguishable from 
non-transgenic control animals and showed no macroscopic or microscopic 
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abnormalities. However, isolation of the gastro-intestinal tract of double transgenic 
embryos that received doxycycline immediately revealed major differences 
compared to single or non-transgenic animals (Fig. 1A). 
Figure 1: Ectopic expression of Sox2 severely affects the intestinal tract
(A) Macroscopic appearances of the digestive tracts from stomach until rectum isolated at E18.5 
of a non-transgenic embryo (top) and double transgenic embryo treated with doxycycline (bottom), 
showing that Sox2 induction leads to dilated and fluid-filled intestines. (B) IHC using an antibody 
against Sox2 on cross-sections of the duodenum, jejunum, ileum, and colon reveals specific nuclear 
staining in the epithelium of double transgenic animals throughout the intestinal tract, whereas Sox2 
is absent in the control. (C) IHC using an antibody against Ki67 shows an increased number of 
cycling cells in the double transgenic embryos, compared to control intestine. Moreover, proliferating 
cells were randomly distributed throughout the intestinal epithelium of the double transgenic animals, 
whereas proliferation is restricted to the prospective crypt compartment at the base of villi in control 
intestines. Scale bars: 2 mm (A), 50 mm (B), 20 mm (C).
In all double transgenic pups ectopic expression of Sox2 in the intestinal 
tract resulted in markedly abnormal intestines that were translucent and fluid-
filled. Immunohistochemical analyses using an antibody against Sox2 (Fig. 1B), 
or an antibody against the N-terminal myc-epitope present in the transgenic Sox2 
protein (data not shown), revealed that nuclear Sox2 was expressed throughout 
the entire intestinal epithelium of the double transgenic animals.
Assessment of Sox2 expression at specific time points of development, 
i.e. E.10.5, E12.5, E14.5 and E16.5, revealed that robust Sox2 expression could 
only be detected in the double transgenic intestinal epithelium from E14.5 onwards 
(Fig. S1A), coinciding with the phase of cell specification in the embryonic gut. 
The level of ectopic Sox2 expression was compared with endogenous Sox2 
levels in the stomach by qPCR analysis, showing a 6-fold increase on RNA level 
(Fig. S1B). As Sox2 expression in the E18.5 embryonic stomach is restricted to 
the basal cells of the forestomach, the qPCR analysis will likely overestimate 
transgenic Sox2 expression. Therefore, we compared expression levels by IHC 
at limiting antibody concentrations, showing that on a cell-to-cell basis transgenic 
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Sox2 is only expressed at slightly higher levels than endogenous stomach Sox2 
(Fig S1C).
Ectopic Sox2 expression causes alterations in proliferation and 
malformation of the developing intestinal tract 
Cross-sections of the intestines ectopically expressing the Sox2 
transgene showed a two-fold increase in luminal space (Fig. S2). In addition, the 
small intestines did not form true, morphological villi. Even the epithelial folds that 
resembled villi were markedly reduced per equivalent surface area (Fig. 1B).
One possible explanation for the dilated intestinal tract could be a 
disturbed balance between proliferation and apoptosis. Using Ki67 staining to 
mark cycling cells (Fig. 1C and S3A), we observed that proliferation in the cells 
of the double transgenic animals was no longer confined to the intervillous, 
primitive crypt regions as in the controls, but distributed randomly throughout the 
epithelium of Sox2 expressing embryos. In addition, the total number of Ki67-
positive epithelial cells increased from approximately 35-40% in controls to 85-
90% in the Sox2 expressing embryos (Fig S3A). Staining for activated caspase 3 
revealed no differences in apoptosis (data not shown).
Thus, ectopic expression of Sox2 impairs villus formation and greatly 
alters the appearance of normal intestinal epithelium. These changes are 
accompanied by an increase and mislocalization of cycling cells. 
Ectopic Sox2 expression in the intestine results in loss of intestinal 
identity
Next, we analyzed the differentiation potential of the embryonic intestinal 
epithelium to understand the phenotypic abnormalities observed in the Sox2 
expressing intestines. Both mucin2 (Muc2) immunohistochemistry and qPCR 
showed a dramatic loss in the number of intestinal mucin producing goblet cells 
in the double transgenic animals (Fig. 2A/C and S3B). 
Similar results were obtained for enterocytes using qPCR for Lactase 
(Lct) (Fig. 2C). We also observed reduced numbers of synaptophysin (Syp) 
positive cells and reduced expression of Chromogranin A (ChgA), both markers 
for enteroendocrine cells though not exclusive for the intestinal epithelium (Fig. 
2B/C and S3C). In addition, Periodic Acid Schiff (PAS) staining demonstrated 
that the intestinal brush border layer was entirely absent in the double transgenic 
animals, while clearly present in the controls (Fig. 2D). As the brush border 
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contains several transporters for micronutrients, lack of absorption across this 
border may explain both the dilatation of the small intestine and the fluid retention 
we observed. We tested the expression level of several transporters expressed in 
the intestinal epithelium by qPCR. Analysis of two members of the solute carrier 
family, Slc2a2 and Slc5a1, which are responsible for active and passive glucose 
transport, respectively 26, showed that these genes were downregulated in the 
double transgenic animals (Fig. 2C). In addition, the expression levels of several 
members of the Aquaporin family, which are of major importance for water 
transport, were downregulated, as shown by qPCR (Fig. S4). 
Overall, ectopic expression of Sox2 in the intestinal epithelium results in 
loss of intestinal identity which is accompanied by reduced expression of various 
transporters. 
Sox2 expression in the intestine results in cell fate conversion
In order to better understand the underlying changes induced by 
expression of Sox2 in the intestinal epithelium, we performed microarray analysis 
using intestines of E18.5 pups of three control and two double transgenic 
animals, which received doxycycline from E8.5 onwards. Hierarchical clustering 
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Figure 2: Sox2 affects the normal differentiation of intestinal epithelium
Cross-sections of the duodenum at E18.5 of controls and double transgenic embryos, which received 
doxycycline. IHC using antibodies against Mucin2 (A) and synaptophysin (B), showed a reduced 
number of goblet cells and enteroendocrine cells, respectively, in the double transgenic animals. (C) 
Analysis of the expression level of marker genes of goblet cells (Muc2), enteroendocrine cells (ChgA) 
and enterocytes (Lct) by qPCR showed a significant reduction of expression in the small intestine 
of double transgenic embryos at E18.5. Additionally, qPCR was used to determine the expression 
levels of two genes specific for the intestinal brush border, i.e. members of the solute carrier family 
(Slc), Slc2a2 and Slc5a1, which are involved in glucose transport. Both are down-regulated in double 
transgenic embryos. (D) Periodic Acid Schiff staining (PAS) revealed the absence of the intestinal 
brush border in Sox2 induced animals compared to the controls. Scale bars: 20 mm (A, B), 25 mm (D).
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of differentially expressed genes revealed large differences between controls and 
double transgenic intestines (Fig. 3A).
Figure 3: Transcriptome analysis reveals upregulation of gastric cell-specific 
transcripts by Sox2
(A) OmniViz Treescape showing the hierarchical clustering of Affymetrix probe sets that matched 
the selection query. Gene expression levels compared with the geometric mean are indicated in 
red for up-regulated genes and in blue for down-regulated genes. The color intensity correlates with 
the degree of change. (B) Sox2-upregulated and Sox2-downregulated gene lists were compared 
based on their associated GO term fractional representations with previously described GO term 
profiles of several other gastrointestinal cells and tissues 41. “Mature intestinal crypt cells” refers to an 
expression profile of genes derived from β-catenin deleted mice 42, which causes crypt cells to mature. 
“Hyperplastic intestinal cells” refers to PTEN-deficient intestinal cells, which become hyperplastic 43. 
Differentially expressed genes in the Sox2 induced animals are involved 
in development and signal transduction, and are associated with a more immature 
and proliferative phenotype (Fig S5A-C). In addition, close examination showed 
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that the downregulated genes in the Sox2 overexpressing animals are involved 
in intestinal transport and lipid handling, typical processes for the absorptive 
function of the intestine (Fig S5D). 
We next used the pattern of GO term enrichment to integrate our Sox2 
profiles with a database of gastric and intestinal cells and tissues of varying 
degrees of differentiation (Fig. 3B). That analysis showed that genes whose 
expression was induced by ectopic Sox2 most resembled the gene expression 
profile of gastric zymogenic chief cells, whereas genes whose expression was 
decreased by Sox2 most resembled genes expressed in mature intestinal cells. 
Thus, by GO term enrichment, Sox2 induced genes expressed by gastric cells 
and reduced expression of normal intestinal genes. Ectopic Sox2 had mixed 
effects on parietal cell genes, potentially due to overlap in the types of genes 
parietal cells express and those that intestinal enterocytes express. For example, 
genes regulating lipid metabolism are characteristic of both enterocytes and 
parietal cells 27.
We followed up the global patterns of gene expression by confirming 
expression changes in individual markers with defined rostral-caudal patterns 
of expression in the gastro-intestinal tract. We analyzed markers identifying 
the presence of the esophagus and non-glandular gastric basal cells, the 
acid producing glandular gastric parietal cells, and gastric mucous neck cells. 
This showed that unlike the controls, the double transgenic animals had focal 
expression of p63-positive basal cells (Fig. 4A and S3D), characteristic of basal 
cells of forestomach and esophagus. 
Sox2-expressing intestines also showed abundant H+/K+ ATPase4ß 
positive cells of the gastric parietal lineage (Fig. 4B and S3E) and GSII lectin 
positive mucous neck cells (Fig. 4C) within the intestinal epithelium. Mist1, a 
marker for the zymogenic chief cell lineage in adult stomach 28, did not reveal a 
specific staining pattern (data not shown), which is in accordance with the lack of 
mature chief cells in the embryonic stomach. In addition, ectopic expression of the 
stomach specific p63, H+/K+ ATPase4α, Mucin5ac (Muc5ac, marks gastric surface 
pit cells) and Keratin13 (Ker13, marks suprabasal cells) genes was detected using 
qPCR in the double transgenic intestine (Fig. 4D). Ectopic expression of Sox2 in 
the intestinal epithelium did not clearly influence the underlying mesenchyme, as 
indicated by the unchanged low expression of the stromally expressed stomach-
specific gene Barx1 (Fig. 4D) 29. Checking the expression of Gastrin revealed 
a reduced expression (Fig. 4D), which is in line with Gastrin producing cells 
being present embryonically in the intestine and pancreas, while emerging in the 
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Figure 4: Sox2 induces stomach-like cells in the intestinal environment
Cross-sections of the stomach and duodenum at E18.5 of controls and double transgenic embryos, 
which received doxycycline. IHC using markers for basal cells (p63) (A) and parietal cells (H+/
K+ATPase4ß) (B) showed positive staining in the stomach. Ectopically expressed Sox2 induced the 
appearance of basal cells and parietal cells in duodenum of double transgenic animals (arrows), 
whereas control duodenum is devoid of staining. Immunofluorescence for GSII lectin (C), a marker 
for the mucous neck cells in the stomach, showed positive cells in the double transgenic intestine 
(arrows), while no expression was found in the control. (D) Analysis of the expression of marker 
genes for basal cells (p63), suprabasal cells (Ker13), parietal cells (H+/K+ATPase4α) and gastric pit/
surface-cell mucin (Muc5ac) by qPCR showed an increase in the small intestine of double transgenic 
animals. No significant change in expression level of the stomach-specific mesenchymal marker 
Barx1 was detected. Expression of the Gastrin hormone was reduced in double transgenic animals. 
(E) Nuclei of normal intestinal epithelium are oriented towards the basal membrane, whereas the 
nuclei of the double transgenic intestinal epithelial cells are positioned more apically, shown by EM. 
Scale bars: 20 mm (A-C), 6 mm (E).
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stomach only at birth 30. Next, electron microscopy confirmed the lack of microvilli 
on the double transgenic intestinal epithelial cells (Fig 4E and S6). Moreover, it 
showed that ectopic Sox2 expression induced a more apical localisation of the 
nuclei, in contrast to the basal orientation in controls (Fig 4E). 
Collectively, our data show that Sox2 expression in the intestinal 
epithelium causes anteriorization of the intestine with intestinal epithelial cells 
adopting the morphological and gene expression profile of immature gastric cells. 
Ectopic Sox2 expression in the intestine alters the functionality of Cdx2, 
but not its expression level 
Considering all the changes caused by Sox2 expression, we examined 
whether Cdx2 expression was also decreased, thereby fitting the suggestion that 
Sox2 and Cdx2 are expressed in a mutually exclusive manner. qPCR showed 
that expression of the Cdx2 mRNA was not altered (data not shown). Surprisingly, 
IHC for Sox2 (Fig. 5A) and Cdx2 (Fig. 5B) revealed that both transcription factors 
were expressed throughout the entire intestinal epithelium of the Sox2 induced 
animals, whereas only Cdx2 was expressed in the control. Moreover, nuclear co-
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Figure 5: Sox2 and Cdx2 are co-expressed
IHC on sequential sections of E18.5 duodenum showed Sox2 expression only in double transgenic 
intestines (A), and Cdx2 expression throughout the epithelium in both control and double transgenic 
embryos (B). Confocal microscopy (C) of control and double transgenic animals showed that Cdx2 
and Sox2 are co-expressed in the same intestinal epithelial cells in Sox2 expression embryos. 
Individual images of DAPI (blue), Cdx2 (green) and Sox2 (red) stainings are shown as inserts. Scale 
bars: 50 mm
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localization of Cdx2 and Sox2 was shown by immunofluorescence using confocal 
microscopy (Fig. 5C).
Thus, although Sox2 induced cellular changes leading to the occurrence 
of anterior gastro-intestinal cell types normally devoid of Cdx2, Cdx2 remained 
co-expressed in the Sox2 double transgenic intestines. However, the microarray 
analysis revealed several known Cdx2 target genes to be clearly downregulated 
in these Cdx2/Sox2 positive cells, including the well-established target gene 
Cdh17 31. These reduced expression levels were confirmed by qPCR for the target 
genes, Hnf4α, Heph, Cdx1 and Mep1α (Fig. 6A) 21 32. Using IHC we confirmed 
that the number of Hnf4α positive cells was strongly decreased in the double 
transgenic animals (Fig. 6B). 
These results suggest that ectopic expression of Sox2 does not directly 
affect the expression of Cdx2 itself, but interferes with the subsequent activation 
of Cdx2 target genes. Therefore, we analyzed the binding of Cdx2 to the promoter 
regions of two known target genes by chromatin immunoprecipitation (ChIP) 
using embryonic intestines from control and double transgenic animals (Fig. 6C 
and S7). We show that ectopic expression of Sox2 in the intestine leads to a 
strong decrease in binding of Cdx2 to its targets Cdh17 and Hnf4α, whereas 
Sox2 does not bind to these sites. Specificity of the Sox2 ChIP was confirmed 
by the detection of increased binding of Sox2 to its target Sox21 in the double 
transgenic embryos (Fig. S7). Thus, ectopic Sox2 expression in the intestinal tract 
does not affect the expression of Cdx2, but inhibits its function as a transcriptional 
regulator by interfering with the binding of Cdx2 to its gene target sites, which in 
turn prevents the activation of the intestinal transcriptome.
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Figure 6: Sox2 affects the expression of Cdx2 target genes by inhibiting Cdx2 
binding to target genes
(A) The expression levels of the Cdx2 target genes Hnf4α, Heph, Cdx1 and Mep1α are significantly 
down-regulated in the small intestine of double transgenic animals at E18.5. (B) IHC with an antibody 
against Hnf4α on cross-sections of duodenum at E18.5 of control and Sox2 overexpressing animals 
showed a dramatic loss of staining in the double transgenic animals.  (C) ChIP assay showed a 
dramatic loss of binding of Cdx2 to Cdh17 and Hnf4a in the double transgenic animals. Amylase 
served as a negative control. Scale bars: 20 mm (B)
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Discussion 
During development of the gastro-intestinal tract, Sox2 is expressed in 
the anterior part of the primitive gut, while the homeobox gene Cdx2 is expressed 
in the posterior part 4. Various studies have suggested that the expression of 
Sox2 and Cdx2 is mutually exclusive, but it remains elusive whether one of the 
two is dominant over the other. Therefore, we ectopically expressed Sox2 in 
the prospective intestinal part of the primitive gut to investigate whether Sox2 
has a dominant role over Cdx2 in the specification of the developing endoderm. 
We show that ectopic expression of Sox2 in the posterior region of the primitive 
gut caused aberrant activation of the foregut transcriptional program, leading 
to anteriorization of the gut with features resembling those of an immature 
embryonic stomach. Sox2 induction did not alter Cdx2 expression, but interfered 
with its function as a transcriptional regulator, providing evidence that Sox2 can 
exert a dominant effect over Cdx2 on cell fate. 
Ectopic expression of Sox2 in the embryonic intestinal tract leads to 
a translucent and dilated intestine, which had a reduced number of villus-like 
outfoldings per surface area. These villi were poorly developed and showed 
increased numbers of cycling cells that were no longer confined to the intervillous 
regions, but were localized randomly throughout the intestinal epithelium. The 
differentiation towards goblet cells, enteroendocrine cells and enterocytes was 
dramatically affected. Instead, the Sox2 expressing epithelium differentiated 
into gastric-like cell types, such as parietal cells and basal cells, demonstrated 
by IHC, qPCR and GO term analysis. GO term comparative expression profile 
analysis also revealed that the genes upregulated by Sox2 were closer to cells 
of mature gastric zymogenic chief cell differentiation than to any of a variety of 
normal intestinal tissue gene expression profiles. These dramatic changes were 
accomplished in the short time-frame that ectopic Sox2 becomes expressed, i.e. 
E14.5-E18.5, demonstrating the dominant influence of Sox2 in the developing 
gut. Apparently, Sox2 is able to convert the cell fate of already committed 
embryonic intestinal cells into stomach-like cells. The prominent effect of Sox2 
in determining cell fate was also highlighted by our previous study, in which we 
have shown that ectopic expression of Sox2 in the lung also results in dramatic 
changes in differentiation 10. 
The fluid filled, swollen appearance of intestines of the Sox2 induced 
animals is most likely caused by the dramatic decreased number of enterocytes 
combined with the disruption of the intestinal brush border. As a consequence of 
the decreased absorptive area, fluid can not be absorbed by the intestine, resulting 
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in fluid retention. Our studies with ectopic Sox2 expression in intestines of mouse 
embryos complement a recent study reporting the effect of Cdx2 ablation in mouse 
embryos 21. Cdx2 ablation severely affects the normal intestinal development, 
since mutant embryos fail to form the colon and rectum properly. Furthermore, the 
duodenum of the Cdx2 mutant animals was distended and became translucent. 
Also the disturbed proliferative pattern strongly resembles our observations. In 
our study the total number of epithelial cells was not significantly altered (data 
not shown), which is in accordance with the equal number of cells in the mitotic 
phase of the cell cycle as revealed by phospho-Histone H3 staining (20-25% 
for both genotypes, data not shown). These results indicate that although Sox2 
expression strongly affects the number and position of cycling cells, it most likely 
also leads to an increased duration of the cell cycle, effectively resulting in an 
equal production of epithelial cells. 
Interestingly, Gao et al. also showed ectopic activation of Sox2 in the 
Cdx2 mutant intestine, which implied that Sox2 may have been responsible for 
inducing the phenotypes that were observed 21. Our results strongly support 
this concept, as we demonstrated that Sox2 induces the differentiation toward 
a premature stomach phenotype, in spite of sustained Cdx2 expression. We 
conclude that loss of Cdx2 by itself is not sufficient to drive the activation of the 
foregut transcriptional program, but requires expression of Sox2 to dominantly 
induce anteriorization.
Inactivation of Cdx2 in adult intestines induced the expression of gastric 
markers, but did not lead to major morphological changes 29. Although these 
authors showed that the gut stem cells in the crypts showed some plasticity to 
express gastric genes, the plasticity of the cells in the developing gut is much 
greater since we and Gao et al showed complete induction of gastric genes and 
cell types 21. This indicates that the adult intestinal epithelial cells have partly lost 
their potential to change their fate upon Cdx2 ablation. 
More recently, Cdx2 was shown to also regulate epithelial cell polarity 
33. Depletion of Cdx2 in the developing mouse embryo from E15.5 onwards, i.e. 
equivalent to the time point that we induce Sox2, led to the formation of irregular 
packed epithelial cells containing large subapical vacuoles and a disorganized 
pattern of several apical and basolateral markers. In our case, staining for ZO-1 
(apical), E-Cadherin (basolateral), and Laminin-1 (basement membrane) revealed 
that epithelial polarity was not clearly affected (data not shown). We also did not 
observe the vacuoles and irregular packing of epithelial cells. These differences 
in phenotype are possibly explained by the incomplete functional downregulation 
of Cdx2 induced by Sox2 expression.
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Ectopic expression of Sox2 did not affect the expression of the intestinal 
specific transcription factor Cdx2. This is in apparent contrast with work published 
by Benahmed and co-workers, who investigated the regulation of Cdx2 expression 
34. Using cellular approaches with a 13 kb genomic fragment covering part of the 
Cdx2 locus, they showed that Sox2 had a profound inhibitory effect on Cdx2 
transcriptional activity. As our study shows that the endogenous locus is not 
affected by Sox2, this either implies that the proposed Sox2 binding site in the 13 
kb fragment is not easily accessible in the endogenous setting or that for proper 
Cdx2 regulation additional domains are required, e.g. the 3’ located enhancer. 
Previous studies have provided limited data to suggest that Cdx2 regulates Sox2 
expression, but no direct binding of Cdx2 to the Sox2 promoter region was shown 
4 21 35. Nishiyama et al recently described a genome wide analysis of CDX2 target 
sites using ChIP technology and clearly demonstrated that CDX2 did not bind 
to the SOX2 locus 36. Verzi et al analyzed the Caco-2 intestinal carcinoma cell 
line for putative CDX2 binding sites and identified a ChIP peak in an intergenic 
region in proximity to the SOX2 locus 32. However, it remains unclear whether the 
binding site had functional relevance to the SOX2 gene.
Although Cdx2 was not affected at the transcriptional level, its function 
is severely affected as deduced from the strong downregulation of several Cdx2 
target genes. We show that Sox2 interferes with the binding of Cdx2 to its genomic 
target sites, thereby preventing its transcriptional activity. At present, the precise 
molecular mechanism to explain the inhibitory effect on Cdx2 DNA binding is 
unclear. Possibly Sox2 competes with co-factors that are needed by Cdx2 for its 
binding activity 32, or Sox2 may induce differentiation into cell types that lack the 
expression of factors required by Cdx2 to bind efficiently to its target sequences.
In conclusion, we show that ectopic expression of Sox2 leads to 
impairment of villus formation and strongly alters the appearance of the normal 
intestinal epithelium. We show anteriorization of the primitive gut, demonstrated 
by cell fate conversion from intestinal epithelial into immature stomach-like cells. 
This demonstrates the dominant influence of Sox2 in the developing gut, since 
Sox2 is able to convert the cell fate of already committed intestinal cells into 
stomach-like cells. Sox2 induction does not alter Cdx2 expression, but inhibits its 
function as transcriptional activator by interfering with its DNA binding capacity. 
This supports the idea that a balance between Sox2 and Cdx2 may dictate proper 
patterning of the foregut endoderm and that Sox2 may exert a dominant effect 
on intestinal cell fate by altering the differentiation program, emphasizing the 
plasticity of the primitive gut. 
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Our work improves the understanding of the mechanisms underlying the 
formation of the gastrointestinal tract and provides insight into the possible origin 
of various human congenital anomalies of the gut, such as Meckel’s diverticulum, 
in which ectopic gastric tissue can be present in the small intestine. In addition, it 
may clarify the functional consequences of the ectopic SOX2 expression that we 
and others observed in human colorectal cancer (manuscript in preparation)24.
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Supplementary Materials and Methods
Microarray analysis
The intestinal tract of three control and three double transgenic embryos, 
which received doxycycline from E8.5 onwards, were isolated at E18.5 and 
individually used for total RNA isolation with Trizol reagent (Invitrogen life 
technologies, Carlsbad, CA, USA). RNA was purified using RNeasy MinElute 
Cleanup kit (Qiagen, Valencia, CA, USA) and cDNA was synthesized using the 
GeneChip Expression 3’-Amplification Reagents One-Cycle cDNA Synthesis kit 
(Affymetrix, Santa Clara, CA, USA). Biotin-labelled cRNA synthesis, purification 
and fragmentation were performed according to standard conditions. Fragmented 
biotinylated cRNA was subsequently hybridised onto Affymetrix Mouse Genome 
430 2.0 microarray chips. 
To examine the quality of the various arrays, several R packages 
(including affyQCreport) were run starting from the CEL files. All created plots, 
including the percentage of present calls, noise, background, and ratio of GAPDH 
39 to 59 (1.4) indicated a high quality of all samples and an overall comparability, 
except for one sample, which was excluded from further analysis. Raw intensity 
values of all samples were normalized by RMA normalization (Robust Multichip 
Analysis), background correction and quantile normalization using Partek version 
6.4 (Partek Inc., St. Louis, MO).
The normalized datafile was transposed and imported into OmniViz 
version 6.0.1 (BioWisdom Ltd., Cambridge, UK) for further analysis. For each 
probe set, the geometric mean of the hybridization intensity of all samples was 
calculated. The level of expression of each probe set was determined relative to this 
geometric mean and 2log-transformed. The geometric mean of the hybridization 
signal of all samples was used to ascribe equal weight to gene expression levels 
with similar relative distances to the geometric mean. Differentially expressed 
genes were identified using statistical analysis of microarrays (SAM). Cutoff 
values for significantly expressed genes were the number of falsely called less 
than 1 (FDR of 0.0006 or less) and a fold change of 2. Functional annotation of 
the statistical analysis of microarrays results was done using Ingenuity Pathway 
Analysis (Ingenuity, Mountain View, CA) and DAVID (http://david.abcc.ncifcrf.
gov). DAVID calculates significant overrepresentation of gene ontology (GO)-
classified biological processes. The results are shown for biological processes, 
which are significantly (P <0.05) enriched after multiple testing.
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To analyze higher-order differentiation patterns defined by the 449 genes 
induced and 906 downregulated significantly by Sox2, each gene list was re-
expressed in terms of the fractional representation of GO terms associated with 
its member genes using the GOurmet software suite.1 The distribution of GO 
term fractional representations were then used as a metric to classify the Sox2 
expression profiles to a database of expression profiles of mature, proliferating, 
and hyperplastic gastrointestinal tissues, as described before.2
Chromatin immunoprecipitation (ChIP)
The small intestines of, respectively, 10 double transgenic and 10 control 
E18.5 embryos were pooled and mechanically disrupted, after incubating for 20 
minutes in ColagenaseII at 37°C. Next we filtered the cell suspension using a 
70mm cell strainer. Formaldehyde was added to a final concentration of 1% for 10 
min on RT to crosslink the samples and this process was stopped by adding 0.15 
M glycine. Cells were washed with PBS and lysed for 10 minutes on ice in cell 
lysis buffer (10mM Tris pH 8.0, 10 mM Nacl, 0.2% NP-40 and complete protease 
inhibitors). After centrifugation the nuclei were resuspended in nuclei lysis buffer 
(50mM Tris pH 8.0, 10mM EDTA, 1% SDS and complete protease inhibitors) and 
the chromosomal DNA was fragmented by sonication (20 cycles of 15 seconds, 
45 seconds in between cycles) to yield DNA fragments with an average size of 
500bp. 
Equal amounts of sample were diluted 1:10 with ChIP dilution Buffer 
(0.01% SDS, 1.1% Tx-100, 1.2 mM EDTA, 16.7mM Tris-HCL pH 8.1 and 167 mM 
Nacl) and from each sample 50 ml was removed to serve as input control. The 
samples were pre-cleared with 80ml Prot A/G agarose beads for 1 hour. Next, 
these samples were incubated O/N with pre-formed complexes of 10 mg antibody 
specific for Sox2 or Cdx2, or control IgG (goat and mouse) with 150 ml Prot A/G 
agarose beads. 
Beads were washed with Low salt immune complex buffer (0.1% SDS, 
1% Tx-100, 2mM EDTA, 20mM Tris-HCL pH 8.0 and 50 mM Nacl), High salt 
immune complex buffer (0.1% SDS, 1% Tx-100, 2mM EDTA, 20mM Tris-HCL pH 
8.0 and 150 mM Nacl), LiCl immune complex buffer (0.25 M LiCl, 1% NP-40, 1% 
deoxycholate, 1mM EDTA and 10mM Tris-HCL pH 8.0) and twice with TE (10mM 
Tris-HCL pH 8.0, 1mM EDTA pH 8.0). The DNA was eluted by adding twice 250 
ml elution buffer (1% SDS and 0.1m NaHCO3). Next the samples and the input 
were incubated at 65°C O/N using 20 ml 5M NaCl to de-crosslink the DNA and 
proteins. The eluted material was phenol-extracted and ethanol-precipitated. The 
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DNA was resuspended in 26 ml of water and qPCRs were performed to analyze 
the enrichment of Cdx2 for binding to Hnf4a and Cdh17, and Sox2 for binding to 
Sox21, using Amylase as control. 
1. Doherty JM, Carmichael LK, Mills JC. Gourmet: a tool for quantitative comparison and 
visualization of gene expression profiles based on gene ontology (GO) distributions. BMC 
Bioinformatics 2006;7:151.
2. Doherty JM, Geske MJ, Stappenbeck TS, Mills JC. Diverse adult stem cells share specific 
higher-order patterns of gene expression. Stem Cells 2008;26:2124-30.
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Supplementary figure legends:
Figure S1: Robust expression of induced Sox2 at E16.5
IHC using an antibody against Sox2 on intestinal cross-sections at E14.5, E16.5 and E18.5 of double 
transgenic animals shows that robust Sox2 expression is observed from E14.5 onwards (A). In order 
to evaluate the expression level of induced Sox2, we compared Sox2 mRNA expression levels of 
Dox-induced double transgenic embryos with the stomach and intestine of control animals. We show 
an approximate 6-fold increase of expression of induced Sox2 compared to the endogenous level in 
the stomach. As expected Sox2 expression in the control intestine was negligible (B). Additionally, we 
analysed the unaffected stomach and the intestinal tract of the induced double transgenic animals 
with immunohistochemistry using limiting amounts of Sox2 antibody. Because the titration of the 
antibody showed diminishing staining, we could perfectly compare the intensity of the staining in 
de stomach and intestine and quantify the expression level of the ectopically expressed Sox2 in 
the intestinal epithelium using ImageJ. This revealed an average increase in intensity of 32% in the 
intestine, compared to endogenous Sox2 expression in the stomach (C). Scale bars: 50 mm.
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Figure S2: Ectopic Sox2 induces significant enlargement of the intestine
The average intestinal lumen size was measured in at least three controls and double transgenic 
animals. The double transgenic animals show a two-fold increase in lumen size. 
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Figure S4: Quantification of the expression of aquaporin family members
Analysis of the expression of Aquaporin family members Aqp1, Aqp2, Aqp4, Aqp7, Aqp8, Aqp11 
showed a downregulation in the double transgenic animals, whereas Aqp 12 was upregulated 
compared to the controls. 
Figure  S5: GO enrichment analysis of control and double transgenic intestines
Enriched GO terms within the set of 1,354-regulated probesets (both up- and downregulated genes) 
for GO biological processes (A), GO molecular function (B) and GO cellular component (C). Enriched 
categories are those identified as significantly enriched (P<0.05) after multiple testing. *P < 0.05; **P 
< 0.01; ***P < 0.001. (C) Enriched GO terms within the set of 906-downregulated probesets for GO 
biological processes (D). Enriched categories are those identified as significantly enriched (P<0.05) 
after multiple testing. *P < 0.05; **P < 0.01; ***P < 0.001.
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Figure S6: Sox2 affects the intestinal brush border
Close up electron microscopy images of the intestinal brush border of control and double transgenic 
E18.5 pups, and of the embryonic stomach, which does not have a brush border. Scale bars: 1.4mm
               Stomach                                                                    Duodenum              
                                                                         Control                                  Double transgenic  
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Figure S7:Sox2 
interferes with Cdx2 
binding to target 
genes
ChiP assay for Cdx2 
shows loss of binding to 
Cdh17 (top panel) and 
Hnf4a (middle panel) in 
the double transgenic 
animals, compared to 
the control. Sox2 does 
not bind to Cdh17 or 
Hnf4a, but does bind to 
its downstream target 
Sox21 (bottom). Mouse 
IgG or goat IgG serve 
as negative antibody 
controls Cdx2 and Sox2, 
respectively. Amylase 
served as negative control 
for the qPCR.
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Genomic region Sequence (forward) Sequence (reverse)
Sox21 GCAGGCGCATAAATAAATAA ATATCCATTCAAAGGGCATT
Cdh17 TTAAAACAACACCACCACCAC CCCCAGTCAAACATTAACCAC
Hnf4a AGGCTGAGGCTATGAGAAC AACTCTCCCCTGACTCCTTGC
Amylase CTCCTTGTACGGGTTGGT AATGATGTGCACAGCTGAA
Gene Sequence (forward) Sequence (reverse)
Aqp4 CTGTGATTCCAAACGAACTG GGCTCCAGTATAATTGATTGCA
Aqp8 CTACTGGGACTTCCATTGGA CCGATGAGGAGCCTAATGAG
H+/K+Atpase4a GACCACTGATGATAATCTGTACCT GATATTTGTGCTCTTGAACTCCTG
Cdx2 GTATGTCTGTGTTGTAAATGCC AAACAATTCCGGTCTTCTTCAG
ChgA CAGAAGTGTTTGAGAACCAGAG TTCTCTTCTCCATAGTGTCCC
Krt13 CTGACTCTGGCTAAGACTGAC AATTCCTTCATCTCCTCTTCGT
Muc2 TGCAACAACTTAACTGCTCTG TCAGTATGGTAATAGCCAGCC
Muc5ac CATGACCTGTTATAGCTCCGA CTCAGTAACAACACAGCCTC
p63 CATTGTCAGTTTCTTAGCAAGG CTCAATCTGATAGATGGTGGT
Slc2a2 CAGAAGACAAGATCACCGGA GCATTGATCACACCGATGTC
Slc5a1 ATTGAAATAGACACAGAAGCCC GTCATCTTTGGTCCTTTATCCT
Lct GCTTCCTATCAGGTTGAAGGT GTCGTCATTCCCAATCTTCAG
Hnf4a CTTTGATCCAGATGCCAAGG GGTCGTTGATGTAATCCTCCA
Mep1a CATCTTCAGCTATAAATGGCTC CTTCTGAAACAATCACAGTCCT
Heph GCAGAAGAGATAGAGTGGGA ATAGCTGTCTTTCTCAGATGTG
Cdx1 AAAGGAGTTTCACTACAGCC GAACCAGATCTTTACCTGCC
Aqp1 CTCCCTAGTCGACAATTCAC CCAATGATCTCAATGCCAG
Aqp2 ACCTCCTTGGGATCTATTTCAC ATCATCAAACTTGCCAGTGAC
Aqp7 GAGCTACAGTTCAGTTGCAG ATGAAGTAGGTTCTCTGAAGTG
Aqp11 TCACAGGAGCATTGTTTAACC ATCAGCACACCTACAGAAGG
Aqp12 CACAGCCTTCTTGTCTACAG GGATTGAAGAAGGCAGATGTG
71
Ectopic expression of Sox2 affects the developmental fate of the intestinal epithelium 
C
ha
pt
er
 3
References
1.  Zorn AM, Wells JM. Vertebrate endoderm development and organ formation. Annu Rev Cell 
Dev Biol 2009;25:221-51.
2.  Wells JM, Melton DA. Early mouse endoderm is patterned by soluble factors from adjacent 
germ layers. Development 2000;127(8):1563-72.
3.  Wells JM, Melton DA. Vertebrate endoderm development. Annu Rev Cell Dev Biol 1999;15:393-
410.
4.  Sherwood RI, Chen TY, Melton DA. Transcriptional dynamics of endodermal organ formation. 
Dev Dyn 2009;238(1):29-42.
5.  Kondoh H, Kamachi Y. SOX-partner code for cell specification: Regulatory target selection and 
underlying molecular mechanisms. Int J Biochem Cell Biol 2010;42(3):391-9.
6.  Kormish JD, Sinner D, Zorn AM. Interactions between SOX factors and Wnt/beta-catenin 
signaling in development and disease. Dev Dyn 2010;239(1):56-68.
7.  Engelen E, Akinci U, Bryne JC, Hou J, Gontan C, Moen M, et al. Sox2 cooperates with Chd7 to 
regulate genes that are mutated in human syndromes. Nat Genet 2011;43(6):607-11.
8.  Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages 
in early mouse development depend on SOX2 function. Genes Dev 2003;17(1):126-40.
9.  Favaro R, Valotta M, Ferri AL, Latorre E, Mariani J, Giachino C, et al. Hippocampal development 
and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci 
2009;12(10):1248-56.
10.  Gontan C, de Munck A, Vermeij M, Grosveld F, Tibboel D, Rottier R. Sox2 is important for 
two crucial processes in lung development: branching morphogenesis and epithelial cell 
differentiation. Dev Biol 2008;317(1):296-309.
11.  Ishii Y, Rex M, Scotting PJ, Yasugi S. Region-specific expression of chicken Sox2 in the 
developing gut and lung epithelium: regulation by epithelial-mesenchymal interactions. Dev 
Dyn 1998;213(4):464-75.
12.  Que J, Luo X, Schwartz RJ, Hogan BL. Multiple roles for Sox2 in the developing and adult 
mouse trachea. Development 2009;136(11):1899-907.
13.  Taranova OV, Magness ST, Fagan BM, Wu Y, Surzenko N, Hutton SR, et al. SOX2 is a dose-
dependent regulator of retinal neural progenitor competence. Genes Dev 2006;20(9):1187-
202.
14.  Que J, Okubo T, Goldenring JR, Nam KT, Kurotani R, Morrisey EE, et al. Multiple dose-
dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. 
Development 2007;134(13):2521-31.
15.  Williamson KA, Hever AM, Rainger J, Rogers RC, Magee A, Fiedler Z, et al. Mutations in SOX2 
cause anophthalmia-esophageal-genital (AEG) syndrome. Hum Mol Genet 2006;15(9):1413-
22.
16.  Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear 
reprogramming. Cell 2008;132(4):567-82.
17.  Beck F, Erler T, Russell A, James R. Expression of Cdx-2 in the mouse embryo and placenta: 
possible role in patterning of the extra-embryonic membranes. Dev Dyn 1995;204(3):219-27.
18.  James R, Kazenwadel J. Homeobox gene expression in the intestinal epithelium of adult mice. 
J Biol Chem 1991;266(5):3246-51.
19.  James R, Erler T, Kazenwadel J. Structure of the murine homeobox gene cdx-2. Expression in 
embryonic and adult intestinal epithelium. J Biol Chem 1994;269(21):15229-37.
20.  Chawengsaksophak K, James R, Hammond VE, Kontgen F, Beck F. Homeosis and intestinal 
tumours in Cdx2 mutant mice. Nature 1997;386(6620):84-7.
21.  Gao N, White P, Kaestner KH. Establishment of intestinal identity and epithelial-mesenchymal 
signaling by Cdx2. Dev Cell 2009;16(4):588-99.
22.  Shaoul R, Marcon P, Okada Y, Cutz E, Forstner G. The pathogenesis of duodenal gastric 
metaplasia: the role of local goblet cell transformation. Gut 2000;46(5):632-8.
23.  Lambert MP, Heller DS, Bethel C. Extensive gastric heterotopia of the small intestine resulting 
in massive gastrointestinal bleeding, bowel perforation, and death: report of a case and review 
of the literature. Pediatr Dev Pathol 2000;3(3):277-80.
72
Chapter 3
24.  Park ET, Gum JR, Kakar S, Kwon SW, Deng G, Kim YS. Aberrant expression of SOX2 
upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and 
related lesions. Int J Cancer 2008;122(6):1253-60.
25.  Roth S, Franken P, van Veelen W, Blonden L, Raghoebir L, Beverloo B, et al. Generation of 
a tightly regulated doxycycline-inducible model for studying mouse intestinal biology. Genesis 
2009;47(1):7-13.
26.  Wright EM, Martin MG, Turk E. Intestinal absorption in health and disease--sugars. Best Pract 
Res Clin Gastroenterol 2003;17(6):943-56.
27.  Mills JC, Syder AJ, Hong CV, Guruge JL, Raaii F, Gordon JI. A molecular profile of the mouse 
gastric parietal cell with and without exposure to Helicobacter pylori. Proc Natl Acad Sci U S A 
2001;98(24):13687-92.
28.  Ramsey VG, Doherty JM, Chen CC, Stappenbeck TS, Konieczny SF, Mills JC. The maturation 
of mucus-secreting gastric epithelial progenitors into digestive-enzyme secreting zymogenic 
cells requires Mist1. Development 2007;134(1):211-22.
29.  Stringer EJ, Duluc I, Saandi T, Davidson I, Bialecka M, Sato T, et al. Cdx2 determines the fate 
of postnatal intestinal endoderm. Development 2012;139(3):465-74.
30.  Larsson LI. Developmental biology of gastrin and somatostatin cells in the antropyloric mucosa 
of the stomach. Microsc Res Tech 2000;48(5):272-81.
31.  Hinoi T, Lucas PC, Kuick R, Hanash S, Cho KR, Fearon ER. CDX2 regulates liver intestine-
cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. 
Gastroenterology 2002;123(5):1565-77.
32.  Verzi MP, Hatzis P, Sulahian R, Philips J, Schuijers J, Shin H, et al. TCF4 and CDX2, major 
transcription factors for intestinal function, converge on the same cis-regulatory regions. Proc 
Natl Acad Sci U S A 2010;107(34):15157-62.
33.  Gao N, Kaestner KH. Cdx2 regulates endo-lysosomal function and epithelial cell polarity. 
Genes Dev 2010;24(12):1295-305.
34.  Benahmed F, Gross I, Gaunt SJ, Beck F, Jehan F, Domon-Dell C, et al. Multiple regulatory 
regions control the complex expression pattern of the mouse Cdx2 homeobox gene. 
Gastroenterology 2008;135(4):1238-47, 47 e1-3.
35.  Mutoh H, Sashikawa M, Sugano K. Sox2 expression is maintained while gastric phenotype is 
completely lost in Cdx2-induced intestinal metaplastic mucosa. Differentiation 2011;81(2):92-8.
36.  Nishiyama A, Xin L, Sharov AA, Thomas M, Mowrer G, Meyers E, et al. Uncovering early 
response of gene regulatory networks in ESCs by systematic induction of transcription factors. 
Cell Stem Cell 2009;5(4):420-33.
37.  Huang Y, Buscop-van Kempen M, Boerema-de Munck A, Swagemakers S, Driegen S, 
Mahavadi P, et al. THE HYPOXIA INDUCIBLE FACTOR 2{alpha} PLAYS A CRITICAL ROLE 
IN THE FORMATION OF ALVEOLI AND SURFACTANT. Am J Respir Cell Mol Biol 2011.
38.  Darbas A, Jaegle M, Walbeehm E, van den Burg H, Driegen S, Broos L, et al. Cell autonomy of 
the mouse claw paw mutation. Dev Biol 2004;272(2):470-82.
39.  Rajatapiti P, van der Horst IW, de Rooij JD, Tran MG, Maxwell PH, Tibboel D, et al. Expression 
of hypoxia-inducible factors in normal human lung development. Pediatr Dev Pathol 
2008;11(3):193-9.
40.  Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative 
PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25(4):402-8.
41.  Doherty JM, Geske MJ, Stappenbeck TS, Mills JC. Diverse adult stem cells share specific 
higher-order patterns of gene expression. Stem Cells 2008;26(8):2124-30.
42.  Fevr T, Robine S, Louvard D, Huelsken J. Wnt/beta-catenin is essential for intestinal 
homeostasis and maintenance of intestinal stem cells. Mol Cell Biol 2007;27(21):7551-9.
43.  He XC, Yin T, Grindley JC, Tian Q, Sato T, Tao WA, et al. PTEN-deficient intestinal stem cells 
initiate intestinal polyposis. Nat Genet 2007;39(2):189-98.
73
Ectopic expression of Sox2 in the mature intestinal tract induces aberrant proliferation
C
ha
pt
er
 4
CHAPTER 4
Ectopic expression of Sox2 in the 
mature intestinal tract induces aberrant 
proliferation, rather than changes in the 
intestinal differentiation program
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Abstract
Increasing evidence is obtained that a balance between the transcription 
factors Sox2 and Cdx2 is essential for proper regionalization of the primitive gut, 
from which the stomach, intestine and other endodermal tissues arise. In the 
digestive tract Sox2 is normally expressed in the rostral part up to the stomach, 
while Cdx2 is expressed in the intestine. Conditional knockout of Cdx2 in the 
developing gut was shown to lead to an anteriorization of the intestine towards 
a more gastric-like phenotype, and caused ectopic expression of Sox2 in the 
intestine. Recently, we showed that ectopic expression of Sox2 in the posterior 
region resulted in a similar conversion of the intestine towards a gastric like 
phenotype, in spite of sustained Cdx2 expression. These data suggested that 
reduced expression of Cdx2 by itself is not sufficient to cause anteriorization, but 
requires simultaneous expression of Sox2, and indicate that Sox2 might have 
a dominant role over Cdx2. While our understanding of the roles of Sox2 and 
Cdx2 in the developing gastrointestinal tract increases, far less is known about 
their roles in the mature intestine. Therefore, we ectopically induced Sox2 in the 
mature intestinal epithelium and examined whether Sox2 expression alters the 
normal homeostasis. We show that ectopic expression has a great impact on the 
morphology of the villi, resulting in the death of the animals within a week. Sox2 
expanded the proliferative compartment throughout the crypt-villus structures, 
indicating that the intestinal cells were converted to a progenitor-like phenotype. 
Immunohistochemistry showed that the main intestinal cell types are still present 
and that no conversion toward a gastric cell type occurred. Moreover, expression 
of Cdx2 was not clearly altered. Our data indicate that ectopic expression of 
Sox2 in the mature intestinal epithelium does not alter the intestinal differentiation 
program, suggesting that the mature intestinal epithelium harbors a limited degree 
of plasticity. Additionally, ectopic expression of Sox2 drives cells into a progenitor 
phenotype. 
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Introduction
The vertebrate digestive tract develops through a complex mechanism 
of patterning, expansion and differentiation of the primitive gut, which itself is 
formed after gastrulation as a result of folding of the definitive endodermal layer 
1-3. In order to meet the changing digestive and absorptive requirements, the 
structure and physiology of the intestinal tract mature during postnatal growth4-5. 
To increase the absorptive area and the surface area of the small intestinal 
wall, the mucosa is formed into finger-like structures, the villi. In between, at the 
base of the villi, the intestinal crypts of Lieberkuhn reside. The large intestine 
lacks villi, but instead the crypts of Lieberkuhn are richly present. The intestinal 
epithelium gradually develops into a highly structured layer and is eventually 
composed of four main differentiated cell types, the absorptive enterocytes and 
colonocytes in the small and large intestine respectively, the mucin producing 
goblet cells, entero-endocrine cells and the Paneth cells that are specific for the 
small intestine. These cells are derived from the stem cells which are localized 
near or at the base of the crypts and give rise to the highly proliferating transit 
amplifying (TA) cells.
Early establishment of the anterior-posterior polarity (A-P) in the 
developing gut is to a large extent determined by two crucial transcription factors, 
i.e. the HMG-box protein Sox2 and the homeodomain containing Cdx2. Sox2 is 
a member of a highly conserved family of transcription factors founded by the 
sex-determining gene Sry. Although individual Sox proteins share common DNA 
binding properties, their specificity is the result of their expression pattern and 
their ability to associate with different partners 6-8. Sox proteins are recognized 
as key players in the regulation of embryonic development and determination 
of cell fate. Sox2 plays an important role during early vertebrate embryogenesis 
and is required later in development in the brain, neural tube, germ cells and 
in the foregut and its derivatives 9-14. In the digestive tract Sox2 starts to be 
expressed at E8.5 in the future foregut and is expressed in the rostral part of 
the gastro-intestinal tract up to the stomach. Sox2 is also one of the key players 
in the induction of pluripotent stem cells from somatic cells15,underscoring its 
involvement in establishing progenitor identity.
Cdx2 is a member of the homeodomain transcription factors, which play 
crucial roles in diverse developmental processes as well in the adult organism, 
with alterations in their function being linked to a number of disorders including 
metabolic diseases and cancer16. Cdx2 is expressed from E8.5 in the posterior 
part of the gut17, and later in development becomes restricted to the intestinal 
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epithelium. The expression domains of Sox2 and Cdx2 have a sharp boundary, 
marking the transition from stomach to duodenum 18-21. 
Homozygous Cdx2 -/- embryos fail to implant properly, resulting from a 
block in differentiation of the trophoblast22. Cdx2 is also an essential transcription 
factor for establishing intestinal cell fate. This was first shown in heterozygous 
Cdx2 knock-out mice, which developed polyps consisting of normally organized 
stomach mucosa in the paracaecal region of the intestine23. Importantly, Sox2 
was ectopically expressed in the overlying endoderm24. It was suggested that 
local sporadic haploinsufficiency of Cdx2 caused an anterior homeotic shift in 
which undifferentiated intestinal endoderm defaulted to a gastric phenotype. 
Chimaeric studies using Cdx2-/- cells in wild-type hosts confirmed these 
observations and also studies done by Cdx2 ablation specifically in the embryonic 
endoderm showed an activation of the foregut transcriptional program, causing a 
forestomach phenotype25-26.  In all cases, ectopic expression of Sox2 was noted. 
This latter observation suggested that Sox2 may have been responsible for 
inducing the phenotypes that were observed. To test this hypothesis, we recently 
showed that ectopic expression of Sox2 in the developing embryonic gut drives 
the activation of the foregut transcriptional program and led to a rapid conversion 
from an intestinal into a premature gastric epithelium, despite simultaneous 
expression of Cdx227. However, binding of Cdx2 to its genomic targets and thus 
its transcriptional activity was strongly reduced. This suggests that the balance 
between Sox2 and Cdx2 function is essential for proper specification of the 
primitive gut and that Sox2 can exert a dominant effect over Cdx2 to alter intestinal 
cell fate by redirecting the intestinal transcriptional program, emphasizing the 
plasticity of the primitive gut. 
 While our understanding of the roles of Sox2 and Cdx2 in the developing 
gastrointestinal tract has increased over the last years, far less is known about 
their roles in the mature gastro-intestinal tract. Studies done in order to elucidate 
the consequences of Cdx2 ablation in the mature intestinal tract resulted in various 
phenotypes. Stringer et al reported that Cdx2 knockout in the mature intestinal 
tract despite the expression of various gastric-associated genes retained a 
normal crypt-villus architecture, showing that Cdx2 loss only resulted in a partial 
conversion towards gastric epithelium28. Interestingly, in contrast to embryonic 
ablation of Cdx2, no induction of Sox2 expression was observed. Furthermore, 
they demonstrated that in absence of Cdx2, the intestinal stem cells were not 
able to differentiate into enterocytes, goblet cells or Paneth cells. In apparent 
contrast Hryniuk et al show that acute Cdx2 loss in the entire mature intestinal 
epithelium caused a rapid decline in health and death of the animals within a 
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week, which was accompanied by disruption of normal villus morphology and a 
decrease in transit amplifying and stem cell compartments29. However, long term 
loss of Cdx2, achieved by suboptimal dosing to evoke partial ablation compatible 
with long term survival, resulted in dysplastic regions in the small intestine, which 
were devoid from Cdx2 and showed some gastric characteristics. Thus, Cdx2 
is necessary and sufficient to direct gut epithelial cells to an intestinal nature 
in adults. Nevertheless, the adult intestine showed a reduced plasticity towards 
gastric conversion. In the embryonic experiments that we and others performed, 
loss of Cdx2 functionality was in all cases accompanied with increased Sox2 
expression, suggesting that both are required to influence the plasticity of the 
intestinal cells. Since in the mature intestinal tract no ectopic Sox2 expression 
was observed, we wondered whether the lack of Sox2 expression underlies the 
limited plasticity of the adult epithelium. 
In the present study we used an inducible mouse model that upon 
doxycyline administration expresses transgenic Sox2 specifically in the 
mature intestinal tract. We show that ectopic Sox2 expression does not alter 
the differentiation process into the main intestinal cell types, but does have a 
great impact on villus morphology, proliferation and crypt formation. Our results 
indicate that the mature intestinal epithelium retains a limited degree of plasticity 
compared with the developing gut. Moreover, ectopic expression of Sox2 drives 
cells into a more progenitor-like phenotype, in concordance with its association 
with establishing progenitor identity. 
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Materials and methods
Transgenic animals
The myc-Sox2 and Villin-rtTA transgenic mouse lines were described 
previously11 30. The administration of doxycycline to the mice in their drinking 
water (2mg/ml doxycycline, 5% sucrose) for 1,3 and 5 days induced expression of 
myc-Sox2 in intestinal epithelium of double transgenic animals. Each experiment 
was performed on at least three control and three double transgenic mice, which 
received doxycycline for the indicated time points. 
Histology
After the mice were sacrificed, the intestinal tract was removed, cut open 
and washed in PBS. Next, sections of approximately 10 cm were spread out 
on filter paper and fixed in 4% phosphate buffered paraformaldehyde overnight, 
processed and embedded in paraffin. Immunohistochemistry (IHC), Periodic 
Acid Schiff staining (PAS) and Hematoxylin and Eosin staining was performed as 
described previously31. Antibodies are listed in Supplemental Table I. Differentiated 
and proliferative cells in the epithelium were quantified by counting at least 3 
microscopic fields relative to the total number of epithelial cells.
79
Ectopic expression of Sox2 in the mature intestinal tract induces aberrant proliferation
C
ha
pt
er
 4
Results
Ectopic Sox2 expression affects the morphology of the mature intestinal 
tract
In the normal digestive tract, Sox2 is expressed in the esophagus and 
stomach, while it is completely excluded from the intestinal tract 32. In contrast, 
Cdx2 is exclusively expressed in the intestine and not in the esophagus and 
stomach33. Previously, we showed that ectopic expression of Sox2 in the 
developing embryonic gut resulted in cell fate conversion of primitive intestinal 
cells into more gastric-like cells, in spite of sustained Cdx2 expression. These 
data suggested that Sox2 is able to convert already committed cell types into 
other ones. In order to investigate whether Sox2 is able to alter the homeostasis of 
the mature intestinal tract and whether it is also able to convert fully differentiated 
intestinal cells towards a more gastric like phenotype, we ectopically expressed 
Sox2 specifically in the intestinal epithelium of adult animals. Therefore, we 
crossed transgenic mice carrying a doxycycline-inducible, myc-tagged Sox2 
gene with the Villin-rtTA transgenic mouse line, which drives expression of the 
rtTA protein in all intestinal epithelial cells 11 30. 
First we noted that treatment with doxycycline for more than 3 days led 
to a decrease in general fitness of the double transgenic animals, all showing 
signs of diarrhea and reduced fur shininess, symptoms which were not observed 
in control animals. After 5 days of treatment this effect became even more 
striking and double transgenic mice actually started to die from this day onward, 
most likely as a result of dehydration, while control animals appeared healthy, 
independent of the number of days of doxycycline treatment. 
We studied the expression pattern of the ectopic Sox2 protein, by 
performing IHC using an antibody against the myc-epitope (data not shown) 
and Sox2. In the control animals, Sox2 was absent in the intestinal epithelium 
(Fig.1A), while in the double transgenic animals nuclear Sox2 was detectable in 
the intestinal epithelium throughout the entire intestinal tract. At day 1 of induction, 
ectopic Sox2 was clearly expressed in both the villus and crypt compartment 
(Fig.1B). At later time points expression of Sox2 became more restricted to the 
villus, in addition to few scattered Sox2-positive cells in the crypt compartment 
(Fig. 1C,D).
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Figure 1: Ectopic expression of Sox2 in the mature intestinal epithelium causes 
morphological changes.
Nuclear Sox2 expression is present in the intestinal epithelium of double transgenic animals after 
1(B), 3(C) and 5(D) days of doxycycline treatment, while in controls Sox2 is absent (A). After 3 days of 
inductionSox2 becomes restricted to the villus.HE staining shows that the villi in the double transgenic 
animals gradually shorten (F, G, H), upon Sox2 induction, compared to the controls (E). Scale bars: 
200mm (A-H).
The loss of crypt expression may be the result of silencing of the 
transgenic Villin-promoter, which we also observed in Apc-driven tumor formation 
(unpublished observation).
Histological analysis revealed that the villi of the small intestine gradually 
shortened after prolonged induction of Sox2 expression (Fig. 1F,G,H), compared 
to the controls (Fig.1E). In addition, the epithelial layer of intestines of the double 
transgenic animals was disorganized and became multilayered (Fig.2E), whereas 
in the control animals a single layer of intestinal cells were well positioned and 
aligned (Fig.2A). Furthermore, we detected in the double transgenic animals 
the formation of vacuoles in the tip of the villi (Fig.2F). Additionally, the highly 
structured crypt-villus units progressively lost their organization and showed an 
aberrant morphology. The crypts were elongated, most apparent after 3 days 
of treatment (Fig.2G), compared to the controls (Fig.2C). The expression of 
Sox2 also induced anomalous crypts, which were present not only at the base 
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of the villus, but also seemed to be positioned within villus structures (Fig. 2H). 
Thus, ectopic expression of Sox2 affects the morphology of the intestinal villi and 
causes the formation of aberrant crypt structures.
Figure 2: Ectopic expression of Sox2 in the mature intestinal epithelium causes 
disorganization of the intestinal epithelium and results in aberrant crypt-villus 
morphology.
Ectopic expression of Sox2 in the mature intestinal epithelium leads to a disorganized, multi-layered 
epithelial layer (E), compared to the controls (A).A representative double transgenic animal is shown, 
which was treated with doxyxyclin for 5 days. Furthermore vacuoles were observed in the tip of the 
villi specifically in the double transgenic animals (F). Additionally the crypt villus axis was altered, 
since crypt became elongated over time (G) and cryp-like structures were observed within the villus, 
most apparent in after 3 days of Sox2 induction (H). Scale bars: 20mm (A-C and E-G) and 100mm 
(D,H).
Ectopic expression of Sox2 causes aberrant positioning of proliferating 
cells
Since we observed structural changes in the villi, we examined the 
proliferative capacity of the epithelial cells. Therefore, we used the general 
proliferation marker Ki-67 (data not shown), and stained for phosho-Histone 
H3, which marks mitotic cells. Proliferation is normally restricted to the crypt 
compartment (Fig.3A), but in the double transgenic animals the proliferative 
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zone of cells is expanded from the crypts to the villus structure (Fig.3B-D and 
b-d). These data indicate that ectopic expression of Sox2 in the mature intestinal 
epithelium causes epithelial cells to convert to a more progenitor-like phenotype. 
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Figure 3: Ectopic expression 
of Sox2 in the mature 
intestinal epithelium affects 
proliferation.
 IHC using phosho-Histone H3 
(PHH3) shows that in the control 
animals proliferation is restricted to 
the crypt compartment (A), In the 
double transgenic animals dividing 
cells are also observed in the villus 
and in the aberrantly positioned 
crypts (B,C,D). More detailed images 
of the villi in control and double 
transgenic animals (a-d).  Scale bars: 
200mm (A-D) and 20mm (a-d).
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Intestinal differentiation is not altered in mice ectopically expressing 
Sox2 
Animals with Sox2 induction detoriated progressively with signs of 
diarrhea and overall reduced health. This indicated a general defect in the 
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Figure 4: Ectopic expression of Sox2 in the mature intestinal tract does not alter the 
differentiation of the intestinal cells.
PAS staining marks the intestinal brush border as a clear pink lining in the contols (A). Until three days 
of Sox2 induction the brush border of the double transgenic animals are intact (B, C), however after 
induction for longer period the brush border appears to vanish (D). IHC for Muc2, which is a marker for 
the goblet cells, shows that goblet cells are present in both the control (E) and the double transgenic 
animals (F-H), although in the latter the localisation is chaotic, because of the dramatic morphological 
alterations. IHC for Cdx2 shows that it is expressed in the intestinal epithelium in both the control (I) 
and the double transgenic animals (J-L). After three days of induction Cdx2 expression is decreased 
at the tip of the villi, whereas is robustly expressed in the crypts (K, L). ).Scale bars: 100mm (A-D) and 
200mm (E-L).
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absorption capacity of the intestinal epithelium. Previously, we showed that ectopic 
expression of Sox2 during intestinal development hampered the formation of the 
brush border, which is essential for intestinal absorptive capacity27. Therefore, 
we performed a PAS staining, which marks the intestinal brush border, visible 
as a thin pink apical lining (Fig. 4A). In the double transgenic animals the brush 
border appeared mostly intact until 3 days of induction (Fig. 4B,C). After 5 days 
of induction, the intestinal brush border is locally vanished (Fig. 4D). Although the 
effects on the brush border are not as dramatic as previously described for the 
embryonic gut, it may partially explain the observed effects on general health.
Since ectopic expression of Sox2 caused alterations in the intestinal 
architecture and resulted in ectopically located proliferating cells, we wondered 
whether the intestinal identity was affected. Therefore, we performed IHC using 
an antibody against Mucin2, which is a marker for the mucin producing goblet 
cells. We show the presence of goblet cells both in the control (Fig.4E) animals as 
well as in the double transgenic animals which were treated with doxycycline for 
various days (Fig. 4F,G,H). However, the localization of the goblet cells was not 
clearly defined due to the dramatic alterations in the morphology of the intestinal 
epithelium. 
The presence of Paneth was analyzed using a specific staining for 
lysozyme (data not shown). We observed that in both the control and double 
transgenic animals Paneth cells are present, but the localization of the Paneth 
cells was not always restricted to the crypt compartment in the Sox2 expressing 
animals. 
Ectopically expressed Sox2 does not induce gastric cell types in adult 
mice 
Previously, we observed that ectopic expression of Sox2 in the embryonic 
intestinal tract, led to the rapid formation of premature gastric-like epithelium. 
Therefore, we analyzed the appearance of the gastric acid producing parietal 
cells with an antibody against N+/K+-ATPase. While we found parietal cells in the 
stomach, we could not detect positive cells in the control or double transgenic 
animals (data not shown). Also Mist1-positive zymogenic chief cells, GSII lectin 
positive mucus neck cells and gastric Muc5ac, were not detectable in the Sox2 
induced intestines, while the stomach was positive (data not shown).
In conclusion, it appears that the main intestinal cell types are present 
in both control and double transgenic animals, although their localization is 
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affected due to the disruption of villus morphology. However, the intestinal brush 
border appeared to gradually decrease and was locally vanished after 5 days 
of Sox2 induction, most likely accounting for the symptoms observed in the 
double transgenic animals. In contrast to the phenotypic changes observed in 
the intestine when Sox2 was expressed during embryonic development, ectopic 
Sox2 expression does not induce the conversion of intestinal cells into gastric cell 
types when expressed in the mature gastrointestinal tract, but rather appears to 
induce a more progenitor phenotype of the cells. 
Sox2 expression in the intestinal tract partially affects Cdx2 expression
In the developing gut, a strict balance between Sox2 and Cdx2 turned out 
to be essential for proper regionalization and organ specificity. Increasing evidence 
is provided that Cdx2 is essential for the maintenance of intestinal identity in adult 
mice. It was recently shown that conditional knock-out of Cdx2 specifically in 
the mature intestinal epithelium also resulted in morphologically altered villi and 
aberrant crypt villus structures29. Additionally, it was shown that conditional knock-
out of Cdx2 in adult intestinal epithelium, resulted in ectopic expression of various 
gastric genes28. However it did not lead to actual conversion into gastric tissue. 
Interestingly, Cdx2 knock-out did not lead to upregulation of Sox2. Therefore, we 
performed IHC for Cdx2 in order to examine whether there were changes in the 
Cdx2 expression pattern. In concordance with our study in which we examined 
the effect of ectopically expressed Sox2 on embryonic gut development27, we 
show that Cdx2 expression is clearly present in both the control (Fig. 4I) and 
double transgenic animals (Fig.4 J,K,L). However, from 3 days of doxycycline 
treatment onwards the expression of Cdx2 seems to decrease in the tip of the villi 
coinciding with the area in which the vacuoles are observed, whereas expression 
downward to the crypts is clearly present. Thus, ectopic expression of Sox2 in 
the mature intestinal does not hamper the expression of Cdx2 dramatically, but 
results in a slight decrease in Cdx2 expression in the tip of the villi.   
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Discussion
In the developing gut, a balance between the transcription factors Sox2 
and Cdx2 is essential for normal development. In mice embryos, it was shown 
independently that both loss of intestinal Cdx2 as well as induced Sox2 expression, 
led to the activation of the foregut transcriptional program, resulting in a gastric-
like phenotype26-27. This plasticity observed during development suggested that 
intestinal cells have a capacity greater than just forming intestinal epithelium. 
Since the adult intestinal epithelium has a high turnover, we wondered whether 
the epithelial cells in the adult intestine have the same plasticity as the embryonic 
cells. Therefore, we ectopically expressed Sox2 in the intestinal epithelium of 
adult mice.
Starting at three days of induction the animals became progressively 
ill and suffered from diarrhea and dehydration. Examination of the intestines 
revealed dramatic changes in the villi, such as progressive shortening and 
disorganization of the intestinal epithelium. The epithelium changed from a clear 
single layer of columnar cells into a multilayered population of cells. Also the 
intestinal brush border vanished locally after 5 days of doxycycline treatment, 
which may account for the progressive illness of the induced animals, most likely 
due to problems with intestinal absorption
Recently, the effect of conditional knock-out of Cdx2 in the mature 
intestine has been described by independent groups. Complete loss of Cdx2 
throughout the whole intestinal epithelium, caused a rapid decline in health 
and ultimately death of the animals within a week, which was accompanied 
by disruption of normal villus morphology and a decrease in transit-amplifying 
and stem cell compartments29. Loss of Cdx2 only in a subset of the crypt-villus 
units, allowed long-term survival of the animals resulting in loss of intestinal 
identity, in addition to the acquisition of some gastric characteristics of the Cdx2-
negative epithelium28-29. Importantly, no induction of ectopic Sox2 expression was 
observed28. The latter is in clear contrast to the embryonic situation in which Cdx2 
loss in all cases was accompanied with ectopic Sox2 expression25-26. 
Our current results show that induced Sox2 expression in the mature 
intestinal tract has a very different outcome compared with loss of Cdx2. The main 
intestinal differentiation program was not affected as shown by the presence of 
goblet and Paneth cells, and no clear evidence of gastric conversion was noted. 
This might be due to the fact that Cdx2 itself is still expressed throughout the 
intestinal epithelium and retains sufficient transcriptional functionality to induce 
an intestinal program. 
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The most profound effect induced by Sox2 is the induction of a proliferative 
phenotype throughout the entire crypt-villus axis, which likely also underlies the 
formation of the aberrant crypts and the multilayered epithelium. This phenotype 
is in accordance with the induction of pluripotency and progenitor identity that has 
frequently been attributed to Sox214-15 34-39. It is however in stark contrast to the 
Cdx2 knock-out phenotype characterized by reduced proliferation that remains 
restricted to the crypt zone28-29.
In conclusion, our results suggest that Sox2 expression by itself is not 
sufficient to aberrantly induce gastric epithelium within the adult intestinal tract, 
and most likely requires the simultaneous loss of Cdx2 functionality. On the other 
hand, although Cdx2 loss results in some gastric characteristics in the mature 
intestine, it shows a clearly reduced efficiency when compared with the embryonic 
gut. In the latter the aberrant Sox2 expression accompanying Cdx2 loss, may 
facilitate a full gastric conversion by inducing more progenitor-like cells allowing 
for an easier reprogramming of the cells into another differentiated phenotype. 
Our results also confirm the limited degree of plasticity of the adult intestinal 
epithelium compared to its embryonic counterpart.
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Abstract 
Congenital gastric type heteroplasia is common in intestinal duplications 
and anomalies, which find their origin in incomplete resorption of the 
omphalomesenteric duct. During development, two transcription factors play 
a determining role in the anterior-posterior specification of the gastrointestinal 
tract. SOX2 is expressed exclusively in the anterior part of the primitive gut, while 
CDX2 is expressed solely in the posterior part. In the absence of CDX2 during 
gut differentiation, ectopic tissue, mostly gastric tissue may arise. However, 
we recently showed that Sox2 leads to aberrant formation of gastric-like cells 
in the prospective intestine of transgenic mice, even in the presence of Cdx2, 
suggesting that Sox2 may have a dominant role in determining intestinal cell fate. 
Therefore we investigated the expression pattern of SOX2 and CDX2 in three 
congenital intestinal anomalies in which ectopic gastric tissue may be present, 
Meckel’s diverticulum (N=8), persistent ductus omphalomesentericus (N=14) 
and intestinal duplications (N=8). CDX2 was detected in intestinal epithelial cells 
in tissue lacking gastric heteroplasia, where SOX2 was absent. In gastric-type 
heteroplasia, a reciprocal expression pattern existed between SOX2 and CDX2 
in the gastric and intestinal tissue, respectively. Interestingly, patches of CDX2 
positive cells were present within the gastric mucosa in a subset of Meckel’s 
diverticula and intestinal duplications, suggesting that it is not the absence of 
CDX2 leading to gastric tissue in the prospective intestinal tissue, but rather 
the ectopic expression of SOX2 in the intestine. This is in concordance with 
our previous mouse studies. Collectively, this indicates that also in humans a 
fine balance between SOX2 and CDX2 expression in de gastrointestinal tract is 
essential for proper development and that ectopic expression of SOX2 may lead 
to malformations of the gut.
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Introduction
Intestinal gastric-type heteroplasia, which refers to the presence of 
ectopic gastric tissue in the intestine, is a rare pathological abnormality detected 
in several congenital anomalies1. The most commonly observed intestinal 
anomalies are persistent omphalomesenteric ducts, Meckel’s diverticula and 
intestinal duplications (Fig. 1). The latter arise after gastrulation when the 
crescent-shaped endodermal germ layer folds to form the primitive gut2. During 
the first trimester of embryonic development, the intestinal epithelium proliferates 
leading to a temporary block of the lumen, followed by a recanalisation in week 
9 of gestation. Incomplete recanalisation is believed to underlie the formation of 
intestinal duplications (Fig. 1A).
Meckel’s diverticula arise from the omphalomesenteric duct (also referred 
to as vitelline duct) that connects the midgut with the yolk sac before placental 
connections are established. Normally, the omphalomesenteric duct involutes 
completely between the fifth to ninth week of gestation. However, if this resorption 
does not occur properly, the complete omphalomesenteric duct, or part of it, may 
persist, which leads to various congenital anomalies3. Persistence of the complete 
omphalomesenteric duct within the abdominal wall may cause a patent ductus 
omphalomesentericus. The lumen of the ductus omphalomesentericus remains 
open from ileum to the umbilicus resulting in faecal contents discharged from 
the umbilicus (Fig. 1B). The umbilicus may also be closed by the skin, leaving 
a blunt-ended umbilicus (Fig. 1C), or a fibrous cord may remain, connecting the 
small intestine to the umbilicus through a so called umbilico-ileal fistula (Fig. 
1D). Failure of the most proximal portion of the duct to obliterate, results in a 
small protrusion from the ileum, typically at the antimesenteric site, the so-called 
Meckel’s diverticulum, which accounts for the most prevalent congenital disorder 
of the gastro-intestinal tract occurring in approximately 2% of the population 
(Fig.1E). In many cases Meckel’s diverticulum does not result into clinical 
symptoms throughout life. 
The diverticula as well as other vitelline duct anomalies contain all layers 
of the intestinal wall. In addition, ectopic tissue, mostly gastric, is commonly 
observed in both intestinal duplications and omphalomesenteric duct anomalies, 
accounting for most of the complications of these malformations. The ectopic 
gastric tissue often causes internal bleedings as a result of ulceration of the 
adjacent ileal mucosa inflicted by the acid produced by the gastric mucosa1, 
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leading to anal blood loss or blood containing stool or with slow onset ferriprive 
anemia3.
The mechanisms responsible for the determination of organ identity in 
the gastrointestinal tract in humans are poorly understood and are mainly based 
on the extrapolation from animal studies. One of the earliest steps in patterning of 
the primitive gut is the regionalization into an anterior and posterior domain, which 
correlates with the mutually exclusive expression of two transcription factors, 
Sox2 and Cdx2, respectively4. Sox2 is a member of a highly conserved family of 
transcription factors founded by the sex-determining gene Sry. Sox proteins are 
key players in the regulation of embryonic development and determination of cell 
fate5-6. Sox2 plays an important role during early vertebrate embryogenesis and 
is required for proper development of the brain, neural tube, trachea and germ 
cells7-12. In addition, it is one of the main factors involved in the differentiation of 
the gastric epithelium11 13. Several congenital malformations in humans, such as 
anophthalmia, microphthalmia and the AEG (anophthalmia-esophageal-genital) 
syndrome14, have been associated with heterozygote mutations in SOX2.
Figure 1: Schematic representation of congenital intestinal anomalies.
(A) Intestinal duplication. (B) Open persistent ductus omphalomesentericus. (C) Persistent ductus 
omphalomesentericius. (D) Umbilico-ileal fistula. (E) Meckel’s diverticulum.
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Cdx2 is a homeobox transcription factor involved in the establishment of 
the anterior-posterior polarity of the gut endoderm and is expressed from E8.5 
in the posterior part of the gut15. Later in development, Cdx2 becomes restricted 
to the intestinal epithelium, with a sharp boundary, marking the transition from 
stomach to duodenum4 16-18. Cdx2 plays a key role in determining intestinal identity, 
as it was shown that loss of Cdx2 function in mouse embryos resulted in colonic 
atresia and in the conversion of intestinal cell types to a gastric-like phenotype, 
concomitant with ectopic activation of Sox2 expression19-20. We recently showed 
the emergence of a comparable phenotype by ectopic expression of transgenic 
Sox2 in the prospective gut endoderm. Exogenous Sox2 did not affect Cdx2 
expression itself, but prevented the binding of Cdx2 to its genomic targets and thus 
its transcriptional activity. Moreover, we showed that ectopic expression of Sox2 
in the developing embryonic gut epithelium was capable of driving cells towards 
a gastric fate, despite the fact that intestinal organ identity had already been 
established21. Taken together, these results show that a strict balance between 
Sox2 and Cdx2 function is required for proper specification of the primitive gut.
In human gastrointestinal congenital diseases very little is known about 
the expression pattern of these transcription factors. It has been proposed that 
at sites of gastric heteroplasia the expression of CDX2 was reduced during gut 
formation22. However, the expression of SOX2 has not been investigated in 
these congenital anomalies. Therefore, we analyzed the expression pattern of 
SOX2 and CDX2 in various congenital anomalies of the gastrointestinal tract with 
gastric-type heteroplasia. 
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Materials and methods
Paraffin embedded tissue from 8 patients with intestinal duplications, 14 
with persistent ductus omphaloentericus and 8 with Meckel’s diverticulum were 
obtained from the department of Pathology of the Erasmus Medical Centre, 
Rotterdam. Patient details are described in Table 1. Sections of 5 mm were 
used for H&E staining or immunohistochemistry and were evaluated by at least 
one pathologist. For immunohistochemistry, sections were deparaffinized and 
rehydrated, followed by antigen retrieval with microwave treatment in Tris-EGTA 
pH 9.0. Sections were blocked with 5% nonfat dry milk in PBS for 10 min and 
incubated with primary antibody diluted in 5% nonfat dry milk in PBS overnight 
at 4°C. Primary antibodies that were used are Sox2 (Immune systems), CDX2 
(Biogenex), and MUC5AC (45M1, Abcam). Secondary antibodies against the 
correct IgG species were conjugated with peroxidase (StreptABC complex/HRP, 
DAKO) followed by DAB colorimetric detection. 
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Table 1: Patient details: sex, age at surgery, localization of resected tissue and clinical 
diagnosis
Sex
Age at 
surgery Localisation Diagnosis
1 V 7 days terminal colon intestinal duplication
2 M 13 days terminal colon intestinal duplication 
3 M 3 days small intestine* intestinal duplication 
4 V 170 days ileocaecal border intestinal duplication 
5 M 155 days distal ileum intestinal duplication
6 M 97 days small intestine intestinal duplication with ectopic gastric mucosa 
7 V 55 days terminal ileum intestinal duplication with ectopic gastric mucosa
8 V 147 days ileocaecal border intestinal duplication with ectopic gastric mucosa
 
9 V 9 days small intestine* persistent ductus omphalomesentericus
10 M 16 days small intestine* persistent ductus omphalomesentericus
11 M 12 days small intestine* persistent ductus omphalomesentericus 
12 M 1 day small intestine* persistent ductus omphalomesentericus 
13 M 5 days small intestine* persistent ductus omphalomesentericus
14 M 1 day small intestine* persistent ductus omphalomesentericus
15 M 38 days small intestine* persistent ductus omphalomesentericus
16 M 1 day small intestine* persistent ductus omphalomesentericus
17 M 294 days umbilicus persistent ductus omphalomesentericus
18 M 165 days umbilicus persistent ductus omphalomesentericus 
19 M 1,1 years small intestine* persistent ductus omphalomesentericus with ectopic 
gastric mucosa
20 M 212 days small intestine* persistent ductus omphalomesentericus with ectopic 
gastric mucosa
21 M 58 days umbilicus persistent ductus omphalomesentericus with ectopic 
gastric mucosa
22 V 2 days umbilicus persistent ductus omphalomesentericus with ectopic 
gastric mucosa
23 V 1,7 years small intestine* Meckel’s diverticulum 
24 M 64,9 years small intestine* Meckel’s diverticulum 
25 V 92 days terminal ileum Meckel’s diverticulum 
26 M 74,3 years small intestine* Meckel’s diverticulum with ectopic gastric mucosa
27 V 6,4 years small intestine* Meckel’s diverticulum with ectopic gastric mucosa 
28 M 12 years Ileocaecal border Meckel’s diverticulum with ectopic gastric mucosa 
29 M 41,2 years Ileoceacal border Meckel’s diverticulum with ectopic gastric mucosa
30 V 40,3 years terminal ileum Meckel’s diverticulum with ectopic gastric mucosa
* precise localisation unknown
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Results
Given the importance of SOX2 and CDX2 in the formation of the 
gastro-intestinal tract, we analyzed the expression pattern of both transcription 
factors in intestinal anomalies with gastric-type heteroplasia, including intestinal 
duplications, persistent omphalomesenteric ducts and Meckel’s diverticula.
   
   
   
   
   
   
   
  C
D
X2
   
   
   
   
   
   
   
   
   
SO
X2
   
   
   
   
   
   
   
   
M
U
C
5A
C
   
   
   
   
   
   
   
  H
E 
B 
F 
H 
d 
h 
f 
b A 
E 
G 
Intestinal Gastric heteroplasia 
C D 
Figure 2: Histological analysis of intestinal duplications.
HE staining, of a representative case of intestinal duplication with gastric heteroplasia, showing 
intestinal epithelium (A) and ectopic gastric mucosa in the intestinal duplication (B). IHC for MUC5AC 
shows specific expression in the gastric heteroplasia (D), while no staining is observed in the 
intestinal epithelium (C). IHC for SOX2 shows expression of SOX2 in the ectopic gastric mucosa 
(F), but not in the intestinal epithelium (E). IHC for CDX2 shows exclusively nuclear expression in 
intestinal epithelium (G), however also ectopic expression of CDX2 in parts of the gastric heteroplasia 
is present (H). Higher magnifications of B,D,F and H are shown in b,d,f and h respectively. Scale bars: 
A-H 200mm and b,d,f,h 20 mm
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We examined 8 cases of intestinal duplications of which 3 showed the 
presence of gastric tissue as determined by histological evaluation (representative 
case shown in Fig. 2). The expression of MUC5AC confirmed the presence 
of gastric tissue in all three cases (Fig. 2D, d), whereas the intestinal mucosa 
was completely devoid of MUC5AC (Fig. 2C), which was comparable with the 5 
cases in which no gastric heteroplasia was present (data not shown). In these 
latter cases no specific nuclear SOX2 expression was observed, except in the 
neuronal plexi (data not shown), which we used as an internal control for SOX2 
Figure 3: Histological analysis of persistent ductus omphalomesentericus.
HE staining, showing intestinal epithelium (A) and ectopic gastric mucosa (B) in a representative case 
of persistent ductus omphalomesentericus with gastric heteroplasia. IHC for MUC5AC shows specific 
expression in the gastric heteroplasia (D), while no staining is observed in the intestinal epithelium (C). 
IHC for SOX2 shows expression of SOX2 in the ectopic gastric mucosa (F), but not in the intestinal 
epithelium (E). IHC for CDX2 shows \ nuclear expression in intestinal epithelium (G), while no specific 
expression of CDX2 is present in parts of the gastric heteroplasia (H). Higher magnifications of B,D,F 
and H are shown in b,d,f and h respectively. Scale bars: A-H 200mm and b,d,f,h 20 mm
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expression23. In the duplications in which gastric tissue was present, specific 
nuclear SOX2 could be detected in the gastric mucosa (Fig.2F, f), while in the 
surrounding intestinal epithelium specific nuclear expression of SOX2 was absent 
(Fig. 2E). Next we analyzed the distribution of CDX2 expression, in order to 
determine the presence of the intestinal epithelium. We detected CDX2 uniformly 
in the intestinal epithelium of all samples (Fig.2G). Interestingly, we also observed 
CDX2 expression in 2 of the 3 duplications with gastric-type heteroplasia within 
the parts which were histologically determined to be gastric tissue (Fig. 2H,h). 
Moreover, these CDX2 positive cells also showed a reduced, but not entirely 
absent, expression of SOX2 (compare Fig. 2f and 2h).
We subjected the omphalomesenteric duct anomalies to an identical 
analysis. First we analyzed the expression pattern of SOX2 and CDX2 in the 
persistent omphalomesenteric ducts. A total of 14 cases were examined, of which 
4 samples contained ectopic gastric tissue based on histological evaluation 
(representative case shown in Fig.3) and IHC for MUC5AC, which was specifically 
expressed at these sites (Fig. 3D,d). The intestinal mucosa was devoid of MUC5AC 
(Fig.3C), as also was seen in the 10 samples consisting exclusively of intestinal 
tissue (data not shown). In the 4 samples with ectopic gastric tissue, nuclear 
staining was observed for SOX2 in the gastric mucosa (Fig. 3F, f), whereas in 
the surrounding intestinal epithelium specific SOX2 expression was absent (Fig. 
3E). CDX2 staining was exclusively detected in the intestinal epithelium (Fig.3G), 
whereas it was not expressed in the gastric tissue (Fig. 3H, h). 
In addition, we examined 8 cases of Meckel’s diverticulum of which 3 
cases with exclusively intestinal tissue (data not shown) and 5 with histologically 
gastric type heteroplasia (representative case shown in Fig. 4). The appearance 
of gastric tissue was confirmed using MUC5AC (Fig. 4D, d), while in the intestinal 
mucosa no MUC5AC was present (Fig. 4C). As expected, no specific SOX2 
expression was observed in the intestinal epithelium (Fig. 4E), whereas in the 
gastric tissue, SOX2 was expressed in the gastric epithelium (Fig. 4F, f). IHC 
for CDX2 showed clear expression in the intestinal epithelium (Fig. 4G) and no 
staining in the ectopic gastric tissue, except for 1 sample, in which we observed 
CDX2 expression in the ectopic gastric mucosa (Fig. 4H, h). 
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Figure 4: Histological analysis of Meckel’s diverticulum.
HE staining, showing intestinal epithelium (A) and ectopic gastric mucosa (B) in a representative case 
of Meckel’s diverticulum with gastric heteroplasia. IHC for MUC5AC shows specific expression in the 
gastric heteroplasia (D), while no staining is observed in the intestinal epithelium (C). IHC for SOX2 
shows expression of SOX2 in the ectopic gastric mucosa (F), but not in the intestinal epithelium (E). 
IHC for CDX2 shows exclusively nuclear expression in intestinal epithelium (G), however also ectopic 
expression of CDX2 in parts of the gastric heteroplasia is present (H). Higher magnifications of B, D, 
F and H are shown in b,d,f and h respectively. Scale bars: A-H 200mm and b,d,f,h 20 mm
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Discussion
Recent studies have addressed the role of Cdx2 and Sox2 in the 
development of the primitive gut into specific organ domains11 20-21. The transcription 
factor Sox2 is normally expressed in the anterior part of the presumptive gut, i.e., 
esophagus and stomach, while Cdx2 is predominantly expressed in the posterior 
part of the gut2. Specific gene ablation of Cdx2 in the intestine of the mouse 
showed an anteriorization event of the intestinal tract, leading to a gastric-like 
phenotype associated with ectopic Sox2 expression20. Recently, we showed 
that this anteriorization event also occurred upon ectopic Sox2 expression in the 
embryonic intestinal epithelium, despite the fact that Cdx2 was still expressed 
in the intestine. Furthermore, we showed that Cdx2 did no longer bind to its 
endogenous target sequences in the presence of Sox2, indicating a functional 
loss of Cdx2 activity. This strongly indicated that it is not solely the lack of Cdx2 
that causes the stomach-like phenotype, but rather requires the expression of 
Sox2 in the intestinal epithelium21.
Although substantial insight has been gained about gut formation in 
mice, the mechanisms and the expression pattern of SOX2 and CDX2 during 
the development of the gastrointestinal tract and in developmental anomalies of 
the digestive tract in humans are largely unknown. Therefore, we investigated 
3 types of congenital malformations of the intestine in humans, i.e. intestinal 
duplications, persistent omphalomesenteric ducts and Meckel’s diverticulum, in 
which frequently ectopic gastric tissue has been observed. In general, a reciprocal 
expression pattern of CDX2 and SOX2 was observed in the intestine and gastric 
tissue, respectively. Interestingly, we observed 3 cases that expressed CDX2 in 
the ectopic gastric type heteroplasia. This would  suggest that the primary reason 
for the appearance of gastric tissue is not just the lack of CDX2, as was proposed 
by Martin et al22, but rather the ectopic expression of SOX2, as we showed in our 
study in mice21. 
Gastric heteroplasia is seen both in intestinal duplications as well as 
anomalies of the omphalomesenteric duct. Both types of malformation arise 
during the first trimester of gestation, though different causes underlie these 
anomalies. Duplicatures are thought to result from improper recanalization of 
the intestinal tube, whereas omphalomesenteric duct anomalies are caused by 
improper resorption of this duct. However, ectopic tissue, mainly gastric tissue, 
is still observed in both kinds of anomalies. A possible explanation could be that 
the intestinal epithelium has a certain degree of plasticity in the first trimester of 
embryonic development. In support of this, Sherwood et al pointed out a phase 
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at E8.75-E9.25 of mouse development when cells at the border of stomach and 
intestine co-express both transcription factors. At E9.5 the cellular border remains, 
but the cells exclusively express either Sox2 or Cdx24. This phase of embryonic 
development coincides with the timing of involution of the omphalomesenteric 
duct. As such, the double-positive cells that we observe, might represent 
descendants from the population of cells described above, which co-express 
both factors during a short phase of intestinal development. Alternatively, after 
the intestinal epithelium is already formed it may still be influenced by ectopic 
expression of factors such as SOX2, resulting in the conversion of the intestinal 
epithelium into a gastric phenotype.  
In conclusion, we showed the expression pattern of SOX2 and CDX2 
in intestinal duplications, persistent omphalomesentericus and Meckel’s 
diverticulum. Our data suggest, as also observed in mice, that ectopic expression 
of SOX2 in the intestinal epithelium might contribute to the cell fate conversion 
from intestinal tissue to gastric tissue, in spite of sustained CDX2 expression. 
This supports the general concept based on animal studies that a strict balance 
between SOX2 and CDX2 during early development is essential for normal 
development of the gastrointestinal tract, also in human.  
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mucinous differentiation
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Abstract
Aim: Colorectal cancer (CRC) can be subdivided in mucinous and 
non-mucinous CRC. A recent study suggested a putative link between SOX2 
expression observed selectively in mucinous CRC, which portend to have a 
worse clinical prognosis. In this study we aimed to further elucidate the expression 
behavior of SOX2, CDX2 and MUC5AC in both mucinous and non-mucinous 
CRC, and to examine whether SOX2 expression can be correlated with specific 
tumor characteristics and prognosis.
Methods and results: We performed immunohistochemical analysis 
on 34 cases of non-mucinous CRC, 12 cases of mucinous CRC and 15 case-
matched normal intestinal mucosa. In contrast to the previously suggested 
link between SOX2 and mucinous CRC, we show ectopic expression of SOX2 
predominantly in non-mucinous cancers. While normally SOX2 and CDX2 
are expressed in a reciprocal manner, SOX2-positive tumor cells co-express 
CDX2. Furthermore, we show that MUC5AC was equally expressed in both 
classes of CRC independent of SOX2. This gastric mucin was also detected in 
morphological normal intestinal tissue neighboring tumor sites, while in control 
samples the normal intestinal mucosa MUC5AC was absent. Additionally, the 
SOX2 expressing non-mucinous CRC had a significantly worse survival than the 
SOX2-negative part (p= 0.0224) in the first patient group that we tested, however 
we did not observe this association in a second patient group, in which we tested 
56 non-mucinous CRCs. 
Conclusions: We observe ectopic SOX2 expression predominantly 
in non-mucinous CRC and show the appearance of cells that simultaneously 
express both SOX2 and CDX2, while normally these transcripts are expressed 
in a mutually exclusive manner. Furthermore, in contrast to previous suggestions 
that the aberrant expression of the gastric mucin MUC5AC can be attributed to 
SOX2, our results suggest that SOX2 is not absolutely required. 
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Introduction
Colorectal cancer (CRC) affects over 400,000 people annually in Europe, 
resulting in approximately 220,000 deaths every year. CRC accounts for the most 
frequent malignancy within the European Union, and is the second most common 
cause of cancer-related mortality. CRC has been classified in different subtypes 
according to criteria based on their histological appearance and mutational status 
1. Proper classification of CRC is becoming increasingly important in the clinic, 
as it will more often determine prognostic outcome and choice of therapeutic 
intervention. 
Approximately 75-90% of the CRCs are non-mucinous, while the 
remaining 10-25% are mucinous or signet ring cell carcinomas2-3. Mucinous CRC 
is defined as a tumor with more than 50% mucinous differentiation on histological 
examination, according to the WHO. These tumors are more common in the 
proximal colon and often show a flat appearance, making their early identification 
more difficult. As a result, they present on average with a higher stage of tumor 
progression at first diagnosis. In addition to their delayed detection, mucinous 
differentiation by itself is associated with a modest increase in mortality compared 
with their non-mucinous counterparts, even when corrected for stage3. Elevated 
levels of mucin have also been associated with worse prognosis for various 
other tumor types, including pancreatic cancer4. Furthermore, in comparison 
to their non-mucinous counterparts, mucinous CRCs more often show ectopic 
expression of MUC5AC, a mucin whose expression is normally restricted to the 
upper gastrointestinal tract2 5-7.
The etiology of this subset of cancers and the mechanism underlying 
the mucinous differentiation and worse prognosis are still poorly understood. 
Recently, Park and co-workers reported aberrant expression of SOX2 specifically 
in a subset of CRCs with mucinous differentiation7. They also reported concordant 
expression of SOX2 with MUC5AC in colorectal cancers or cell lines thereof, 
and the activation of a MUC5AC reporter construct by SOX2. In support of their 
results, overexpression of SOX2 in COS-7 cells induced the mRNA expression 
of endogenous MUC5AC, indicating that the MUC5AC expression observed in 
mucinous CRCs, may indeed result from the ectopic SOX2 expression8. The 
SOX2 gene encodes for a HMG-box containing transcription factor with a potent 
role in determining cell fate. In recent years, it has gained substantial attention 
as one of the factors required to obtain induced pluripotent stem (iPS) cells 
from adult somatic cells9. In the adult gastrointestinal tract, SOX2 expression 
is restricted to the gastric and esophageal epithelium, whereas it is completely 
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excluded from the intestine10-11. Additionally, we and others have shown that 
during embryonic development a strict balance between SOX2 and CDX2, which 
is a key transcription factor in determining intestinal identity, is essential for proper 
development of the intestinal tract 12-13.
Recently, a number of studies have reported ectopic expression of Sox2 
in different kinds of cancers, including lung, esophagus and breast cancer10 
14. In these tumor types, aberrant Sox2 expression was associated with worse 
prognosis, attributed to the induction of a precursor-like state induced by Sox2. 
As such, the ectopic SOX2 expression observed in CRCs may likewise affect 
tumor progression.
 In this study we aimed to further elucidate the expression patterns of 
SOX2, CDX2 and MUC5AC in both mucinous and non-mucinous CRC, and 
to examine whether SOX2 expression can be correlated with specific tumor 
characteristics and prognosis. 
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Materials and methods
Human samples
Formalin-fixed, paraffin embedded tissue blocks were obtained from the 
department of Pathology, Erasmus Medical Centre Rotterdam. Material of patients 
from the first group were selected based on their tumor being either mucinous 
(N=12) or non-mucinous (N=34), and healthy intestinal tissue (N=15). Mucinous 
CRC was defined as a tumor with more than 50% mucinous differentiation on 
histological examination, according to the WHO 2010. The second group of 
patients were selected based on their tumor being non-mucinous and at least 
2 years follow-up time (N=56). All H&E and immunohistochemically stained 
sections were evaluated by a pathologist. 
Immunohistochemistry
Sequential 5 mm sections of the paraffin blocks were used for H&E 
staining and immunohistochemistry. For immunohistochemistry, sections were 
deparaffinized and rehydrated, followed by antigen retrieval with microwave 
treatment in Tris-EGTA pH 8.0. Sections were blocked with 5% non-fat dry milk 
in PBS for 10 minutes and incubated with primary antibody diluted in 5% non-
fat dry milk in PBS overnight at 4°C. The following antibodies were used: 1:500 
SOX2 (Immune systems), 1:200 MUC5AC (Abcam) and 1:20 CDX2 (Biogenex). 
Secondary antibodies against the correct IgG species were conjugated with 
peroxidase (Dako) using StreptABC complex/HRP (Dako) or HRP-DAB 
colorimetric detection. Immunohistochemistry for SOX2 and CDX2 were only 
scored as positive when a clear nuclear staining was observed.
Statistical analysis
Ordinal variables were tested for association using the Chi-square test or 
the Fisher’s exact test when appropriate. Continuous variables were tested with 
the Wilcoxon ranksum test with study-set as grouping variable. Survival curves 
were visualized with Kaplan Meier curves. The logrank test or when appropriate 
the logrank test for trend was used to test differences between survival curves. 
Time to survival was analyzed using the Cox proportional hazards model. Overall 
survival was defined as time from diagnosis to death or last date of follow-up. 
Endpoint was death of any cause. A P-value < 0.05 was considered statistically 
significant. All P-values are two-sided. Computations were done with the STATA 
statistical package, release 11.2 (STATA Corp. College Station. TX). 
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Results
SOX2 is expressed in non-mucinous CRC, rather than mucinous CRC
SOX2 has been associated with various malignancies in humans, 
including lung, esophageal and breast cancer10 14. Since it was previously reported 
that SOX2 was expressed specifically in mucinous colorectal cancers 7, we initially 
performed immunohistochemistry on 34 non-mucinous CRC, 12 mucinous CRC 
and 15 samples of normal mucosa, to determine the expression pattern of SOX2 
in human CRC. Specific nuclear expression of SOX2 was detected in 13 of the 
34 (38%) non-mucinous CRCs (Fig. 1A,a), whereas only a single mucinous 
CRC showed SOX2 expression (8%). A representative case of a SOX2-negative 
mucinous tumor is shown in Fig.1B. In general, SOX2 was clearly detectable in 
patches of the tumor. Morphologically the ectopically SOX2 expressing cells were 
indistinguishable from the SOX2-negative cells in the same tumor. Furthermore, 
we did not observe SOX2 expression specifically at the invasive front of a tumor. 
As expected, SOX2 was absent in normal intestinal tissue (data not shown). As 
an internal positive control for SOX2 expression, we used the submucosal and 
myenteric plexuses present in the intestine, which are known to express SOX2 
(Fig. 1B insert)15.
Figure 1: SOX2 expression is observed predominantly in non-mucinous CRC.
Immunohistochemistry for SOX2 in non-mucinous and mucinous CRCs. SOX2 expression was 
present in 13/34 non-mucinous CRCs (A, (overview) and (a) higher magnification of (A), whereas it 
was observed only in 1/12 mucinous CRCs. (B) Representative figure of a SOX2-negative mucinous 
CRC. Insert shows SOX2-positive neuronal plexus. In all cases, SOX2 IHC was only scored as 
positive when a clear nuclear staining was observed. The faint cytoplasmic staining was observed in 
most samples, and was considered as aspecific background staining. Scale bars: A, B and a 200mm
Non-Mucinous  Mucinous  
S
O
X
2 
A B a 
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CDX2 is co-expressed in the SOX2 expressing CRC cells 
In the mature gastrointestinal tract SOX2 is normally exclusively 
expressed in the rostral part of the digestive tract, i.e. in the esophagus and 
stomach epithelium, whereas it is completely excluded from the CDX2-positive 
intestine11. Since we detected ectopic SOX2 expression in intestinal tumors, 
we wondered whether there was simultaneous loss of CDX2, which would be 
suggestive for loss of intestinal identity. All samples stained uniformly for CDX2 
(Fig 2B,D) including the SOX2-positive patches (Fig 2C), indicating that intestinal 
identity was retained. Thus, in contrast to the mutual exclusive expression 
pattern of SOX2 and CDX2 in the normal gastro-intestinal tract, we observed co-
expression of both proteins in a subset of CRCs.
Figure 2: Co-expression of SOX2 and CDX2 in CRC.
Immunohistochemistry for (A,C) SOX2 and (B,D) CDX2 in two examples of non-mucinous CRCs. The 
upper tumor shows the reciprocal expression of SOX2 and CDX2, typically observed in the normal 
intestinal epithelium. Interestingly, SOX2 and CDX2 are clearly co-expressed in tumors with SOX2-
positive patches. Scale bars: A, B 200mm, C,D 50mm
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MUC5AC is expressed independently from SOX2 in both non-mucinous 
and mucinous CRC
Since it was previously shown that expression of SOX2 directly correlated 
with MUC5AC 7-8, we performed immunohistochemistry for this gastric foveolar 
mucin. Whereas MUC5AC expression was absent in the mucosa of normal 
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Figure 3: Aberrant expression of MUC5AC is independent of SOX2 expression.
Immunohistochemistry for MUC5AC (left) and SOX2 (right) on CRCs. (A,B) Example of a mucinous 
tumor showing positive MUC5AC staining, despite the complete absence of nuclear SOX2. (C,D) 
Example of a non-mucinous tumor, partially showing co-expression of MUC5AC and SOX2 (asterisk), 
and a MUC5AC-positive section devoid of SOX2 (arrowhead). (E,F) Ectopic MUC5AC expression 
was also observed in histologically normal SOX2-negative epithelium (E; arrowhead) adjacent to non-
mucinous tumor tissue (E; asterisk).  Scale bars: A-F 200mm
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intestinal tissue, specific staining was observed in both the mucinous (Fig. 3A) and 
non-mucinous CRC (Fig. 3C) with similar frequency in both types. Ten out of 12 
mucinous CRC expressed MUC5AC (83%), and 22 of the 34 non-mucinous CRC 
(65%). MUC5AC was detectable in mucinous CRC, but showed no correlation 
with SOX2 expression (Fig 3B). Moreover, MUC5AC was not exclusively 
expressed at sites with SOX2 expression in the non-mucinous CRC, as regions 
within the tumors displayed both cells that were only positive for MUC5AC and 
cells that co-expressed SOX2 and MUC5AC (Fig. 3C,D; asterisk and arrowhead, 
respectively. Furthermore, expression of MUC5AC was also detected in some 
areas of morphologically unaffected mucosa adjacent to tumor tissue (Fig. 3E), 
rather than in the actual carcinoma. These sites did not display SOX2 expression 
(Fig 3F). Thus, in our sample set we observed numerous examples of cells 
aberrantly expressing MUC5AC independent of SOX2.
Ectopic SOX2 expression and patient survival 
Next, we analyzed the survival of patients with mucinous or non-mucinous 
CRC in relation with the expression of SOX2, to identify whether SOX2 expression 
can be correlated with survival. Comparing the overall survival of the total group 
of non-mucinous CRC with their mucinous counterpart did not show significant 
differences in survival (p=0.26) (Fig 4A). However, when we subdivided the group 
of non-mucinous CRC into SOX2-positive and negative groups, the patients with 
SOX2-positive CRC showed a statistically significant reduced survival compared 
to both the mucinous and the non-mucinous SOX2-negative group (p=0.02) (Fig 
4B). 
The finding that patients with a SOX2 expressing tumor showed a shorter 
survival than patients with SOX2-negative non-mucinous CRC, suggests that SOX2 
might be useful as a prognostic marker. Therefore, we performed an explorative 
analysis on an additional set of 56 non-mucinous CRCs, which were analyzed 
for SOX2 expression. Out of the 56 tumors, 19 ectopicallly expressed SOX2. 
However, in this second cohort the survival of the patients with the SOX2-positive 
tumors was not significantly different from the SOX2-negative CRCs (p=0.56). 
Next, we compared both study groups, to determine whether there was a 
difference in study population that might explain the difference in survival (Table 
1). 
No statistically significant differences were found for the median age of 
the patients, patient’s sex, or left- versus right-sided localization of the tumor. 
Furthermore, the differentiation grade and tumor stage were also comparable 
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Figure 4: SOX2 expression in non-mucinous CRC correlates with poor survival.
(A) Kaplan Meier survival curves of all mucinous (red) and non-mucinous (blue) CRC of our first test 
cohort, reveals no significant difference in life expectancy (p=0.26). In (B) Kaplan Meier curves are 
shown of the same patients in which the non-mucinous CRC are separated in a SOX2-negative group 
(blue) and SOX2-positive (green) one. The non-mucinous SOX2-positive group showed a significant 
worse survival compared to both other groups (p=0.02). 
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between both groups. Lastly, in both study groups SOX2 was expressed in 
approximately one third of the tumors. 
In conclusion, SOX2 is expressed in approximately one third of the non-
mucinous CRCs. In the first group we tested, the SOX2-positive group showed 
a significantly shorter survival, compared to the SOX2-negative group. However, 
in a second cohort this correlation was not found. The difference between both 
results is not due to differences in patient or tumor characteristics. 
Table 1: Patient and tumor characteristics for each study and test results for difference 
between studies.
Mucinous
N=12
non-mucinous 1
N=34
Non-mucinous 2
N=56
Significance
Non-mucinous1
 vs 
non-mucinous2
Median(iqr)
Age in years 60(6) 60(11) 62( 10) 0,37*
N(%)
Sex       M 5(36) 21(62) 31( 55)
             V 7(64) 13(38) 25( 45) 0,55#
Side      L 10(91) 28(82) 43( 77)
             R 1(9)  6(18) 13( 23) 0,53#
Differentiation
          Good 0 3(9)   2 ( 4)
      Moderate 4(33) 24(71)  49( 88)
          Poor 0 7(21)  4( 7)  0,10##
       Unknown 8(67) 0(0)   1( 2)
Distant metastasis 
            No 10(83) 27(79) 51(91)
           Yes 2(17) 7(21)  5(  9) 0,2&
Stage
I 2(17) 7(21) 14(25)
II 4(33) 12(35) 21(38)
III 1(8) 7(21) 15(27)
IV 2(17) 7(21) 5(9) 0,58#
unknown 3(25) 1(3) 1(2)
Sox2        No 11(92) 21(62) 37( 66)
                Yes 1(8) 13(38) 19( 34) 0,68#
*   Mann Whitney U-test
#   Chi-squared test 
## Chi-squared test, good+moderate combined and unknowns excluded
&   Fisher exact test
Due to rounding percentages do not always add up to 100%.
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Discussion
Colorectal cancer (CRC) can be subdivided in mucinous and non-
mucinous CRC. A recent study suggested a putative link between SOX2 
expression observed selectively in mucinous CRC, which portend to have a 
worse clinical prognosis 7. Recently, aberrant Sox2 expression was associated 
with worse prognosis in lung and esophagus cancer 10, attributed to the induction 
of a precursor-like state induced by Sox2. As such, the ectopic SOX2 expression 
observed in CRCs may likewise affect tumor progression. In this study we aimed 
to further elucidate the expression behavior of SOX2, CDX2 and MUC5AC in both 
mucinous and non-mucinous CRC, and to examine whether SOX2 expression 
can be correlated with specific tumor characteristics and prognosis.
Our results show that SOX2 is expressed in approximately one third 
of the colorectal cancers. In stark contrast to the results of Park et al.we did 
however not observe any correlation with mucinous differentiation7. In fact, the 
proportion of non-mucinous cancers showing SOX2-positivity was significantly 
higher than their mucinous counterparts (13/34 versus 1/12). An explanation 
for these different observations, may reside in the use of different antibodies or 
different scoring of SOX2-positivity or mucinous differentiation.
In the normal gastro-intestinal tract SOX2 and CDX2 are expressed in 
a mutually exclusive manner, i.e. CDX2 marks all the intestinal epithelial cells, 
whereas SOX2 is expressed in the stomach and esophagus. Here we report 
that the SOX2-positive patches in colorectal cancers retain normal expression 
of CDX2, meaning that both proteins are co-expressed in the same cells. We 
previously showed that co-expression of Sox2 and Cdx2 in the developing 
embryonic mouse intestine resulted in a loss of Cdx2 binding to its target 
sequences, leading to loss of intestinal identity and the acquisition of a gastric-
like phenotype13. As such, the aberrant SOX2 expression could likewise affect 
the differentiation direction of the colorectal cancer cells. However, histological 
evaluation of the SOX2-positive cells did not provide any indication of differences 
in the cellular phenotype of SOX2-positive and negative cells, as both showed 
the typical dysplastic features of colorectal cancer. 
Previously, a second link between SOX2 and the acquisition of gastric 
features was made by showing within colorectal cancers concordant expression 
of SOX2 with the gastric foveolar mucin MUC5AC7. In support of this, SOX2 was 
also shown to activate MUC5AC reporter constructs and to increase MUC5AC 
expression in COS-7 cells7-8. MUC5AC expression is however observed in a 
large proportion of colorectal cancers, far exceeding the fraction of SOX2-positive 
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tumors5-6. Also in our case, we observed between 65-83% of MUC5AC-positive 
tumors. Moreover, in our sample set we observed numerous examples of cells 
aberrantly expressing MUC5AC independent of SOX2, indicating that although 
SOX2 may contribute to MUC5AC expression, it is not absolutely required. Taken 
together, our data do not support a role for aberrant SOX2 in the induction of 
gastric features within colorectal cancer.
Aberrant SOX2 expression has however also been linked to the induction 
of precursor-like features in various cancer types, associated with bad prognosis10. 
Therefore, we tested the survival of patients with SOX2-positive and SOX2-
negative tumors in two different cohorts. In the first cohort, the survival of the 
SOX2-positive subgroup was significantly less compared to the SOX2-negative 
group. This is in support of several recent publications showing that increased 
SOX2 expression in colorectal cancers correlated with lymph node metastases 
and distant recurrence16-18. In the second cohort we could not detect differences 
in survival. These apparent contradicting results were not due to differences in 
age or sex of the patients in both cohorts, nor were significant differences found 
in tumor localization, differentiation grade of the tumor, or stage of the disease. 
Since the majority of the SOX2 positive cases do not show a uniform SOX2 
expression, but have patchy staining patterns, it is conceivable that in a significant 
number of cases the SOX2 positive are missed in case only a small portion of the 
tumor is available for analysis. Therefore, SOX2 should be validated in a bigger 
cohort to test whether SOX2 indeed imposes a worse prognosis. 
In conclusion, we show that SOX2 is expressed in non-mucinous CRC 
rather than mucinous CRC. Expression of SOX2 coincides in all cases with CDX2, 
whereas MUC5AC is not exclusively expressed in SOX2-positive colorectal 
cancer cells.  Additionally, we have indications that SOX2 expression in non-
mucinous CRC is associated with a worse survival.
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Abstract
Wnt5a is essential during embryonic development, as indicated by 
mouse Wnt5a knockout embryos displaying outgrowth defects of multiple 
structures including the gut. The dynamics of Wnt5a involvement in these 
processes is unclear, and perinatal lethality of Wnt5a knockout embryos has 
hampered investigation of Wnt5a during postnatal stages in vivo. Although in vitro 
studies have suggested a relevant role for Wnt5a postnatally, solid evidence for a 
significant impact of Wnt5a within the complexity of an adult organism is lacking. 
We generated a tightly-regulated inducible Wnt5a transgenic mouse model 
and investigated the effects of Wnt5a induction during different time-frames 
of embryonic development and in adult mice, focusing on the gastrointestinal 
tract. When induced in embryos from 10.5 dpc onwards, Wnt5a expression 
led to severe outgrowth defects affecting the gastrointestinal tracts, limbs, 
facial structures and tails, closely resembling the defects observed in Wnt5a 
knockout mice. However, Wnt5a induction from 13.5 dpc onwards did not cause 
this phenotype, indicating that the most critical period for Wnt5a in embryonic 
development is prior to 13.5 dpc. In adult mice, induced Wnt5a expression did not 
reveal abnormalities, providing the first in vivo evidence that Wnt5a has no major 
impact on mouse intestinal homeostasis postnatally. Protein expression of Wnt5a 
receptor Ror2 was strongly reduced in adult intestine compared to embryonic 
stages. Moreover, we uncovered a regulatory process where induction of Wnt5a 
causes downregulation of its receptor Ror2. Taken together, our results indicate 
a role for Wnt5a during a restricted time-frame of embryonic development, but 
suggest no impact during homeostatic postnatal stages. 
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Introduction
Whereas the relevance of canonical Wnt/b-catenin signaling in intestinal 
homeostasis and cancer is well established 1-2, so-called non-canonical Wnt 
signaling is far less understood. Non-canonical Wnt signaling is represented 
by multiple alternative signaling routes that act independent of b-catenin 
transcriptional activity and are typically activated by non-canonical Wnt ligands. 
Wnt5a is the most extensively studied non-canonical ligand and has gained 
substantial attention over the last years as it is being implicated in various human 
diseases including cancer, inflammatory diseases and metabolic disorders 3-5. 
Signaling pathways that can be activated by Wnt5a include Wnt/Ca2+ and Wnt/
JNK pathways, also referred to as the planar cell polarity pathway, are primarily 
known to mediate oriented cell movements during development 3-4 6-8. Additionally, 
Wnt5a can inhibit b-catenin signaling, although promoting effects have also 
been demonstrated in receptor overexpression experiments 9. Importantly, 
which pathway is actually activated by Wnt5a greatly depends on the context, 
especially dictated by receptor presence. The best characterized Wnt5a receptor 
is receptor tyrosine kinase-like orphan receptor 2 (Ror2) 9-12. Members of the 
family of Frizzled receptors, Ror1 and receptor-like tyrosine kinase Ryk have also 
been implicated to act as (co)receptors in Wnt5a signaling 4 9 13-14. 
The indispensable nature of Wnt5a during embryogenesis is indicated by 
the perinatal lethality of homozygous Wnt5a knockout mice 8. During development, 
Wnt5a expression is predominantly detected in structures undergoing extensive 
outgrowth, including the limbs, tail and facial structures 8 15. Expression in these 
structures is in a graded fashion with highest levels towards the outer tips and 
most pronounced between 10 and 14 days post coitum (dpc) 8 15. Loss of Wnt5a 
results in a drastic shortening of these structures in mouse embryos 8. Importantly, 
the embryonic phenotype of Ror2 homozygous knockout mice closely resembles 
the Wnt5a knockout phenotype, although appearing milder 16-17. Thus, during 
embryonic development both Wnt5a and its main receptor Ror2, are essential for 
the proper outgrowth of multiple structures. This also applies to the gastrointestinal 
tract. Normal gut development involves temporal and spatial specific expression 
of Wnt5a and Ror2. Both Wnt5a and Ror2 expression peak between 10.5 and 
13.5 dpc, a critical period when midgut elongation occurs. Wnt5a expression 
is restricted to the mesenchyme of the caudal midgut and rostral hindgut (i.e. 
future distal small intestine and proximal large intestine), suggested to correlate 
with regions of the small intestine that undergo elongation 18-20. Ror2 expression 
shows a complex region-specific pattern in both the mesenchyme and epithelium 
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20.  Homozygous knockout of either Wnt5a or Ror2 results in shortened embryonic 
intestines, in addition to an imperforate anus in Wnt5a knockout embryos 18.  The 
dynamics of Wnt5a functioning are not completely understood to date. Given 
that endogenous Wnt5a expression in the gut is most prominent between 10.5-
13.5 dpc and diminishes after that might be an indication that Wnt5a is most 
crucially involved in developmental elongation processes in this specific period. 
However, it remains to be clarified whether the functioning of Wnt5a extends 
beyond this stage. Relevant postnatal roles of Wnt5a have been suggested 
based upon associative Wnt5a expression studies and in vitro studies. Hence, 
enhanced Wnt5a expression has been observed in a variety of human diseases, 
including inflammatory conditions 21-22, metabolic disorders 4-5 23 and a multitude 
of cancer types, among which colorectal cancer 3 24-25. Also, a wide variety of in 
vitro studies have implicated Wnt5a in multiple cellular processes, including cell 
growth, differentiation, migration and invasion 3-4 7 26. Despite these supportive 
data, solid in vivo evidence for a significant postnatal impact of Wnt5a is lacking. 
To date, it has not been possible to modulate and investigate the activities of 
Wnt5a in an adult organism. We have generated an inducible Wnt5a transgenic 
mouse model, enabling in vivo determination of the relevance and activities of 
Wnt5a during desired time-frames. Transgenic Wnt5a expression was induced 
during specific time-frames of embryonic development and during adulthood, 
followed by a phenotypic analysis focusing on the intestinal tract.
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Materials and methods 
Generation of inducible Wnt5a mouse model and in vivo 
doxycyline administration
To generate the TetO-Wnt5a construct, a 1.1 kb XbaI fragment was 
isolated from a TetO-FLAG-Wnt5a vector (kindly provided by Dr. R. Nusse, 
Stanford University, CA), and inserted into the pTRE-Tight vector containing 
an additional 0.68 kb b-globin intron. The 2.4 kb expression cassette was XhoI 
digested from the plasmid backbone, gel-purified and injected into C57Bl/6J 
oocytes by standard procedures. TetO-Wnt5a positive founders were identified by 
PCR using transgene specific primers SCT2F (5’-CTACACCCTGGTCATCATCC) 
and mWnt5AFLAG-R (5’-TCGTACCTAGAGACCACCAAG).
TetO-Wnt5a mice were interbred with hnRNP-rtTA2S-M2 mice 27, 
obtaining double transgenic mice. Wildtype and single transgenic mice were 
generated simultaneously and served as control animals. Doxycycline (dox) was 
administered via the drinking water (2 mg/ml dox, 5% sucrose). Induction during 
embryogenesis was performed by administering dox to timed pregnant females.
All mice were generated, bred and maintained under specific pathogen-
free conditions at the animal facility of the Erasmus MC University Medical 
Center. All animal experiments were approved by the Institute’s Animals Ethics 
Committee and were carried out in accordance with Dutch legislation.
Cell culture and treatments
Tail fibroblasts were isolated from adult mice by incubating tail tips in 
Dulbecco’s modified essential medium (DMEM, Lonza) complemented with 0.14 
U/ml Blendzyme (Roche), 1% antibiotics/antimycotics (Gibco) and 0.5% fetal 
bovine serum (FBS, Sigma Aldrich) for 3 hours at 37°C. Mixture was put on a cell 
strainer and cells were cultured in DMEM with 1% antibiotics/antimycotics and 
10% FBS at 37oC, 5% CO2. Mouse embryonic fibroblasts (MEFs) were isolated 
from embryos of 13.5-15.5 dpc and cultured and transfected as previously 
described.28 When indicated, cells were induced with 1 ug/ml dox. HEK293T cells 
were cultured in DMEM with 10% FBS, 1% p/s at 37oC, 5% CO2. 
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b-catenin reporter assay
b-catenin reporter assay in MEFs was performed as previously described 
28. A Ror2 expression vector (kindly provided by Dr. A.  Kikuchi, Osaka University, 
Japan) was co-transfected to assure sufficient receptor availability for the 
transgenic Wnt5a. Transfected cells were provided with 1 ug/ml dox for 24 hours 
of which the final 16 hours cells were simultaneously stimulated with either 25% 
of L-control or L-Wnt3a conditioned medium. Luciferase activities were measured 
using the dual-luciferase reporter assay system (Promega) and a LUMIstar 
luminometer. Assays were performed in duplicate and performed twice. 
Immunoblotting 
Cultured cells and snap-frozen intestinal tissue specimens were lysed 
in Laemmli sample buffer containing 0.1M DTT and incubated at 95 °C for 10 
min. Western blotting was performed according to standard chemoluminescent 
procedures or using fluorescent Odyssey immunoblotting (LI-COR Biosciences, 
Lincoln, NE, USA) 28. Antibodies are indicated in Supplementary Table I. 
Quantification was performed using Odyssey Li-Cor software. 
Skeletal preparations and staining
Embryos were skinned, eviscerated, fixed overnight in 96% ethanol 
containing 1% glacial acetic acid. Cartilage was stained overnight in 0.5 mg/ml 
Alcian Blue. Soft tissues were dissolved in 1.5% potassium hydroxide for 3 hours 
followed by staining of bone overnight in Alizarin Red and destaining in 0.5% 
potassium hydroxide/20% glycerol. 
Tissue processing and histology
Adult intestines, whole embryos or embryonic intestines were isolated, 
washed in PBS and fixed overnight in 4% PBS-buffered paraformaldehyde (4% 
PFA) at 4°C. Fixed embryonic intestines were pre-embedded in 5% bacto-agar 
(BD) in PBS and cut into 6-8 pieces enabling proper identification of the different 
regions. All mouse materials were embedded in paraffin according to routine 
protocols.
Haemotoxylin eosin (HE), Periodic Acid Schiff (PAS) and Alkaline 
Phosphatase (AP) stainings were performed according to routine protocols. 
Immunohistochemistry was performed using antigen retrievals and antibodies 
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as indicated in Supplementary Table II. Visualization was performed using the 
Envision+ System or StreptABCcomplex/HRP (Dako). 
RNA isolation, cDNA synthesis and quantitative PCR
RNA was isolated from snap-frozen embryonic intestines and adult 
duodenum tissues using Nucleospin RNA II Kit (Machery-Nagel, Düren, 
Germany), followed by cDNA generation using iScript cDNA Synthesis Kit (Bio-
Rad). Quantitative PCR was performed using Sensimix SYBR Green (Bioline) or 
TaqMan (in case of Axin2/Actb) Gene Expression Assays (Applied Biosystems) 
and run in the IQ5 Real time PCR detection system (Bio-Rad). Primers are shown 
in Supplementary Table III. Expression levels were corrected for expression of 
Actb, averaged and presented as fold changes.
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Results
Tight regulation of functionally active Wnt5a protein in TetO-Wnt5a 
transgenic mouse model
We generated TetO-Wnt5a mouse founder lines carrying the mouse 
Wnt5a gene under the control of a Tet-inducible promoter. This promoter is 
inducible by the rtTA transcription activator in a doxycyline (dox) dependent 
manner. TetO-Wnt5a founders were crossed with the hnRNP-rtTA transgenic 
mouse line, which drives ubiquitous expression of the rtTA2S-M2 gene 27. Dox 
administration allows transgenic Wnt5a induction only in double transgenic 
mice carrying both TetO-Wnt5a and hnRNP-rtTA constructs. Wnt5a expressing 
founders were identified by culturing tail fibroblasts, providing a founder with 
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Figure 1. Tight regulation of functionally active Wnt5a protein in TetO-Wnt5a 
transgenic mouse model. 
(A) Wnt5a immunoblot of tail fibroblasts and (B) MEFs. Wnt5a antibody only detects overexpressed 
Wnt5a because of low sensitivity. b-catenin reporter assay showing that Wnt3a-induced b-catenin 
signaling is reduced following transgenic Wnt5a induction, * p=0.015. Two individual MEF lines 
were used for each genotype. (C) Intestine of adult mice induced for 1 week analyzed by Wnt5a 
immunoblot (du=duodenum, col=colon) and by (D) immunohistochemical Wnt5a staining. Abundant 
Wnt5a expression is revealed in double transgenic embryos (dox from 10.5 dpc onwards). and  (E) 
adult intestine. 
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robust Wnt5a protein expression upon dox administration without displaying 
Wnt5a expression in controls (figure 1A).
Similar results were observed in mouse embryonic fibroblasts (MEFs) 
(figure 1B and S1A). To validate the functionality of the transgenic Wnt5a protein, 
we determined its capability to inhibit canonical Wnt/b-catenin signaling. MEF 
lines of control and double transgenic genotypes were stimulated with Wnt3a 
to enhance b-catenin signaling and doxycyline was added to induce transgenic 
Wnt5a (figure 1B, upper panel). b-catenin mediated transcription was significantly 
decreased upon induction of transgenic Wnt5a (figure 1B, lower panel). This 
indicates that upon dox induction in double transgenic MEFs, the cells produce 
functionally active Wnt5a protein.
In vivo dox administration successfully induced transgenic Wnt5a 
expression in double transgenic mice exclusively, as shown by immunoblotting 
and immunohistochemistry (figure 1C-E). Induction was a rapid process 
since transgenic Wnt5a was detected already within 24 hours following 
dox administration (figure S1B). In adult and embryonic mice, expression 
of transgenic Wnt5a protein was verified along the entire intestinal tract by 
immunohistochemistry (data not shown).  When induction was performed during 
embryonic development from 10.5 dpc onwards, transgenic Wnt5a expression 
was observed in gut mesenchyme and epithelium at 13.5 dpc, shifting towards 
a predominant epithelial expression pattern at 18.5 dpc (figure 1D). In the adult 
intestine, induced Wnt5a was most prominent in the epithelial cells and stromal 
expression was clearly present although less abundant, displaying an overall 
diffuse staining in addition to several intensely stained individual cells (figure 
1E). Wnt5a expression was not detected in muscle cells. Although all following 
experiments were performed with above described TetO-Wnt5a founder line 
unless mentioned differently, we validated a second TetO-Wnt5a founder which 
displayed a mosaic Wnt5a expression pattern (figure 6C and S1C).
Induced Wnt5a expression deregulates embryonic development
Wnt5a is indispensable during mouse development, since its absence 
results in defective embryonic outgrowth and perinatal lethality 8. We induced 
Wnt5a expression during several time-frames of embryogenesis to investigate 
the developmental consequences of overexpressing Wnt5a. Dox-induced double 
transgenic mice will be further referred to as Wnt5aind and compared to dox-
induced control mice. Wnt5a induction from 6.5 dpc to 13.5 dpc resulted in severe 
developmental defects (figure 2A). 
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Figure 2. Induced Wnt5a expression deregulates embryonic development. 
Macroscopic appearance of dox-induced control versus double transgenic embryos. Time-frames 
of dox administration are indicated by blue bars against timeline.  (A) Wnt5aind embryos at 13.5 dpc, 
induced from 6.5 dpc onwards, were already necrotic. (B,C) Embryos at respectively 13.5 and 18.5 
dpc, induced from 10.5 dpc onwards, showing deficient outgrowth of face, limbs and tail. (D-G) 
Skeletal stainings of 17.5-18.5 dpc embryos, comparing similarly aged embryonic structures. (D) 
Overview of control (upper) and Wnt5aind (lower) phenotype. Limbs and tails are not complete in 
this figure panel. Clear shortening is observed affecting (E) tail (F) head (G) forelimb (a=autopod, 
z=zeugopod, s=stylopod).  
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Externally, primarily the head, limbs and tail showed outgrowth defects. 
As the Wnt5aind embryos had already died in utero at 13.5 dpc, necrosis precluded 
a more detailed examination of these embryos. Starting induction of transgenic 
Wnt5a later, i.e. at 10.5 dpc, did not result in embryonic lethality but led to facial 
deformities and shortened limbs and tail (figure 2B-C). Similar defects were 
observed using our mosaic Wnt5a founder (figure S2A). Later dox inductions, 
from 13.5 dpc to 18.5 dpc, did not lead to apparent developmental defects in 
Wnt5aind embryos (figure S2B). Examination of skeletal stainings provided insight 
regarding the basis of the externally visible defects in late-stage embryos that had 
been induced from 10.5 dpc onwards (figure 2D). The tails of Wnt5aind embryos 
were clearly shortened, caused by a decreased number of vertebrae (figure 
2E). In the head, the most severely shortened bones are those in the upper jaw, 
while lower jaw elements were mildly shortened (figure 2F). Limb shortening was 
chiefly caused by deficient outgrowth of individual skeletal elements, including 
stylopodal and zeugopodal bones which appear thicker than normal as well 
(figure 2G). Autopods appeared underdeveloped with shorter and thicker digits 
and a delay of ossification events, but no obvious loss of skeletal elements as has 
been reported for Ror2 and Wnt5a knockout embryos was observed. Together, 
these experiments revealed that Wnt5a overexpression causes embryonic 
defects resembling those observed in Wnt5a KO and Ror2 KO embryos, affecting 
the structures whose progenitors normally express Wnt5a in a graded fashion. 
Time dependency, i.e. before 13.5 dpc, of the Wnt5a overexpression phenotype 
matches the period in which endogenous Wnt5a is normally expressed most 
abundantly 8 15 18-20.  
Induced Wnt5a expression disturbs embryonic intestinal elongation
In the developing gastrointestinal tract, Wnt5a expression is detected in 
the mesenchyme of the caudal midgut, rostral hindgut and stomach fundus 18-20. 
Loss of Wnt5a leads to severely shortened gastrointestinal tracts 18. Interestingly, 
we found that time-specific Wnt5a overexpression from 10.5 dpc until 18.5 dpc 
also resulted in drastic shortening of the small and large intestine, cecum and 
stomach (figure 3A-C). 
Furthermore, Wnt5aind embryos displayed an imperforate anus (figure 
3D), as has also been observed in Wnt5a KO embryos 18. A similar phenotype 
was revealed using the mosaic TetO-Wnt5a founder line, albeit less drastic 
(figure S2C). The phenotype was not observed when Wnt5a expression was 
induced from 13.5 dpc onwards (figure S2D). This indicates that the activities 
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by which induced Wnt5a interferes with intestinal elongation mainly take place 
between 10.5 and 13.5 dpc, which is the phase of intestinal elongation when 
a rapid increase in length occurs and when Wnt5a is normally expressed most 
abundantly. Together, our data demonstrate that ubiquitous Wnt5a overexpression 
causes gastrointestinal elongation defects resembling those observed in Wnt5a 
KO and Ror2 KO embryos, when induced from 10.5 dpc but not from 13.5 dpc 
onwards, reflecting the time-frame when Wnt5a is normally expressed at highest 
levels 8 15 18-20.
Figure 3. Induced Wnt5a expression disturbs embryonic intestinal elongation. 
Gastrointestinal structures of 18.5 dpc embryos induced from 10.5 dpc onwards. (A) Overview of 
gastrointestinal tracts (B) Higher magnification of the large intestine and (C) cecum. (D) The Wnt5aind 
embryonic anus is imperforated. 
A
Control
 Control                                        Wnt5aind
B
D
C
Wnt5aind
Figure 3
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Figure 4. Wnt5a does 
not alter cell fate during 
intestinal development. 
Stainings of intestinal cross-
sections of 18.5 dpc embryos 
of control versus double 
transgenic genotypes, all 
induced from 10.5 dpc onwards. 
(A) HE and (B) PAS staining 
show unaffected histology 
and goblet cell presence. (C) 
Staining for synaptophysin 
and (D) SMA reveal no 
differences in enteroendocrine 
cells and smooth muscle cells 
respectively. (E-G) Cdx2, 
b-catenin and phospho-Histone 
H3 appear unaffected. 
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Figure 5. Induced Wnt5a 
expression is well-
tolerated in the adult 
mouse intestine. 
Stainings of intestinal sections 
of adult mice induced for 1 week. 
(A) HE and (B) PAS staining 
show unaffected histology 
and goblet cell presence. (C) 
Staining for synaptophysin 
and (D) lysozyme reveal no 
differences in enteroendocrine 
cells and paneth cell presence 
respectively. (E) SMA staining 
reveals no obvious differences. 
(F) b-catenin staining shows 
equal membranous and nuclear 
(arrowheads) expression. 
(G) phospho-Histone H3 
staining indicates unaffected 
proliferation.
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Wnt5a does not alter cell fate during intestinal development
To investigate whether the differentiation state of the embryonic Wnt5aind 
shortened intestines was altered, intestines of embryos induced from 10.5 dpc 
until 18.5 dpc were isolated and analyzed extensively. Hematoxylin eosin (HE) 
staining revealed no histological aberrations in Wnt5aind embryonic intestines 
(figure 4A). 
Presence of goblet and enteroendocrine cells was not influenced by Wnt5a 
induction as determined by Periodic Acid Schiff (PAS), Muc2 and synaptophysin 
staining (figure 4B-C and S3A). Smooth muscle actin (SMA) staining showed 
normal smooth muscle layer development and expression of homeobox protein 
Cdx2 was unaffected (figure 4D-E). Furthermore, no abnormal localization 
of either b-catenin or E-cadherin expression was observed in the intestines of 
Wnt5aind embryonic intestines (figure 4F and S3B). Proliferation of intestinal 
cells determined by phospho-histone H3 staining revealed no gross differences 
in proliferation rate among the different genotypes (figure 4G). Altogether this 
indicated that Wnt5a has no impact on embryonic intestinal cell fate, in line with 
similar findings in Wnt5a knockout embryos 18.
Induced Wnt5a expression is well-tolerated in the adult mouse intestine
To determine the consequences of increased Wnt5a expression 
postnatally, we performed doxycycline inductions in adult mice for multiple 
durations, including 1 day, 1 week and 3-5 months. During the induction period, 
the overall appearance of the mice remained unaffected. Following the inductions, 
mice were examined for abnormalities with a specific focus on the intestinal tract. 
No gross abnormalities in length and macroscopic appearance were observed 
as a consequence of transgenic Wnt5a induction. HE staining revealed no 
histological abnormalities in the intestines of Wnt5aind mice (figure 5A).
Staining for specific intestinal cell types including PAS for goblet cells, 
synaptophysin for enteroendocrine cells,  lysozyme for Paneth cells, SMA for 
muscle and stromal cells and alkaline phosphatase (AP) for enterocytes all 
showed no changes upon transgenic Wnt5a expression in adult mice (figure 
5B-E and S3C). Immunohistochemical staining of b-catenin revealed no aberrant 
expression, displaying membranous and nuclear b-catenin in Wnt5aind intestine 
comparable to corresponding control mice (figure 5F). E-cadherin staining was 
unaffected (figure S3D) and also proliferation of intestinal cells was unaltered 
(figure 5G). Altogether, induced Wnt5a expression is tolerated well by adult mice 
and does not affect postnatal intestinal homeostasis and cell fate. 
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Wnt5a downregulates Ror2 protein in embryonic and adult intestine
As Ror2 is an important receptor mediating Wnt5a signaling, we 
determined Ror2 protein expression by immunohistochemistry. All embryos 
were subjected to dox induction from 10.5 dpc onwards and adult mice were 
induced for 1 week. Examination of Ror2 protein expression in 13.5 and 18.5 dpc 
Figure 6. Wnt5a downregulates Ror2 protein in embryonic and adult intestine. 
All embryos were subjected to dox induction from 10.5 dpc onwards and adult mice were induced 
for 1 week. In adults, intensely stained stromal cells assumingly represent IgG producing cells, 
unintentionally detected by our secondary anti-mouse antibodies. (A) Immunohistochemical Ror2 
staining of cross-sections of 13.5 and 18.5 dpc embryonic intestines of control genotypes. Relatively 
low Ror2 expression is observed  in adult intestine of control genotype (lower panel). (B) Drastically 
reduced Ror2 expression in Wnt5aind embryonic and adult intestines. (C) Mosaic Wnt5a expression in 
18.5 dpc Wnt5aind embryonic intestine using the alternative TetO-Wnt5a founder (upper panel). Ror2 
expression is reduced in a general fashion. (D,E) Relative Wnt5a and Ror2 RNA expression in 17.5 
dpc embryonic and adult intestine respectively.  
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embryonic intestines of control genotypes revealed abundant expression in the 
mesenchyme and muscle layers, and membranous Ror2 in the epithelium (figure 
6A).
In the adult intestine of control genotypes, Ror2 protein levels were strongly 
reduced compared to embryonic stages, presenting mainly in the muscle layers 
while along the crypt-villus structures only low level expression was observed in 
crypt compartments (figure 6A, lower panel). Reduced Ror2 expression in adult 
compared to embryonic intestine was confirmed on RNA level (data not shown). 
Interestingly, we found that intestinal Ror2 protein expression was strongly 
reduced in corresponding Wnt5aind mice (figure 6B). This Ror2 downregulation 
was particularly clear at embryonic stages, when a major reduction in all gut 
compartments, including muscle, epithelium and mesenchyme was observed. 
In the adult intestine, Wnt5a induction reduced the expression of Ror2 in muscle 
cells and to barely detectable levels in crypt cells. Notably, using the alternative 
founder with a mosaic Wnt5a expression pattern we also observed an overall 
downregulation of Ror2 protein in 18.5 dpc Wnt5aind intestines, even in regions that 
do not overexpress Wnt5a. This indicates that secreted transgenic Wnt5a ligands 
acted in a paracrine fashion (figure 6C). Ror2 RNA levels were not affected in 
the Wnt5aind intestines of both the embryonic and adult stages, despite the clear 
increase in Wnt5a RNA production (figure 6D and E), demonstrating that Wnt5a 
does not regulate Ror2 expression at the level of RNA production. In contrast to the 
reduced Ror2 protein levels that we observed in Wnt5aind embryonic intestines, we 
did not observe altered Ror2 protein expression in the intestines of homozygous 
Wnt5a knockout mice compared to wildtype or heterozygous littermates (figure 
S4A-B). We did however observe downregulation of endogenous Ror2 protein 
on cultured HEK293T cells and MEFs upon Wnt5a stimulation (figure S5). Taken 
together, our data show that Wnt5a reduces its receptor Ror2 on the protein level 
in a paracrine fashion.  
Induced Wnt5a expression enhances downstream signaling in 
embryonic intestine 
The finding that induced Wnt5a expression reduces Ror2 protein levels 
raised the question what the consequences are for downstream Wnt5a signaling. 
We determined the levels of Wnt5a downstream targets in embryonic intestines 
(induced 10.5-17.5 dpc) by immunoblotting. Ror2 protein levels were strongly 
reduced in Wnt5aind mice, confirming the immunohistochemical analyses (figure 
7A).
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Figure 7. Induced Wnt5a expression enhances downstream signaling in embryonic 
intestine despite Ror2 downregulation. 
Immunoblotting and quantification. Expression levels were corrected for loading controls or in the case 
of pDvl2, presented as the proportion of pDvl2 of total Dvl2, and averaged. Representative blots are 
shown. (A) Immunoblotting of 17.5 dpc embryonic intestines induced from 10.5 dpc onwards, showing 
Ror2 downregulation in Wnt5aind intestines as well as slightly enhanced levels of pDvl2, represented 
by the upper band, and increased pJNK levels. (B) Relative Axin2 RNA expression levels in 17.5 
dpc embryonic intestine induced from 10.5 dpc onwards. (C) Immunoblotting of duodenum tissues 
of adult mice induced for 1 week, showing Ror2 downregulation in Wnt5aind intestines whereas pDvl2 
and pJNK appear less consistently affected. (D) Relative Axin2 RNA expression levels in duodenum 
tissues of adult mice. 
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Several studies have shown that Wnt5a can induce Dvl2 phosphorylation, 
presumably in a Ror2 dependent manner 13 29-30. In line with this, we observed 
a reproducible 1.4-fold increase in phosphorylated Dvl2 levels (upper bands). 
Moreover, levels of the Wnt5a downstream target pJNK were clearly increased in 
Wnt5aind embryonic intestines, showing a 1.8 fold increase. Thus, although Ror2 
levels are strongly reduced in Wn5aind embryos, Wnt5a signaling is enhanced. 
Despite possible modulation of Wnt/b-catenin signaling by Wnt5a, we observed 
no changes in RNA expression levels of the b-catenin target gene Axin2 in 
Wnt5aind embryonic intestines (figure 7B). 
Similar analyses were performed on duodenal tissues of adult animals 
induced for 1 week. Immunoblotting for Ror2 revealed a 2-fold downregulation in 
Wnt5aind adult intestines, and confirmed the relatively low expression compared 
to the embryonic situation (figure 7C). No significant differences in pDvl2 were 
observed upon Wnt5a induction, whereas pJNK levels were at most slightly 
increased. In accordance with the embryonic intestines, Axin2 RNA expression 
levels were not changed in adult Wnt5aind duodenum (figure 7D). Taken together, 
despite the drastic downregulation of Ror2 protein in Wnt5aind intestines, 
embryonic levels of pDvl2 and pJNK were enhanced, indicating a net gain of 
Wnt5a signaling. In the adult Wnt5aind intestine, enhanced Wnt5a signaling was 
not clearly observed. 
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Discussion
Wnt5a undoubtedly plays a significant role during embryonic 
development, as indicated by multiple outgrowth defects affecting limbs, tail, face 
and the gastrointestinal tract in Wnt5a knockout mice 8 18. However, not much 
is known on the dynamics of Wnt5a functioning to date. Although endogenous 
Wnt5a expression in the gut is most prominent before 13.5 dpc and diminishes 
after that period, it is not known whether Wnt5a is involved beyond this time-
frame of development. In addition, relevant postnatal roles of Wnt5a have been 
suggested based upon associative Wnt5a expression studies and in vitro studies. 
Unfortunately, it has not been possible to date to modulate and investigate the 
activities of Wnt5a in an adult organism as a consequence of the perinatal lethality 
of Wnt5a knockout mice. We have generated an inducible Wnt5a transgenic 
mouse model, and induced transgenic Wnt5a expression during specific time-
frames of embryonic development and during adulthood, followed by a phenotypic 
analysis focusing on the intestinal tract. 
Regarding the consequences of Wnt5a induction in embryos from 10.5 dpc 
onwards, the observed defects including shortened snout, limbs and tail resemble 
those seen in Wnt5a and Ror2 knockouts and correspond to structures in whose 
progenitors Wnt5a is normally expressed 8 15-17 20. Our results demonstrate that 
embryonic Wnt5a gain of function results in a phenotype resembling a Wnt5a loss 
of function situation, a phenomenon reported more often 31-32. Importantly, these 
phenotypic defects were not observed when Wnt5a was induced from 13.5 dpc 
onwards. Together with the knowledge that Wnt5a is most prominently expressed 
before 13.5 dpc, this suggests that developmental outgrowth processes involving 
Wnt5a mainly occur before 13.5 dpc. Similar phenotypical resemblance and 
time-dependency of the phenotype apply to the gastrointestinal tract. When we 
induced transgenic Wnt5a from 10.5 dpc onwards, intestinal length was severely 
reduced, as is observed in Wnt5a knockout embryos 18. Intestinal elongation was 
not affected when Wnt5a was induced from 13.5 dpc onwards. During normal 
embryogenesis, intestinal Wnt5a expression is restricted to the mesenchyme of 
the caudal midgut and rostral hindgut, thereby providing positional information 
directing intestinal elongation 18-20. However, both in the Wnt5a overexpression 
and Wnt5a knockout situation, such a regionalized endogenous Wnt5a gradient 
is lost, resulting in lack of positional cues required for directional elongation, likely 
explaining the comparable elongation defects. Supportively, time dependency 
of our Wnt5a-mediated gut phenotype coincided with the period during which 
endogenous Wnt5a is normally expressed most prominently, i.e. between 10.5 
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and 13.5 dpc. Together, our data indicate that Wnt5a is involved in intestinal 
elongation processes that occur before 13.5 dpc and that proper regionalized 
Wnt5a expression between 10.5-13.5 dpc is required for complete elongation 
18-20. An alternative explanation for the observed intestinal shortening might be 
presented by the strongly downregulated Ror2 protein levels in our Wnt5aind 
embryos, thereby phenocopying a Ror2 knockout situation. However, we do not 
consider this a solid explanation, given the residual Ror2 protein expression and 
increased levels of pDvl2 and pJNK in Wnt5aind embryonic intestines, indicating 
a net gain of Wnt5a signaling. Although we cannot exclude that the enhanced 
signaling is mediated via alternative Wnt5a receptors, such as the Frizzleds, it 
suggests that Ror2 reduction has not hampered Wnt5a signaling. Ror2 has been 
shown to undergo clathrin-mediated internalization upon Wnt5a stimulation and 
to present in early endosomes 33-34. Subsequent routes taken by Ror2 remain 
elusive. Other Wnt5a-related receptors including Fz2, Fz4 and Fz5 may undergo 
lysosomal degradation following internalization 35-37. Our results support the 
possibility that Ror2 follows this route as well, involving a process more often 
observed after receptor-ligand endocytosis where receptors are either recycled 
to the membrane or directed to lysosomes for degradation 38. As shown for the 
EGF receptor, high ligand exposure directs more receptors towards lysosomal 
degradation as a mechanism to restrict signaling. This seems a likely scenario for 
Ror2 to follow the high Wnt5a levels induced in our mice. 
Beyond the involvement of Wnt5a in embryonic development, relevant 
postnatal roles of Wnt5a have been suggested based upon associative Wnt5a 
expression studies and in vitro studies. However, our data show that the adult 
mouse intestine is not affected by induced Wnt5a expression, neither showing 
histological aberrations nor changes in b-catenin signaling. This might appear 
surprising since Wnt5a can potentially interact with multiple signaling pathways 
and has been attributed modulating capacities with regard to cell proliferation, 
migration and differentiation 3-4 7 26. On the other hand, our results imply that 
the main function of Wnt5a exists during embryonic outgrowth events, which 
obviously do not occur during the maintenance of adult intestinal homeostasis. 
Supportively, levels of endogenous Wnt5a expression in adult intestine are 
relatively low compared to levels in developing gut 18-20 24, also applying to 
Ror2 expression levels (figure 6A-C). Considering this, it might be speculated 
that sufficient Ror2 expression is needed to acquire an effect following Wnt5a 
induction. However, embryonic Wnt5a induction from 13.5 dpc onwards did 
not result in a phenotype despite abundant Ror2 presence, showing that the 
phenotypic consequences do not entirely depend on the presence of Ror2. 
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Extra-intestinal aberrations resulting from postnatal hnRNP-rtTA-driven Wnt5a 
expression were not observed, although other adult organs were not investigated 
in sufficient detail to allow firm conclusions. 
Taken together, our results indicate a role for Wnt5a during a restricted 
time-frame of embryonic development, but suggest no impact during homeostatic 
postnatal stages. Conditional Wnt5a knockout studies in adult animals could 
ideally further support our findings. Furthermore, as increased Wnt5a expression 
is typically observed in diseased situations, additional triggers may be needed 
to reveal postnatal activities of Wnt5a. In the future, this can be investigated by 
exposing our newly generated inducible Wnt5a mouse model to specific stress 
conditions or combining it with disease models. 
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Supplementary figure legends 
Supplementary figure 1. Further validation of the TetO-Wnt5a mouse model. 
(A) Wnt5a immunoblot showing multiple MEF lines derived from all different genotypes, all induced in 
vitro with dox. Wnt5a is detected in double transgenic MEF lines exclusively. (B) Immunohistochemical 
staining reveals induced Wnt5a expression in double transgenic adult mouse intestine already within 
24 hours after dox administration. (C) Double transgenic adult intestine of the alternative TetO-Wnt5a 
founder induced for 1 week, displaying a mosaic expression pattern of induced Wnt5a protein.
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Supplementary figure 2. Induced Wnt5a deregulates embryonic development and 
intestinal elongation. 
(A) 17.5 dpc embryos of control versus double transgenic genotypes using the alternative mosaic 
TetO-Wnt5a founder, dox-induced from 10.5 dpc onwards. Developmental defects are similar to 
the defects observed using the regular TetO-Wnt5a founder (B) 18.5 dpc embryos of control and 
double transgenic genotypes (regular founder) induced from 13.5 dpc do not reveal gross differences 
in development. (C) Gastrointestinal tracts isolated from 17.5 dpc control and double transgenic 
embryos using the mosaic TetO-Wnt5a founder, induced from 10.5 dpc onwards. (D) Gastrointestinal 
tracts isolated from 18.5 dpc control and double transgenic embryos (regular founder), induced from 
13.5 dpc onwards. 
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Supplementary figure 3. Induced Wnt5a does not alter cell fate during intestinal 
development and adult homeostasis. 
Immunohistochemical stainings of intestinal sections of 18.5 dpc embryos induced from 10.5 dpc 
onwards and adult mice induced for 1 week. Representative images are shown from similar regions 
of the gastrointestinal tract when comparing control and Wnt5aind intestine within a staining. (A) Muc2 
staining indicating unchanged goblet cell presence in Wnt5aind embryonic intestine. (B) E-cadherin 
staining showing no effect upon Wnt5a induction in embryonic intestine. (C) Alkaline phosphatase 
(AP) staining of adult intestine indicating similar appearance of enterocytes in control and Wnt5aind 
intestines (D) E-cadherin staining of adult intestines reveals no differences between control and 
Wnt5aind intestines. 
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Supplementary figure 4. Ror2 protein expression is not altered in the intestines of 
Wnt5a knockout embryos. 
(A)  Immunohistochemical Ror2 staining on the intestines of Wnt5a+/+, Wnt5a+/- and Wnt5a-/- 17.5 dpc 
embryos. (B) Immunoblot and quantification of Ror2 protein in intestines of Wnt5a+/+, Wnt5a+/- and 
Wnt5a-/- 17.5 dpc embryos, corrected for corresponding tubulin levels and averaged.
Supplementary figure 5. Wnt5a downregulates Ror2 protein in HEK293T and MEF 
cells in vitro. 
(A) Ror2 immunoblot of HEK293T cells stimulated with control, Wnt5a or Wnt3a conditioned medium 
for indicated durations. Endogenous Ror2 protein levels are clearly reduced following Wnt5a 
stimulation but not in response to control or Wnt3a conditioned medium. Graph shows quantification 
of corresponding individual lanes. (B) Ror2 immunoblot of MEF lines of hnRNP-rtTA and TetO-
Wnt5a;hnRNP-rtTA genotypes with/without dox induction, next to a hnRNP-rtTA MEF line stimulated 
exogenously with control or Wnt5a conditioned medium. Dox induction in TetO-Wnt5a;hnRNP-rtTA 
lines and exogenous Wnt5a stimulation on hnRNP-rtTA cells reduce endogenous Ror2 protein levels. 
Graph shows quantification of corresponding individual lanes.
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Supplementary materials and methods
Table I Antibodies immunoblotting
Primary antibodies
Antibody Dilution Company
Goat-anti-Wnt5a 1:500 R&D
Mouse-anti-Ror2 1:200 gift R. Nusse (DSHB)
Rabbit-anti-Tubulin
Rabbit-anti-Dvl2
Rabbit-anti-phospho-SAPK/JNK
Mouse-anti-Actin
1:10000
1:200
1:500
1:2500
Abcam
Santa Cruz
Cell Signaling
Santa Cruz
Secondary antibodies
Rabbit-anti-goat-HRP 1:10000 DAKO
Goat-anti-mouse IgG IRDye 680 1:5000 Westburg
Goat-anti-rabbit IgG IRDye 800CW 1:5000 Westburg
Donkey-anti-goat IgG IRDye 680 1:5000 Westburg
Table II Antibodies and antigen retrievals immunohistochemistry
Primary antibodies 
Antibody Dilution Company                   Antigen retrieval
Goat-anti-Wnt5a
Mouse-anti-Ror2
Mouse-anti-E-cadherin
1:200
1:200-1:1000
1:1000
R&D
DSHB (gift R. Nusse)
BD Transduction Lab.   
Citrate pH6
TE pH9
Citrate pH6
Rabbit-anti-β-catenin 1247-1 1:2000 Epitomics TE pH9
Rabbit-anti-lysozyme
Mouse-anti-SMA
1:12500
1:250
Dako
Dako
5’ 0.1% Pronase
Citrate pH6
Mouse-anti-Cdx2
Rabbit-anti-Mucin2
Rabbit-anti-phosphoHistone H3
1:20
1:400
1:800
Biogenex                           
Santa Cruz Biotechn.     
Upstate                             
TE pH9
TE pH9
TE pH9
Rabbit-anti-Synaptophysin 1:250-1:750 Dako                              Citrate pH6
Secondary antibodies 
HRP-conjugated goat-anti-mouse IgG (EnVisionTM) n/a Dako
HRP-conjugated goat-anti-rabbit IgG (EnVisionTM) n/a Dako
HRP-conjugated goat-anti-rat
HRP-conjugated rabbit-anti-goat
1:250
1:250
Jackson Immuno Research
Dako
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Table III Primers quantitative PCR
Wnt5a F   5’cctatgagagcgcacgcatc 3’
Wnt5a R  5’ggagccagacactccatgac 3’
Ror2 F  5’gaaggcccgtggtgctttac 3’
Ror2 R  5’cccatcttgctgccatctcg 3’
Actb F  5’agacctctatgccaacacag 3’
Actb R  5’cacagagtacttgcgctcag 3’
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Discussion
The overall aims of the research described in this thesis were to investigate 
in more detail the role of Sox2 in establishing and maintaining organ identity in 
the digestive tract, together with the examination of ectopic Sox2 expression in 
human diseases of the intestinal tract, such as colorectal cancer and various 
congenital anomalies. 
The results of these studies indicate that ectopic expression of Sox2 
in the developing intestinal epithelium of the mouse causes an anteriorization 
event of the intestinal epithelium, leading to a gastric-like phenotype. This effect 
is however not observed in the mature intestinal tract, suggesting that mature 
intestinal cells have a lower plasticity. In the mature intestinal epithelium, ectopic 
expression of Sox2 appears to drive the intestinal cells into a more progenitor-like 
phenotype. Our findings are of interest in light of human diseases in which ectopic 
gastric tissue is seen in the intestine, such as Meckel’s diverticulum, intestinal 
duplications and duodenitis. It gives valuable information about the possible 
aetiology of these diseases and it may provide a new platform for therapeutic 
strategies. 
The developing and mature intestinal tract show different degrees of 
plasticity towards gastric conversion 
One of the earliest steps in patterning the primitive gut is the regionalization 
into an anterior and posterior domain, which correlates with the expression of 
Sox2 and Cdx2, respectively. Later in development Cdx2 becomes restricted 
to the intestinal epithelium with a sharp boundary, marking the transition from 
stomach to duodenum, while Sox2 is expressed in the stomach and esophagus1-4. 
This apparent reciprocal expression pattern of Sox2 and Cdx2 suggest that these 
factors influence each other. However, it remains unclear whether Sox2 or Cdx2 
has a dominant role in determining the fate of the developing gut endoderm.
We used the mouse line described in Chapter 2 to specifically induce Sox2 
expression in the presumptive intestinal tract during development. The results of 
this study are described in Chapter 3 of this thesis. The findings provide strong 
evidence that expression of Sox2 in the developing gut drives the activation of 
the foregut transcriptional program and leads to conversion from an intestinal into 
a premature gastric-like epithelium, despite simultaneous expression of Cdx2. 
In the mature intestinal tract this effect is not observed (Chapter 4), but instead 
we show that ectopic expression of Sox2 in the mature intestinal tract drives 
cells into a more progenitor-like state, as aberrantly localized proliferating cells 
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were observed in the villus compartment. Similar observations were made when 
Cdx2 was ablated in the developing and mature intestinal tract. When ablated 
in the developing intestinal tract, this led to a rapid conversion into gastric-like 
epithelium, whereas Cdx2 deletion in the mature tract fails to reproduce this 
phenotype5-7. 
We conclude that the developing and mature intestinal tracts differ in 
their plasticity towards gastric conversion, following modulation of Sox2 or Cdx2 
expression during each time frame. This difference in plasticity might be caused 
by the fact that the mature intestine has more specialized and dedicated niches 
for the stem cells when compared with the developing gut. In this respect, there 
may be two important mechanisms restricting the plasticity of the mature intestinal 
tract. First, one of the main players involved in enforcing stem cell features in the 
adult gut is the Wnt/β-catenin signalling pathway8. Ablation of β-catenin or its 
down-stream effector Tcf4 specifically in the adult intestinal tract, results in the 
rapid loss of stem cells and crypt structures9-10. Surprisingly, the role of β-catenin 
signalling in the developing gut appears to be less important, as active β-catenin 
signalling is only detectable in prospective crypt cells postnatally11. As such, 
the increased activity of this pathway in adults to enforce intestinal identity may 
reduce the possibilities for gastric conversion by factors like Sox2. Secondly, it 
has been reported that the intestinal stem cell niche is supported by the Paneth 
cells, which reside at the base of the crypts. These Paneth cells secrete various 
growth factors that strongly support stem cell maintenance12. As these cells are 
functional from birth onwards, their presence may further reduce plasticity of the 
mature intestinal tract.
The outcome of ectopic Sox2 expression will also be determined by the 
expression levels of both ectopic Sox2 and endogenous Cdx2. It has been shown 
that Sox2 has dose-dependent effects in development. For example, normal 
expression levels of Sox2 cause the future esophagus and anterior stomach to 
form into a stratified squamous epithelium, whereas in mice with lower levels 
of expression the formation of a more pseudo-stratified, columnar epithelium 
occurred13. Cdx2 on the other hand has varying expression levels along the 
anterior- posterior axis of the mature gut, with its peak expression in the colon2. 
At sites where Cdx2 expression is relatively low during development, the effect of 
ectopic Sox2 may be more pronounced. Alternatively, it may be that the reduced 
plasticity of the mature intestinal tract is related to other factors such as the 
presence of Paneth cells and the dominant influence of β-catenin signalling. 
In contrast to the intestine, where the proliferative zone is restricted to the 
crypt compartment, the dividing stem cell progeny of the stomach is located more 
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apically, at the isthmus of the gastric pits14. The expanded proliferative zone and 
the aberrant localization of proliferating cells at the tip of the villi might suggest 
a partial conversion of the mature intestinal epithelium to a stomach like nature. 
We may investigate this hypothesis of delayed conversion by administrating 
suboptimal dosages of doxycycline, which would allow these animals to survive 
for a longer period, thereby possibly leading to the formation of gastric tissue in 
the intestine. 
In support of the latter, a similar approach was taken by the group of 
Hryniuk et al., who deleted Cdx2 throughout the complete intestinal epithelium6. 
They described an acute effect following full ablation of Cdx2, and a long-term 
effect of Cdx2 in only a part of the intestinal epithelium. Acute deletion of Cdx2 
caused diarrhea and rapid wasting of the animals within a week, symptoms we 
also observed by ectopic expression of Sox2 in the intestine. In addition, the 
morphology of the villi was dramatically affected in the Cdx2 knock-out mice. 
Furthermore, deletion of Cdx2 caused loss of enterocytes and to a lesser extent 
loss of enteroendocrine and Paneth cells. Within this one week time frame, no 
evidence for gastric conversion was observed. On the other hand, long-term 
deletion of Cdx2 in only a subset of the crypt-villus structures resulted in the 
formation of patches of metaplasia, which were devoid of the four main intestinal 
cells, but instead expressed the gastric parietal cell marker H+/K+ ATPase, as 
well as other stomach-related genes. Using a similar approach, Stringer et al. also 
reported a partial conversion towards gastric epithelium after 19 weeks follow-
up7. These results indicate that longer time of Sox2 induction in the intestinal 
epithelium likewise could cause conversion into stomach cells.
The reason for the different effects of acute and chronic Cdx2 loss might 
also lie in the crypt compartment, where the stem cells reside. In contrast to the 
acute loss of Cdx2, chronic loss of Cdx2 caused the formation of aberrant crypt-
villus structures. These structures apparently consist of a stem cell population that 
is independent of the niche containing Paneth cells. The small intestine contains 
both cycling and quiescent stem cells, which are responsible for tissue renewal 
and the regenerative response after injury, respectively. In the small intestine 
four to six stem cells reside in the crypt15. The crypt base columnar (CBC) cells, 
interspersed between Paneth cells, represent the cycling population of stem cells, 
which are distributed throughout the intestine, and are marked by the G protein-
coupled protein Lgr516-17. The quiescent stem cells on the other hand are marked 
by the Polycomb group protein Bmi1, and are located at the +4 cell position 
immediately after the uppermost Paneth cells in the crypts of the proximal small 
intestine18. It might be that chronic Cdx2 ablation induced a situation of injury, 
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inducing the quiescent stem cells to become activated. In a similar way long-term 
ectopic expression of Sox2 might induce a situation of injury, which would lead to 
the activation of the quiescent stem cells, leading to different effects of acute and 
chronic expression of Sox2. We observed the formation of crypt-like structures 
in the mature intestinal tract and it is plausible that long-term expression of Sox2 
in the intestinal tract, results in the formation of metaplasia and conversion into a 
gastric phenotype.
Ectopic Sox2 expression in the intestinal tract and progenitor identity 
We demonstrated that ectopic expression of Sox2 in the presumptive 
intestinal epithelium of the developing mouse embryo activated the foregut 
transcriptional program, causing conversion from an intestinal into a premature 
gastric epithelium, despite simultaneous expression of Cdx2. In addition to the 
gastric differentiation, we also observed a high proportion of cells that were actively 
dividing, suggesting that the ectopic Sox2 induced a progenitor-like phenotype 
in a substantial proportion of the cells. This also appears to be the case in the 
mature intestinal tract, based on the aberrantly positioned proliferating cells and 
the appearance of apparently crypt-like structures in the villi.
Our data that Sox2 might impose progenitor identity within the gut is in 
concordance with current literature 19-22. Sox2 is one of the transcription factors 
shown to be necessary to preserve pluripotency of embryonic stem cells and 
self-renewal of tissue-specific adult stem cells, together with Oct 3/4, N-Myc and 
Nanog23-24. Null mutations of each of these genes result in embryonic lethality 
due to the inability to maintain pluripotent cells. Additionally, it was demonstrated 
that reduction of Sox2 expression in mouse embryonic stem cells induced 
differentiation into trophoectoderm, strongly indicating that Sox2 function is 
critical for the maintenance of pluripotency25-27. In cooperation with Oct4, N-Myc 
and Klf4, Sox2 is capable to induce pluripotent stem cell-like properties in 
terminally differentiated somatic cells, the so-called iPS cells23-24. Furthermore, 
sustained expression of SOX2 in the neural progenitors of the vertebrate nervous 
system, inhibits neural differentiation and leads to the maintenance of progenitor 
characteristics, while inhibition of SOX2 results in the early onset of neuronal 
differentiation21. As such, our work seems to provide another example which 
shows that Sox2 is associated with progenitor identity. 
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Ectopic expression of Sox2 in the intestinal epithelium causes 
conversion into gastric-like cells rather than an esophageal phenotype.
Although Sox2 is expressed both in the esophagus and stomach, it is 
interesting that ectopic expression of Sox2 in the intestinal epithelium, results in 
conversion specifically into cells with gastric characteristics, rather than towards 
an esophageal phenotype. A possible explanation may be the specific epithelium-
type and the function of these organs, relative to that of the intestine. In contrast 
to the simple columnar epithelial layer found in the stomach and intestine, the 
esophagus consists of stratified squamous epithelium, in concordance with its 
primarily transport function, compared to the secretory and absorptive function of 
the stomach and intestine. In these functions the stomach and intestine are closer 
related, and therefore conversion from intestinal towards stomach-like epithelium 
is more likely to occur, and may require less alterations of their transcriptional 
program.
Furthermore, Sox2 alone may not be capable of fully anteriorizing the 
intestine in the absence or presence of other regulatory signals. For example, 
it has been shown that bile inhibits the squamous differentiation program of 
esophageal epithelial cells28. Bile acids are made in the liver, stored in the gall 
bladder and then secreted into the intestine. The influence of bile therefore might 
inhibit the formation of an esophageal phenotype, upon ectopic expression of 
Sox2 in the intestinal tract. 
Ectopic expression of SOX2 in human congenital anomalies of the 
intestine.
Since little was known about the aetiology of intestinal congenital 
anomalies in human, we examined the expression pattern of the transcription 
factors SOX2 and CDX2 in cases of intestinal duplication, persistent 
omphalomesenteric duct and Meckel’s diverticulum, described in Chapter 5. In all 
three congenital anomalies of the intestine the presence of gastric or gastric-like 
cells in the affected intestinal tissue had been described previously. In general, 
we found a reciprocal expression pattern of CDX2 and SOX2 in the intestine and 
gastric tissue, respectively. Interestingly, we observed however three cases that 
co-expressed CDX2 in the ectopic gastric type heteroplasia, suggesting that the 
primary reason for the appearance of gastric tissue is not just the lack of CDX2, 
as was proposed by Martin et al29, but rather the ectopic expression of SOX2, as 
we showed in our study in mice.
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Sherwood et al described that during mouse development, Sox2 and 
Cdx2 are expressed from the anterior and posterior endoderm, respectively. 
They however pointed out a phase at E8.75-E9.25 when cells at the cellular 
border of stomach and intestine co-express both transcription factors. At E9.5 the 
cellular border remains, but the cells exclusively express either Sox2 or Cdx24. 
This phase of embryonic development coincides with the timing of involution of 
the omphalomesenteric duct, i.e. the temporary connection between the midgut 
endoderm and the yolk sac. These observations could be of value to understand 
the expression pattern we observed in the congenital anomalies in human. 
Our data show that in pathological situations apparently cells are present that 
express both SOX2 and CDX2. These cells might represent descendants from 
the population of cells described above, which co-express both factors during a 
short phase of intestinal development, at the same time when involution of the 
omphalomesenteric duct takes place. These cells are able to form either intestinal 
or gastric epithelium. Timing, spacing, cues from the surrounding mesenchyme 
and the expression level of both transcription factors relative to each other might 
induce the choice towards either gastric or intestinal tissue. Extrapolating our 
mouse data to our findings in the human congenital anomalies, we could say that 
in cases where cells express both SOX2 and CDX2 in an intestinal background, 
SOX2 is dominant over CDX2 and will lead to a conversion of this cell towards a 
gastric like cell.
The fact that in humans the ectopic gastric tissue is present only in 
patches, while in mice we induce a gastric-like phenotype throughout the whole 
small intestine, might be caused by the fact that in the human situation a limited 
amount of cells are present, which express both factors. This is in contrast to the 
situation in the mouse model in which we ectopically expressed Sox2 throughout 
the whole intestinal epithelium. It is worth mentioning that the dominance of either 
Sox2 or Cdx2 is dependent on the tissue it is expressed in. We showed that ectopic 
expression of Sox2 in the intestinal epithelium caused differentiation towards 
a gastric phenotype. On the other hand, when Cdx2 is ectopically expressed 
in the mouse stomach, it causes a transformation towards intestinal mucosa, 
while retaining Sox2 expression30-31. A possible explanation is that the relative 
amount of expression of each transcription factor is critical for determining in 
which direction a cell will differentiate. For example, when Sox2 is relative lowly 
expressed and ectopic Cdx2 expression is abundant, then Cdx2 is more likely to 
overrule the effects of Sox2 and drive cell fate towards intestinal differentiation. 
In support of this, intestinal metaplasia is predominantly found in the antrum and 
the proximal lesser curvature of the stomach, where Sox2 is expressed at lower 
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levels than in other parts of the stomach, and ectopic Cdx2 is more likely to 
induce the formation of intestinal metaplasia31-32.
Sox2 expression in human colorectal cancer
In chapter 6 we showed that SOX2 was ectopically expressed in non-
mucinous CRC, in contrast to a previous study, which suggested that SOX2 
expression was associated with mucinous differentiation33. In addition, we show 
in concordance with our mouse and human congenital anomaly data, that also in 
human CRC, cells exist that co-express SOX2 and CDX2. Whereas in the normal 
intestinal epithelium ectopic SOX2 may contribute to gastric conversion, we do not 
believe this to be the case in the colorectal cancer cells, despite the expression of 
the gastric mucin MUC5AC that is observed in a large proportion of CRCs. First 
of all, aberrant MUC5AC expression is independent of SOX2 (chapter 6), and is 
more likely the result of hyperactivation of the mucin gene cluster in which both 
MUC5AC and the intestinal mucin MUC2 are located. Secondly, to the best of our 
knowledge the emergence of gastric cell types have not been reported in CRC.    
We showed different effects of SOX2 on patient survival in the two 
groups that were tested. In our first test group, we showed that ectopic Sox2 
was associated with a significantly shorter survival, which is in accordance with 
some recent publications34-36. However, our second test group did not show this 
association, most likely because the predictive value of the second group is 
currently too low. Based on studies done in other cancer types, it would however be 
plausible that SOX2 is involved in inducing a more aggressive kind of tumors37-38. 
For example, it has been shown that overexpression of SOX2 is associated with a 
worse survival in lung and esophageal squamous cell carcinomas by supporting 
proliferation and anchorage independent growth[ref38]. For prostate cancer, 
SOX2 expression levels was shown to correlate with advanced histological 
grade and to reduce sensitivity to apoptotic stimuli[ref 40], whereas in melanoma 
SOX2 appears to enhance invasion[ref 39]. Although we did not observe SOX2 
specifically at invasive fronts in the CRCs we tested, it remains however possible 
that ectopic expression of SOX2 induces characteristics of stemness and allows 
cells to migrate and differentiate beyond their natural niche. A possible way to 
test the migration capacity of CRC cells upon SOX2 expression is to ectopically 
express SOX2 in a human CRC cell line and perform a migration assay. 
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Clinical relevance and future perspectives
In regenerative medicine, knowledge about factors that are able to 
determine cell fate is of great relevance. During the past years great effort has 
been made to characterize the intestinal stem cell 16 18 and to culture these 
stem cells in vitro39, with eventually the goal to be able to regenerate tissue that 
might be used for transplantation in patients with intestinal diseases. It would 
be convenient to be able to generate from stem cells from the intestine, also 
other tissues for instance stomach, by adding or removing factors. It would be 
interesting to see whether cultured organoids from intestinal stem cells are able 
to convert into stomach cells upon Sox2 induction. These cells could then be 
cultured into functional stomach cells and used for transplantations. The big 
advantage would be that these intestinal stem cells, which are present in great 
amounts in the human intestinal tract, might be easily accessible and used as 
basic cells to create different tissues. Furthermore, problems concerning rejection 
of donor material, might be overcome when tissue is made from cells from the 
patients own body.
In this thesis we have investigated in more detail the role of Sox2 in 
establishing organ identity. In addition, we have investigated the possible role of 
Sox2 in colorectal tumor formation and progression. The outcome of our research 
adds more insight in the transcriptional regulation underlying the development of 
the gastro-intestinal tract. Furthermore, our data improve our understanding of the 
mechanisms behind metaplasia and provides possibilities for future therapeutic 
applications within the regenerative medicine field.
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Summary
Various molecular factors have been identified which play an essential 
role in the formation of organs of the digestive tract, including the transcription 
factors Sox2 and Cdx2. In the digestive tract, Sox2 expression is restricted to the 
stomach and esophagus, while Cdx2 is exclusively expressed in the intestine. 
Normally, the expression of these transcription factors is mutually exclusive. 
Once formed, organ identity is strongly maintained and rarely converted into 
another tissue type. However, in various diseases ectopic gut tissue arises 
outside its organ boundaries, including Barrett’s esophagus, intestinal metaplasia 
in the stomach and gastric heteroplasia in the intestinal tract. The mechanisms 
underlying the formation of this ectopic tissue are not fully understood. 
In chapter 1 we give a general introduction about the organization and 
function of the gastro-intestinal tract, together with a description of the relevant 
transcriptional regulators, i.e. SOX2 and CDX2.  In mice, conditional ablation 
of Cdx2 from the developing gut endoderm results in severe malformation of 
the intestinal tract and anteriorization of the posterior gut. Interestingly, this 
anteriorization coincided with ectopic expression of Sox2, indicating that Cdx2 
and Sox2 influence each other. Therefore, we investigated the role of the 
transcription factor Sox2 in establishing and maintaining organ identity, together 
with the examination of ectopic Sox2 expression in various human diseases 
of the intestinal tract, such as colorectal cancer (CRC) and various congenital 
anomalies. 
Chapter 2 describes the newly generated Villin-rtTA mouse model that 
we used in our studies for the ectopic induction of Sox2 in the intestinal tract. In 
chapter 3 we have used this villin-rtTA transgenic mouse line to demonstrate 
that ectopic expression of Sox2 in the presumptive intestinal epithelium of 
the developing mouse embryo activated the foregut transcriptional program, 
causing conversion from an intestinal to a premature gastric epithelium, despite 
simultaneous expression of Cdx2. These results indicate that ectopic expression 
of Sox2 in an intestinal background has a dominant effect over Cdx2. 
In order to investigate whether the mature intestinal tract still possesses 
a degree of plasticity, which would allow conversion of committed intestinal cells 
to transform into cells which have gastric characteristics, we also induced Sox2 
expression in the mature intestinal epithelium. Our results described in Chapter 4, 
suggest that Sox2 expression by itself is not sufficient to aberrantly induce gastric 
epithelium in the adult intestinal tract, and most likely requires the simultaneous 
loss of Cdx2 functionality. Our results confirm the limited degree of plasticity of the 
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adult intestinal epithelium compared to its embryonic counterpart. Furthermore, 
we show that ectopic expression of Sox2 induces proliferation throughout the 
entire crypt-villus axis, which likely underlies the formation of aberrant crypts 
and multilayered epithelium that we observe. This phenotype is in accordance 
with the induction of pluripotency and progenitor identity that has frequently been 
attributed to Sox2.
As shown in mice, the embryonic intestinal epithelium has a certain 
degree of plasticity and ectopic expression of Sox2 results in anteriorization 
of the intestine, in spite of sustained Cdx2 expression. Contrasting the mouse 
data, in human little is known about the expression patterns and effects of SOX2 
and CDX2 in the gastro-intestinal tract. Therefore, we examined the expression 
pattern of both transcription factors in several congenital diseases of the intestine, 
in which ectopic gastric tissue can be present. The results described in chapter 
5 show that ectopic expression of SOX2 in the developing human intestinal tract 
might underlie the formation of gastric tissue. We demonstrate that in some gastric 
heteroplasia cases, CDX2 is expressed simultaneously with SOX2, suggesting 
that in human development the intestinal epithelium is also able to change its 
identity, in accordance with our mouse studies.
In recent years, SOX2 expression has been linked to tumor progression for 
various cancer types, and has also been associated with mucinous differentiation 
in colorectal cancer. In contrast to the latter, we show in chapter 6 that ectopic 
expression of SOX2 is present in non-mucinous CRC, rather than in mucinous 
CRC, and that the gastric mucin MUC5AC is expressed independently of SOX2, 
in both the tumor as well as morphological normal tissue adjacent to the tumor. 
Furthermore, we have indications that ectopic expression of Sox2 is associated 
with a worse survival of these patients. 
The canonical Wnt/β-catenin signaling pathway is well-known for its 
prominent role in regulating development and homeostasis of the intestinal tract. 
The role of the non-canonical Wnt signaling pathway on these processes is 
however far less understood. In chapter 7 of this thesis we investigated the role 
of Wnt5a induction during different time frames of embryonic gut development 
and the mature intestinal tract. Our results indicate a role for Wnt5a in intestinal 
elongation during a restricted time-frame of embryonic development, but suggest 
no impact during homeostatic postnatal stages. In contrast to Sox2, ectopic 
expression of Wnt5a during the embryonic phase does not affect intestinal identity. 
Lastly, in the general discussion (chapter 8) we discuss our findings and 
indicate their clinical relevance. Moreover, suggestions for additional experiments 
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that might contribute to our understanding of the role of Sox2 in determining and 
maintaining organ identity in the gastrointestinal tract are provided.   
Overall, we show that although the gut is committed to the intestinal 
lineage, the developing intestinal tract possesses a certain degree of plasticity, 
making it possible to change the intestinal fate, both in mice and humans. As a 
result of ectopic expression of Sox2 conversion of intestinal cells into a cell type 
found more anteriorly might underlie ectopic gastric tissue formation in several 
human diseases. Our current knowledge gives new insights in the possible 
aetiology of these diseases and provides a new base for therapeutic interventions. 
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Samenvatting
Om nutriënten op te nemen uit voedsel en vloeistoffen, heeft het lichaam 
een gespecialiseerd orgaanstelsel ontwikkeld, het spijsverteringskanaal, welke 
ondermeer de mond, slokdarm, maag en darmen omvat. Histologisch gezien 
is het maag-darmstelsel in principe een holle buis die uit vier verschillende 
lagen bestaat, waarvan de mucosa het meest gespecialiseerd is. De aanleg 
van het spijsverteringskanaal en geassocieerde organen wordt tijdens de 
ontwikkeling bepaald door een verscheidenheid aan factoren. Twee factoren 
die een centrale rol hebben in de vroege aanleg zijn de transcriptiefactoren 
Sox2 en Cdx2. Beide factoren zijn betrokken bij de zogenaamde specificatie 
van het spijsverteringskanaal, waarbij de expressie van Sox2 beperkt is tot 
de slokdarm en maag, terwijl Cdx2 exclusief tot expressie komt in de darm. 
Normaliter overlappen Cdx2 en Sox2 expressie elkaar niet in gezond weefsel. 
Wanneer het spijsverteringskanaal eenmaal is gevormd, blijft de identiteit van 
de verschillende onderdelen (slokdarm, maag, dunne darm, etc) behouden. 
Er zijn echter verschillende aandoeningen bekend, waarbij weefsel dat 
specifiek is voor een bepaald onderdeel van het spijsverteringskanaal op een 
verkeerde plaats wordt gevonden, zoals Barretts’s slokdarm (darmweefsel in 
de slokdarm), darmmetaplasie in de maag, en maagheteroplasie in de darmen. 
Het onderliggende mechanisme van de formatie van dit zogenaamde ectopisch 
weefsel is onduidelijk. 
In hoofdstuk 1 geven wij een algemene introductie betreffende de 
organisatie en functie van het maag-darmstelsel, tezamen met een beschrijving 
van de relevante transcriptiefactoren SOX2 en CDX2. In muizen leidt de inactivatie 
van Cdx2 in het ontwikkelende darmepitheel tot ernstige malformatie van het 
darmstelsel en tot anteriorisatie van het posteriore deel van de darm, dat wil 
zeggen het darmepitheel gaat sterk gelijken op het maag- en slokdarmepitheel. 
Interessant genoeg, valt deze anteriorisatie samen met ectopische expressie van 
Sox2, suggererend dat Cdx2 en Sox2 elkaar beïnvloeden. Wij hebben onderzoek 
gedaan naar de rol van de transcriptiefactor Sox2 in het ontstaan en behouden 
van orgaanidentiteit, evenals naar ectopische Sox2 expressie in verscheidene 
humane aandoeningen van het darmstelsel, zoals dikke darmkanker en 
verschillende aangeboren afwijkingen van het maag-darmstelsel.
Hoofdstuk 2 beschrijft het nieuw ontwikkelde Villin-rtTA muismodel 
die wij hebben gebruikt in onze studies om Sox2 ectopisch tot expressie te 
brengen specifiek in het darmstelsel. In dit muismodel komt het rtTA eiwit alleen 
tot expressie in het darmepitheel dankzij de darmspecifieke Villin promoter. De 
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activiteit van het rtTA eiwit als transcriptiefactor kunnen we vervolgens reguleren 
door middel van het toedienen van doxycycline aan het drinkwater. Hierdoor kan 
het rtTA eiwit binden aan het tetracycline responsive regulatory element (TRE) 
in de promoter regio van het te induceren gen, waardoor dit gen gereguleerd 
tot expressie kan komen. In hoofdstuk 3 beschrijven wij dat de geïnduceerde 
expressie van Sox2 in het epitheel van het ontwikkelende spijsverteringskanaal 
wat normaal de darm moet vormen, leidt tot de activatie van genen specifiek voor 
het maagweefsel. Het uiteindelijke resultaat is de conversie van darmepitheel 
naar een prematuur maagepitheel, ondanks dat Cdx2 tegelijk tot expressie 
komt. Deze resultaten wijzen erop dat ectopische expressie van Sox2 in een 
darmachtergrond een dominant effect heeft over Cdx2.
Om te onderzoeken of het volledig ontwikkelde darmstelsel van volwassen 
dieren dezelfde mate van plasticiteit vertoont, hebben wij ook in het volwassen 
darmepitheel Sox2 geïnduceerd. Deze resultaten, beschreven in hoofdstuk 
4, suggereren dat alleen ectopische expressie van Sox2 niet voldoende is 
om maagepitheel te induceren in het volwassen darmstelsel. Onze resultaten 
bevestigen een gelimiteerde mate van plasticiteit in het volwassen darmepitheel, 
in vergelijking tot de ontwikkelende darm in de muis embryo. Tevens tonen wij 
aan dat ectopische expressie van Sox2 in de volwassen darm leidt tot proliferatie 
in de gehele crypt-villus unit, de formatie van extra crypten en de formatie van 
meerlagig darmepitheel. Dit fenotype komt overeen met de inductie van een 
pluripotente en voorloperidentiteit, welke frequent wordt toebedeeld aan de 
expressie van Sox2. 
Verschillende studies met muismodellen, waaronder ons eigen werk 
beschreven in hoofdstuk 3, hebben aangetoond dat het embryonale darmepitheel 
een zekere mate van plasticiteit heeft. Bovendien hebben wij aangetoond dat de 
ectopische expressie van Sox2 leidt tot een anteriorisatie van de primitieve darm, 
ondanks dat Cdx2 expressie wordt behouden. In tegenstelling tot beschikbare 
muisdata, is er weinig bekend over de expressie patronen van SOX2 en CDX2 
in het humane maag-darmstelsel. Daarom hebben wij de expressiepatronen van 
beide transcriptiefactoren onderzocht in verscheidene aangeboren afwijkingen 
van de darm, waarin ectopisch maagweefsel in de darmen aanwezig kan zijn. 
De resultaten, welke zijn beschreven in hoofdstuk 5, laten zien dat in sommige 
gevallen van maagheteroplasie, CDX2 tegelijk met SOX2 tot expressie komt. 
Dit suggereert dat ook tijdens de humane ontwikkeling, het darmepitheel van 
identiteit kan veranderen, in overeenstemming met onze muisdata.
In de afgelopen jaren is de expressie van SOX2 in verband gebracht met 
tumorprogressie in verschillende soorten kanker. Bovendien is SOX2 in verband 
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gebracht met de mucineuze differentiatie van dikke darmkanker. In sterke 
tegenstelling tot de laatst genoemde observatie, beschrijven wij in hoofdstuk 
6 dat ectopische expressie van SOX2 juist in niet-mucineuze dikke darmkanker 
aanwezig is. Bovendien tonen wij aan dat de maagspecifieke mucine MUC5ac 
onafhankelijk van SOX2 tot expressie komt, in zowel de tumor als ook in het 
omliggende morfologisch normale weesfel. Daarnaast hebben wij indicaties dat 
ectopische expressie van SOX2 is geassocieerd met een slechtere overleving 
van deze patiënten.
De canonical Wnt/b-catenine  signaaltransductie route is bekend 
vanwege haar prominente rol in de regulatie van ontwikkeling en homeostase 
van het darmstelsel. De centrale speler van dit mechanisme is b-catenine. In 
de afwezigheid van een Wnt signaal, zal b-catenine worden afgebroken. Echter 
wanneer Wnt liganden hun receptoren binden, zal het degradatiecomplex 
worden geïnactiveerd en zal b-catenine niet worden afgebroken. Het zal worden 
getransporteerd naar de celkern, waar het verscheidene transcriptiefactoren 
kan binden, wat vervolgens leidt tot de activatie van verschillende doelgenen, 
welke belangrijk zijn voor de homeostase van het darmstelsel. In tegenstelling tot 
canonical Wnt/b-catenine, is er nog maar weinig bekend over de rol van de non-
canonical Wnt signaalroute in darmontwikkeling en homeostase. De non-canonical 
Wnt pathway functioneert onafhankelijk van b-catenine. De meest bestudeerde 
non-canonical wnt ligand is Wnt5a. In hoofdstuk 7 van dit proefschrift hebben 
wij het effect van Wnt5a inductie onderzocht tijdens verschillende tijdspunten van 
de embryonale darmontwikkeling en het volwassen darmstelsel. De resultaten 
wijzen op een rol voor Wnt5a in de verlenging van de darm tijdens een specifiek 
tijdspunt in de embryonale ontwikkeling, maar suggereert geen effect op het 
handhaven van de darmstructuur in het volwassen stadium. In tegenstelling 
tot Sox2, tast ectopische expressie van Wnt5a tijdens de embryonale fase de 
darmidentiteit niet aan. 
Tot slot, bediscussiëren wij in de algemene discussie (hoofdstuk 8) 
onze bevindingen en geven wij de klinische relevatie aan. Bovendien geven wij 
suggesties voor aanvullende experimenten die kunnen bijdragen aan ons begrip 
over de rol van Sox2 in het bepalen en behouden van orgaanidentiteit in het 
maag-darmstelsel.
Samenvattend tonen wij aan dat zowel in muis als mens het ontwikkelende 
darmstelsel een zekere mate van plasticiteit heeft, wat het mogelijk maakt om 
de identiteit van de darm te veranderen. Als gevolg van ectopische expressie 
van Sox2 vindt er conversie plaats van darmcellen naar cellen die meer anterior 
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worden gevonden in het maag-darmstelsel, wat mogelijk een belangrijke bijdrage 
kan leveren aan de vorming van ectopisch maagweefsel zoals die gezien wordt 
in verscheidene humane ziekten. Onze huidige kennis geeft nieuwe inzichten 
in de mogelijke etiologie van deze ziekten en geeft een nieuwe basis voor 
therapeutische interventies.
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